Download:
pdf |
pdfNational HIV Surveillance System (NHSS)
Attachment 5.
HIV Surveillance Report
Volume 26
Diagnoses of HIV Infection in the
United States and Dependent Areas, 2014
The HIV Surveillance Report is published annually by the Division of HIV/AIDS Prevention, National Center
for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC),
U.S. Department of Health and Human Services, Atlanta, Georgia.
Data are presented for diagnoses of HIV infection reported to CDC through July 2015.
The HIV Surveillance Report is not copyrighted and may be used and reproduced without permission. Citation
of the source is, however, appreciated.
Suggested citation
Centers for Disease Control and Prevention. HIV Surveillance Report, 2014; vol. 26.
http://www.cdc.gov/hiv/library/reports/surveillance/. Published November 2015. Accessed [date].
On the Web: http://www.cdc.gov/hiv/library/reports/surveillance/
Confidential information, referrals, and educational material on HIV infection
CDC-INFO
1-800-232-4636 (in English, en Español)
1-888-232-6348 (TTY)
http://www.cdc.gov/cdc-info/requestform.html
Acknowledgments
Publication of this report would not have been possible without the contributions of the state and territorial
health departments and the HIV surveillance programs that provided surveillance data to CDC.
This report was prepared by the following CDC staff and contractors: Zanetta Gant, Kristen Hess, Anna
Satcher Johnson, Xiaohong Hu, Jianmin Li, Baohua Wu, Xiuchan Guo, Hong Zhu, Yuan Liu, Marie Morgan,
Michael Friend, Mi Chen, Sridevi Wilmore, John Gerstle, Shelley Ren, Jason Price, Irene Hall, Timothy
Green, Kimberly Crenshaw, the HIV Incidence and Case Surveillance Branch, the Quantitative Sciences and
Data Management Branch, and the Prevention Communication Branch.
HIV Surveillance Report
2
Vol. 26
Contents
Contents
Commentary
5
Technical Notes
12
Tables
1a
1b
2a
2b
3a
3b
4a
4b
5a
5b
6a
6b
7a
7b
8a
8b
9
10
11
Section 1 Diagnoses of HIV Infection and Diagnoses of Infection Classified as Stage 3 (AIDS)
Diagnoses of HIV infection, by year of diagnosis and selected characteristics, 2010–2014—United States
Diagnoses of HIV infection, by year of diagnosis and selected characteristics, 2010–2014—United States and
6 dependent areas
Stage 3 (AIDS), by year of diagnosis and selected characteristics, 2010–2014 and cumulative—United States
Stage 3 (AIDS), by year of diagnosis and selected characteristics, 2010–2014 and cumulative—United States
and 6 dependent areas
Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2014—United States
Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2014—United States and
6 dependent areas
Stage 3 (AIDS), by race/ethnicity and selected characteristics, 2014—United States
Stage 3 (AIDS), by race/ethnicity and selected characteristics, 2014—United States and 6 dependent areas
Diagnoses of HIV infection, by transmission category, race/ethnicity, and selected characteristics, 2014—
United States
Diagnoses of HIV infection, by transmission category, race/ethnicity, and selected characteristics, 2014—
United States and 6 dependent areas
Stage 3 (AIDS), by transmission category, race/ethnicity, and selected characteristics, 2014—United States
Stage 3 (AIDS), by transmission category, race/ethnicity, and selected characteristics, 2014—United States and
6 dependent areas
Diagnoses of HIV infection among children aged <13 years, by race/ethnicity, 2010–2014—United States
Diagnoses of HIV infection among children aged <13 years, by race/ethnicity, 2010–2014—United States and
6 dependent areas
Stage 3 (AIDS) among children aged <13 years, by race/ethnicity, 2010–2014 and cumulative—United States
Stage 3 (AIDS) among children aged <13 years, by race/ethnicity, 2010–2014 and cumulative—United States
and 6 dependent areas
Stage 3 (AIDS) among children aged <13 years, by year of diagnosis, 1992–2014—United States and
6 dependent areas
Diagnoses of HIV infection among adult and adolescent Hispanics/Latinos, by transmission category and place
of birth, 2014—United States and 6 dependent areas
Stage 3 (AIDS) among adult and adolescent Hispanics/Latinos, by transmission category and place of birth,
2014—United States and 6 dependent areas
Section 2 Deaths and Survival after a Diagnosis of HIV Infection or Stage 3 (AIDS) Classification
12a Deaths of persons with diagnosed HIV infection, by year of death and selected characteristics, 2010–2013—
United States
12b Deaths of persons with diagnosed HIV infection, by year of death and selected characteristics, 2010–2013—
United States and 6 dependent areas
13a Deaths of persons with diagnosed HIV infection ever classified as stage 3 (AIDS), by year of death and
selected characteristics, 2010–2013 and cumulative—United States
13b Deaths of persons with diagnosed HIV infection ever classified as stage 3 (AIDS), by year of death and
selected characteristics, 2010–2013 and cumulative—United States and 6 dependent areas
HIV Surveillance Report
3
18
20
22
24
26
28
30
32
34
42
50
58
66
66
67
67
68
69
70
71
73
75
77
Vol. 26
14a Deaths of persons with diagnosed HIV infection, by race/ethnicity and selected characteristics, 2013—
United States
14b Deaths of persons with diagnosed HIV infection, by race/ethnicity and selected characteristics, 2013—
United States and 6 dependent areas
15a Deaths of persons with diagnosed HIV infection ever classified as stage 3 (AIDS), by race/ethnicity and
selected characteristics, 2013—United States
15b Deaths of persons with diagnosed HIV infection ever classified as stage 3 (AIDS), by race/ethnicity and
selected characteristics, 2013—United States and 6 dependent areas
16a Survival for more than 12, 24, and 36 months after a diagnosis of HIV infection during 2005–2010, by selected
characteristics—United States
16b Survival for more than 12, 24, and 36 months after a diagnosis of HIV infection during 2005–2010, by selected
characteristics—United States and 6 dependent areas
17a Survival for more than 12, 24, and 36 months after a stage 3 (AIDS) classification during 2005–2010, by
selected characteristics—United States
17b Survival for more than 12, 24, and 36 months after a stage 3 (AIDS) classification during 2005–2010, by
selected characteristics—United States and 6 dependent areas
18a
18b
19a
19b
20a
20b
21a
21b
22
23
24
25
26
27
79
81
83
85
87
88
89
90
Section 3 Persons Living with Diagnosed HIV Infection or with Infection Ever Classified as
Stage 3 (AIDS) (Prevalence)
Persons living with diagnosed HIV infection, by year and selected characteristics, 2010–2013—United States 91
Persons living with diagnosed HIV infection, by year and selected characteristics, 2010–2013—United States 93
and 6 dependent areas
Persons living with diagnosed HIV infection ever classified as stage 3 (AIDS), by year and selected
95
characteristics, 2010–2013—United States
Persons living with diagnosed HIV infection ever classified as stage 3 (AIDS), by year and selected
97
characteristics, 2010–2013—United States and 6 dependent areas
Persons living with diagnosed HIV infection, by race/ethnicity and selected characteristics, year-end 2013— 99
United States
Persons living with diagnosed HIV infection, by race/ethnicity and selected characteristics, year-end 2013— 101
United States and 6 dependent areas
Persons living with diagnosed HIV infection ever classified as stage 3 (AIDS), by race/ethnicity and selected 103
characteristics, year-end 2013—United States
Persons living with diagnosed HIV infection ever classified as stage 3 (AIDS), by race/ethnicity and selected 105
characteristics, year-end 2013—United States and 6 dependent areas
Section 4 Data for States and Metropolitan Statistical Areas
Diagnoses of HIV infection, by area of residence, 2014—United States and 6 dependent areas
Stage 3 (AIDS), by area of residence, 2014 and cumulative—United States and 6 dependent areas
Adults and adolescents living with diagnosed HIV infection, by race/ethnicity and area of residence, year-end
2013—United States and 6 dependent areas
Adults and adolescents living with diagnosed HIV infection ever classified as stage 3 (AIDS), by race/ethnicity
and area of residence, year-end 2013—United States and 6 dependent areas
Diagnoses of HIV infection, 2014, and persons living with diagnosed HIV infection (prevalence), year-end
2013, by metropolitan statistical area of residence—United States and Puerto Rico
Stage 3 (AIDS), 2014 and cumulative, and persons living with diagnosed HIV infection ever classified
as stage 3 (AIDS) (prevalence), year-end 2013, by metropolitan statistical area of residence—United States
and Puerto Rico
Web Addresses for Reports of State and Local HIV Surveillance
HIV Surveillance Report
4
107
108
110
112
114
118
123
Vol. 26
Commentary
DEFINITIONS AND DATA SPECIFICATIONS
The Centers for Disease Control and Prevention
(CDC) collects, analyzes, and disseminates surveillance data on HIV infection; these data are one of the
nation’s primary sources of information on HIV in the
United States. The annual surveillance report, published by the Division of HIV/AIDS Prevention
(DHAP), summarizes information about diagnosed
HIV infection in the United States and dependent
areas. HIV surveillance data are used by CDC’s public
health partners in other federal agencies, health departments, nonprofit organizations, academic institutions,
and the general public to help focus prevention efforts,
plan services, allocate resources, develop policy, and
monitor trends in HIV infection.
Estimated numbers and rates of diagnoses of HIV
infection during 2010–2014 are included from all 50
states, the District of Columbia, and 6 U.S. dependent
areas (American Samoa, Guam, the Northern Mariana
Islands, Puerto Rico, the Republic of Palau, and the
U.S. Virgin Islands).
During 2010–2014, the annual estimated number
and rate of diagnoses of HIV infection in the United
States remained stable. Estimated numbers and rates
of diagnoses of HIV infection increased in some subgroups and decreased in others. Variations in trends
among groups are expected and may be due to differences in testing behaviors, targeted HIV testing initiatives, or changes in the numbers of new HIV
infections in some subgroups.
In 2014, the HIV surveillance case definition was
revised to adapt to changes in diagnostic criteria used
by laboratories and clinicians. The laboratory criteria
for defining a confirmed case of HIV infection were
changed to accommodate multitest algorithms that do
not include previously required tests (e.g., Western
blot). New to the case definition is the inclusion of
criteria for differentiating HIV-1 and HIV-2 infections and for recognizing early HIV infection (stage
0), during which viral loads may be high enough and
CD4 T-lymphocyte counts low enough to be confused
with stage 3 (AIDS). In addition, the revised definition consolidates the staging systems for adults/adolescents and children, simplifies surveillance criteria
for opportunistic illnesses (OIs) indicative of stage 3,
and incorporates revisions of clinical criteria (i.e.,
medical record documentation) for reporting diagnoses without laboratory evidence. Because retroactive
implementation of some features (e.g., the new staging system) of the 2014 case definition would be
impractical, the following criteria were used to classify cases in this report:
• Cases diagnosed before 2014 were classified
according to the 2008 HIV case definition.
• Cases diagnosed in 2014 were classified according to the 2014 HIV case definition.
The new CD4-based criteria for stage 3 (AIDS)
among children resulted in a large increase in the number of stage 3 (AIDS) classifications among pediatric
cases diagnosed during 2014. Before implementation
of the 2014 revised case definition, an OI diagnosis
was required for a pediatric case to meet the criteria
for stage 3 classification.
The term diagnosis of HIV infection is defined as a
diagnosis of HIV infection regardless of the stage of
disease (stage 0, 1, 2, 3 [AIDS], or unknown) and
refers to all persons with a diagnosis of HIV infection.
The term HIV infection, stage 3 (AIDS), and its condensed version—stage 3 (AIDS)—refer specifically to
persons with diagnosed HIV whose infection was classified as stage 3 (AIDS) during a given year (for diagnoses) or whose infection has ever been classified as
stage 3 (AIDS) (for prevalence and deaths). For more
REPORT CHANGES
In response to requests for expanded data from our
partners, this report now includes tables that provide
additional stratifications by transmission category
and race/ethnicity. Tables 5a/b and 6a/b display data
on diagnoses of HIV infection and stage 3 (AIDS),
respectively, by transmission category and selected
characteristics for each racial/ethnic group. Tables
14a/b display data on deaths of persons with diagnosed HIV infection, by race/ethnicity and selected
characteristics; Tables 15a/b display data on deaths
of persons with diagnosed HIV infection ever classified as stage 3 (AIDS), by race/ethnicity and
selected characteristics.
HIV Surveillance Report
5
Vol. 26
information on the stages of HIV infection, please
review the Technical Notes.
The data on diagnoses of HIV infection reflect the
date of diagnosis (diagnosed by December 31, 2014;
reported to CDC as of July 31, 2015), not the date of
report to CDC. Similarly, the data specific to stage 3
(AIDS) reflect the first date the criteria for stage 3
(AIDS) were met. HIV diagnoses do not necessarily
represent new infections (incidence): some infections
may be classified as recent; others may be classified as
longstanding. Because of reporting delays, the actual
number of cases diagnosed in a given year may be
higher than the numbers of diagnoses of HIV infection
(unadjusted) presented for recent years; however, fluctuations in the numbers of diagnoses for a calendar year
typically subside after 2 to 3 years of reporting. Where
indicated, counts of diagnoses and deaths have been
statistically adjusted (estimated) to correct for delays in
reporting, but not for incomplete reporting.
•
•
HIGHLIGHTS OF ANALYSES
The statements in this section, unless otherwise indicated, are based on estimated (statistically adjusted)
data. All rates are per 100,000 population. The standard used for reporting trends in numbers and rates is
based on an increase or a decrease of 5% or more
during the specified time frame (e.g., when comparing
2010 and 2014). Exceptions to this standard were
made where numbers were small or rates were based
on small numbers.
Please read all table titles and footnotes carefully to
ensure a complete understanding of the displayed data.
•
Diagnoses of HIV Infection and Diagnoses of
Infection Classified as Stage 3 (AIDS)
Diagnoses of HIV infection
From 2010 through 2014, the annual estimated number and the rate of diagnoses of HIV infection in the
United States remained stable (Table 1a). In 2014, the
estimated rate was 13.8.
• Age group: From 2010 through 2014, the rate
for persons aged 25–29 years increased. The
rates for children (aged less than 13 years) and
persons aged 13–14, 15–19, 35–39, 40–44, 45–
49, 50–54, 55–59, and 60–64 years decreased.
The rates for persons aged 20–24, 30–34, and 65
years and older remained stable. In 2014, the
highest rate was for persons aged 25–29 years
HIV Surveillance Report
•
6
(35.8), followed by the rate for persons aged 20–
24 years (34.3).
Race/ethnicity: From 2010 through 2014, the
rates for American Indians/Alaska Natives and
Asians increased. The rates for blacks/African
Americans, Native Hawaiians/other Pacific
Islanders, and persons of multiple races
decreased. The rates for Hispanics/Latinos and
whites remained stable. In 2014, the rates were
49.4 for blacks/African Americans, 18.4 for
Hispanics/Latinos, 15.4 for persons of multiple
races, 10.6 for Native Hawaiians/other Pacific
Islanders, 9.5 for American Indians/Alaska
Natives, 6.2 for Asians, and 6.1 for whites.
Please use caution when interpreting data for
Native Hawaiians/other Pacific Islanders: the
numbers are small.
Sex: From 2010 through 2014, the rate for
female adults and adolescents decreased; the rate
for males remained stable. In 2014, males
accounted for 81% of all diagnoses of HIV infection among adults and adolescents. The rate for
male adults and adolescents was 27.4, and the
rate for females was 6.1.
Transmission category: From 2010 through
2014, among male adults and adolescents, the
annual number of diagnosed HIV infections
attributed to male-to-male sexual contact
increased. The number of infections attributed
to injection drug use, male-to-male sexual contact and injection drug use, or heterosexual contact decreased. Among female adults and
adolescents, the number of infections attributed
to injection drug use or heterosexual contact
decreased. In 2014, among male and female
adults and adolescents, the diagnosed infections
attributed to male-to-male sexual contact (70%,
including male-to-male sexual contact and
injection drug use) and those attributed to heterosexual contact (24%) accounted for approximately 94% of diagnosed HIV infections in the
United States.
Region: From 2010 through 2014, the rates of
diagnoses of HIV infection in the Northeast and
the South decreased; the rates in the Midwest
and the West remained stable. In 2014, rates
were 18.5 in the South, 14.2 in the Northeast,
11.2 in the West, and 8.2 in the Midwest.
Vol. 26
Stage 3 (AIDS)
From 2010 through 2014, the annual estimated number and the estimated rate of infections classified as
stage 3 (AIDS) in the United States decreased (Table
2a). In 2014, the estimated rate of infections classified
as stage 3 (AIDS) was 6.6.
• Age group: From 2010 through 2014, the rates
for all age groups except children (aged less than
13 years) decreased. In 2014, the highest rate
was for persons aged 45–49 years (13.7), followed by the rate for persons aged 40–44 years
(12.9). Because of the change in case definition,
the trend among children (aged less than 13
years) was not assessed.
• Race/ethnicity: From 2010 through 2014, rates
for all race/ethnicity groups decreased. In 2014,
the rates were 25.4 for blacks/African Americans,
12.6 for persons of multiple races, 7.7 for
Hispanics/Latinos, 4.0 for American Indians/
Alaska Natives, 3.5 for Native Hawaiians/other
Pacific Islanders, 2.7 for whites, and 2.1 for
Asians. Please use caution when interpreting data
for Native Hawaiians/other Pacific Islanders: the
numbers are small.
• Sex: From 2010 through 2014, the rates for male
and female adults and adolescents decreased. In
2014, males accounted for 75% of all infections
classified as stage 3 (AIDS) among adults and
adolescents. The 2014 rate for males was 12.0;
the 2014 rate for females was 3.8.
• Transmission category: From 2010 through
2014, the annual number of infections classified
as stage 3 (AIDS) among male adults and adolescents with HIV infection attributed to maleto-male sexual contact, injection drug use,
male-to-male sexual contact and injection drug
use, or heterosexual contact decreased. The
number of infections classified as stage 3
(AIDS) among female adults and adolescents
with HIV infection attributed to injection drug
use or heterosexual contact decreased.
• Region: From 2010 through 2014, the rates of
infections classified as stage 3 (AIDS) in the 4
regions of the United States decreased. In 2014,
rates were 9.2 in the South, 6.8 in the Northeast,
4.7 in the West, and 3.9 in the Midwest.
HIV Surveillance Report
Deaths
Deaths of persons with diagnosed HIV infection
From 2010 through 2013 in the United States, the
annual estimated number and rate of deaths of persons
with diagnosed HIV infection decreased (Table 12a).
In 2013, the estimated rate of deaths of persons with
diagnosed HIV infection was 5.1. Deaths of persons
with diagnosed HIV infection may be due to any cause
(i.e., may or may not be related to HIV infection).
• Age group: From 2010 through 2013, the rate of
deaths for persons aged 65 years and older
increased. The rates of deaths for persons aged
15–19, 20–24, 30–34, 35–39, 40–44, 45–49, and
50–54 years decreased. The rates for children
(aged less than 13 years at death) and persons
aged 13–14, 25–29, 55–59, and 60–64 years
remained stable.
• Race/ethnicity: From 2010 through 2013, the
rates of deaths for all race/ethnicity groups
decreased: American Indians/Alaska Natives,
Asians, blacks/African Americans, Hispanics/
Latinos, Native Hawaiians/other Pacific Islanders,
whites, and persons of multiple races. In 2013, the
highest rate of deaths was for blacks/African
Americans: 19.4. Please use caution when interpreting data for Native Hawaiians/other Pacific
Islanders: the numbers are small.
• Sex and transmission category: From 2010
through 2013, the rates of deaths for male and
female adults and adolescents decreased. The
number of deaths among males with diagnosed
HIV infection attributed to perinatal transmission increased. The number of deaths among
males with infection attributed to injection drug
use, male-to-male sexual contact and injection
drug use, or heterosexual contact decreased. The
number of deaths among males with diagnosed
HIV infection attributed to male-to-male sexual
contact remained stable. The number of deaths
among females with infection attributed to injection drug use or heterosexual contact decreased.
The number of deaths among female adults and
adolescents with infection attributed to perinatal
transmission remained stable. Please use caution
when interpreting trend data for persons with
infection attributed to perinatal transmission: the
numbers are small.
7
Vol. 26
deaths among females with infection attributed
to perinatal transmission remained stable. Please
use caution when interpreting data for persons
with infection attributed to perinatal transmission: the numbers are small.
• Region: From 2010 through 2013, the rates of
deaths in the 4 regions of the United States
decreased. In 2013, the rate was 6.1 in the
Northeast, 5.1 in the South, 2.7 in the West,
and 2.2 in the Midwest.
• Region: From 2010 through 2013, the rates of
deaths in the 4 regions of the United States
decreased. In 2013, the rate was 7.7 in the
Northeast, 6.4 in the South, 3.3 in the West,
and 2.8 in the Midwest.
Deaths of persons with infection ever
classified as stage 3 (AIDS)
From 2010 through 2013 in the United States, the
annual estimated number and rate of deaths of persons
with infection ever classified as stage 3 (AIDS)
decreased (Table 13a). In 2013, the estimated rate of
deaths of persons with stage 3 (AIDS) was 4.1.
Deaths of persons with stage 3 (AIDS) may be due to
any cause.
• Age group: From 2010 through 2013, the rate of
deaths among persons aged 65 years and older
increased. Rates of deaths among persons aged
15–19, 20–24, 30–34, 35–39, 40–44, 45–49, and
50–54 years decreased. Rates among children
(aged less than 13 years) and among persons
aged 13–14, 25–29, 55–59, and 60–64 years
remained stable.
• Race/ethnicity: From 2010 through 2013, the
rates of death for American Indians/Alaska
Natives, blacks/African Americans, Hispanics/
Latinos, Native Hawaiians/other Pacific
Islanders, and persons of multiple races
decreased. The rates of deaths for Asians and
whites remained stable. The highest death rate
was for blacks/African Americans: 15.3. Please
use caution when interpreting data for Native
Hawaiians/other Pacific Islanders: the numbers
are small.
• Sex and transmission category: From 2010
through 2013, the overall rates for male and
female adults and adolescents decreased. The
number of deaths among males with stage 3
(AIDS) whose HIV infection was attributed to
perinatal transmission increased. The number of
deaths among males with infection attributed to
injection drug use, male-to-male sexual contact
and injection drug use, or heterosexual contact
decreased. The number of deaths among males
with infection attributed to male-to-male sexual
contact remained stable. Among female adults
and adolescents, the number of deaths with
infection attributed to injection drug use or heterosexual contact decreased. The number of
HIV Surveillance Report
Survival
Survival after a diagnosis of HIV infection
Unadjusted data on diagnoses of HIV infection made
during 2005–2010 in the United States were used to
describe the proportions of persons surviving 12, 24,
and 36 months after a diagnosis of HIV infection
(Table 16a).
• Year of diagnosis: Survival increased with the
year of diagnosis for diagnoses made during
2005–2010, although year-to-year differences
were small.
• Age group: Survival decreased as age at diagnosis increased, particularly among persons aged
50 years and older at time of diagnosis.
• Race/ethnicity: Survival was greatest among
Native Hawaiian/other Pacific Islanders, followed by Asians, Hispanics/Latinos, whites, and
persons of multiple races. Survival was lowest
among American Indians/Alaska Natives and
blacks/African Americans.
• Transmission category: Survival was greatest
among children regardless of transmission category; survival was slightly lower among children
with diagnosed HIV infection attributed to perinatal exposure. Among adults and adolescents,
survival was greatest among males with diagnosed HIV infection attributed to male-to-male
sexual contact, females with infection attributed
to heterosexual contact, and males with infection
attributed to male-to-male sexual contact and
injection drug use. Survival was intermediate
among male adults and adolescents with infection attributed to heterosexual contact. Survival
was lowest among male and female adults and
adolescents with infection attributed to injection
drug use.
8
Vol. 26
Prevalence: Persons Living with
Diagnosed HIV Infection and
Persons Living with Infection Ever
Classified as Stage 3 (AIDS)
• Region: Survival was greatest among persons
residing in the Midwest and the West, followed
by those in the Northeast and the South.
Survival after stage 3 (AIDS) classification
Unadjusted data from diagnosed infections classified
as stage 3 (AIDS) during 2005–2010 in the United
States were used to describe persons surviving 12, 24,
and 36 months after stage 3 (AIDS) classification
(Table 17a).
• Year of diagnosis: In general, survival increased
with the year of diagnosis for diagnoses made
during 2005–2010, although year-to-year differences were small.
• Age group: In general, survival decreased as age
at diagnosis increased, particularly among persons aged 35 years and older. Survival was
greatest for persons aged 13–14 years and persons aged 15–19 years at the time of stage 3
(AIDS) classification.
• Race/ethnicity: Survival was greatest among
Native Hawaiians/other Pacific Islanders, followed by Asians, Hispanics/Latinos, persons of
multiple races, whites, blacks/African Americans,
and American Indians/Alaska Natives.
• Transmission category: Survival was greatest
among children with infection attributed to
perinatal transmission, followed by male adults
and adolescents with infection attributed to
male-to-male sexual contact. Survival was intermediate among male adults and adolescents with
infection attributed to male-to-male sexual contact and injection drug use and among male and
female adults and adolescents with infection
attributed to heterosexual contact. Survival was
lowest among male and female adults and adolescents with infection attributed to injection
drug use.
• Region: Survival was greatest among persons
residing in the West, followed by those in the
Northeast and the Midwest. Survival was lowest
in the South.
HIV Surveillance Report
Prevalence of diagnosed HIV infection
From 2010 through 2013, the estimated number of persons in the United States living with diagnosed HIV
infection increased (Table 18a). At the end of 2013, an
estimated 933,941 persons in the United States were
living with diagnosed HIV infection. The estimated
prevalence rate of diagnosed HIV infection was 295.1.
• Age group: At the end of 2013, persons aged 45–
49 and persons aged 50–54 years made up the
largest percentage of persons living with diagnosed HIV (17% each). The highest rate (754.3)
was among persons aged 45–49 years, followed by
those aged 50–54 (717.2) and those aged 40–44
(565.7). From 2010 through 2013, the largest percentage increase in rates (41%) was among persons aged 65 years and older (from 84.0 in 2010 to
118.5 in 2013).
• Race/ethnicity: At the end of 2013, the highest
rate (1,018.1) and the largest percentage (43%)
were those among blacks/African Americans.
Among the remaining race/ethnicity groups, the
rates were 523.5 for persons of multiple races,
350.8 for Hispanics/Latinos, 162.8 for Native
Hawaiians/other Pacific Islanders, 150.3 for
whites, 123.2 for American Indians/Alaska
Natives, and 70.9 for Asians.
• Sex and transmission category: At the end of
2013, the estimated rates were 547.4 for male
adults and adolescents, 167.7 for female adults
and adolescents, and 4.6 for children (aged less
than 13 years at year-end 2013). Among a total
of 705,165 males (aged 13 years and older at
year-end 2013), 70% of infections were
attributed to male-to-male sexual contact, 11% to
injection drug use, 10% to heterosexual contact,
7% to male-to-male sexual contact and injection
drug use, and 1% to perinatal transmission.
Among a total of 226,361 females (aged 13 years
and older at year-end 2013), 74% of infections
were attributed to heterosexual contact, 23% to
injection drug use, and 2% to perinatal transmission. Among a total of 2,415 children aged less
than 13 years at year-end 2013, 83% of infections were attributed to perinatal transmission.
9
Vol. 26
• Region: At year-end 2013, the prevalence rates
were 420.5 in the Northeast, 343.6 in the South,
241.2 in the West, and 165.3 in the Midwest.
• Region: At year-end 2013, the prevalence rates
were 247.9 in the Northeast, 182.3 in the South,
140.0 in the West, and 84.8 in the Midwest.
Prevalence of stage 3 (AIDS)
From 2010 through 2013, the estimated number of persons living with infection ever classified as stage 3
(AIDS) increased (Table 19a). At the end of 2013, an
estimated 516,401 persons in the United States were living with infection ever classified as stage 3 (AIDS). The
estimated prevalence rate of infections classified as
stage 3 (AIDS) was 163.2.
• Age group: At the end of 2013, the highest rate
(456.8) and the largest percentage (20%) were
those among persons aged 50–54 years, followed
by persons aged 45–49 (454.6 and 19%, respectively). From 2010 through 2013, the largest percentage increase in rates (41%) was among
persons aged 65 years and older (from 56.7 in
2010 to 79.7 in 2013).
• Race/ethnicity: At the end of 2013, the highest
rate (554.8) and the largest percentage (42%)
were those among blacks/African Americans.
Among the remaining race/ethnicity groups, the
rates were 318.5 for persons of multiple races,
205.5 for Hispanics/Latinos, 88.1 for Native
Hawaiians/other Pacific Islanders, 80.9 for
whites, 64.7 for American Indians/Alaska
Natives, and 36.9 for Asians.
• Sex and transmission category: At the end of
2013, the estimated rates were 306.0 for male
adults and adolescents, 90.4 for female adults
and adolescents, and 0.5 for children (aged less
than 13 years). Among a total of 394,124 males
(aged 13 years and older at year-end 2013), 65%
of infections were attributed to male-to-male
sexual contact, 14% to injection drug use, 12%
to heterosexual contact, 8% to male-to-male sexual contact and injection drug use, and 1% to
perinatal transmission. Among a total of 122,005
females (aged 13 years and older at year-end
2013), 71% of infections were attributed to heterosexual contact, 26% to injection drug use, and
2% to perinatal transmission. Among a total of
272 children aged less than 13 years at year-end
2013, 94% of infections were attributed to perinatal transmission.
HIV Surveillance Report
ADDITIONAL RESOURCES
The following were prepared by using HIV surveillance data:
• MMWR articles (selected): http://www.cdc.gov/
hiv/library/reports/mmwr.html
• Other surveillance reports: http://www.cdc.gov/
hiv/library/reports/surveillance/
• Public-use slides updated annually: http://www
.cdc.gov/hiv/library/slidesets/
• NCHHSTP Atlas [interactive tool for accessing
HIV/AIDS, STD, TB, and hepatitis data]:
http://www.cdc.gov/nchhstp/atlas/
SUGGESTED READINGS
CDC. Establishing a holistic framework to reduce
inequities in HIV, viral hepatitis, STDs, and tuberculosis in the United States. http://stacks.cdc.gov/
view/cdc/11585. Published October 2010. Accessed
October 15, 2015.
CDC. Estimated HIV incidence in the United States,
2007–2010. HIV Surveillance Supplemental Report
2012;17(No. 4). http://go.usa.gov/p8P4. Published
December 2012. Accessed October 15, 2015.
CDC. HIV surveillance—United States, 1981–2008.
MMWR 2011;60(21):689–693.
CDC. Monitoring selected national HIV prevention and
care objectives by using HIV surveillance data—
United States and 6 dependent areas—2013. HIV Surveillance Supplemental Report 2015;20(No. 2).
http://www.cdc.gov/hiv/library/reports/surveillance/.
Published July 2015. Accessed October 15, 2015.
CDC. Revised surveillance case definition for HIV
infection—United States, 2014. MMWR 2014;63
(RR-03):1–10.
CDC. Revised surveillance case definitions for HIV
infection among adults, adolescents, and children
aged <18 months and for HIV infection and AIDS
among children aged 18 months to <13 years—
United States, 2008. MMWR 2008;57(RR-10):1–12.
10
Vol. 26
CDC. Terms, definitions, and calculations used in CDC
HIV surveillance publications. http://www.cdc.gov/
hiv/statistics/recommendations/terms.html. Published September 2014. Accessed October 15, 2015.
CDC. Vital Signs: HIV diagnosis, care, and treatment
among persons living with HIV—United States,
2011. MMWR 2014;63(47):1113–1117.
CDC. Vital Signs: HIV infection, testing, and risk
behaviors among youths—United States. MMWR
2012;61(47):971–976.
CDC. Vital Signs: HIV prevention through care and
treatment—United States. MMWR 2011;60(47):1618–
1623.
CDC. Vital Signs: HIV testing and diagnosis among
adults—United States. MMWR 2010;59(47):1550–
1555.
Cohen SM, Gray KM, Ocfemia MC, Johnson AS,
Hall HI. The status of the National HIV Surveillance System, United States, 2013. Public Health
Rep 2014;129(4):335–341.
Hall HI, Song R, Rhodes P, et al. Estimation of HIV
incidence in the United States. JAMA 2008;300(5):
520–529.
Johnson AS, Hall HI, Hu X, Lansky A, Holtgrave DR,
Mermin J. Trends in diagnoses of HIV infection in
the United States, 2002–2011 [Research Letter].
JAMA 2014;312(4):432–434. doi:10.1001/jama
.2014.8534.
Prejean J, Song R, Hernandez A, et al. Estimated HIV
incidence in the United States, 2006–2009. PLoS
One 2011;6(8):e17502. doi:10.1371/journal.pone
.0017502.
HIV Surveillance Report
11
Vol. 26
Technical Notes
SURVEILLANCE OF HIV INFECTION
STAGES OF HIV INFECTION
This report includes case report data from 50 states,
the District of Columbia, and 6 U.S. dependent
areas (American Samoa, Guam, the Northern
Mariana Islands, Puerto Rico, the Republic of
Palau, and the U.S. Virgin Islands) in which laws or
regulations require confidential reporting to the
jurisdiction (not to CDC), by name, for adults, adolescents, and children with confirmed diagnoses of
HIV infection. After the removal of personally
identifiable information, data from these reports
were submitted to CDC. Although AIDS cases have
been reported to CDC since 1981, the implementation of HIV infection reporting has differed from
state to state. All states, the District of Columbia,
and 6 U.S. dependent areas had fully implemented
name-based HIV infection reporting by April 2008.
Please use caution when interpreting data on diagnoses of HIV infection. HIV surveillance reports
may not be representative of all persons with HIV
because not all infected persons have been (1) tested
or (2) tested at a time when the infection could be
detected and diagnosed. Also, some states offer
anonymous HIV testing; the results of anonymous
tests are not reported to the confidential name-based
HIV registries of state and local health departments.
Therefore, reports of confidential test results may not
represent all persons who tested positive for HIV
infection. In addition, testing patterns are influenced
by many factors, including the extent to which testing is routinely offered to specific groups and the
availability of, and access to, medical care and testing services. The data presented in this report provide
a minimum estimate of persons for whom HIV infection has been diagnosed and reported to the surveillance system. Finally, because surveillance practices
among jurisdictions differ, the reporting and the
updating of a person’s clinical and vital status differ
among states. The completeness of reporting of HIV
infection is estimated at more than 80% [1].
Both the 2008 and 2014 HIV case definitions were
used to classify HIV infection among adults and adolescents and among children [2, 3].
The 2008 case definition was used to classify cases
diagnosed from the beginning of the epidemic through
2013. For adults and adolescents, this definition incorporates an HIV infection staging system that includes
AIDS (HIV infection, stage 3). The 2008 stages of
HIV infection are defined as follows:
HIV Surveillance Report
• HIV infection, stage 1: No AIDS-defining condition and either CD4 count of ≥500 cells/L or
CD4 percentage of total lymphocytes of ≥29.
• HIV infection, stage 2: No AIDS-defining condition and either CD4 count of 200–499 cells/L or
CD4 percentage of total lymphocytes of 14–28.
• HIV infection, stage 3 (AIDS): Documentation
of an AIDS-defining condition or either a CD4
count of <200 cells/L or CD4 percentage of total
lymphocytes of <14. Documentation of an AIDSdefining condition supersedes a CD4 count or
percentage that would not, by itself, be the basis
for a stage 3 (AIDS) classification.
• HIV infection, stage unknown: No reported
information on AIDS-defining conditions and no
information available on CD4 count or percentage.
The 2014 case definition was used to classify cases
diagnosed in 2014. It is similar to the 2008 case definition except for the following: (1) inclusion of criteria for stage 0, (2) the inclusion of CD4 testing
criteria for stage 3 in children, and (3) changes in the
cutoffs for CD4 percentage of total lymphocytes
used for classification of stages 1 and 2 in persons
aged 6 years and older. The stages of HIV infection
in the 2014 case definition are based on age-specific
CD4+ T-lymphocyte counts or percentages of total
lymphocytes and are defined as follows:
• HIV infection, stage 0: First positive HIV test
result within 6 months after a negative HIV test
result. The stage remains stage 0 until 6 months
after the first positive test result. After 6 months,
the stage may be reclassified as 1, 2, 3, or
unknown if based on a CD4+ T-lymphocyte
12
Vol. 26
result or the diagnosis of an OI. The diagnosis of
an AIDS-defining condition or a low CD4 test
result before the 6 months have elapsed does not
change the stage from stage 0 to stage 3.
• HIV infection, stages 1, 2, and 3: Documentation of an AIDS-defining condition (excluding
stage 0 as described above) is stage 3. Otherwise,
the stage is determined by the lowest CD4 test
result [3, p 7].
• HIV infection, stage unknown: No reported
information on AIDS-defining conditions and no
information available on CD4 count or percentage.
The new CD4-based criteria for stage 3 (AIDS)
among children resulted in an increase in the number
of annual stage 3 (AIDS) classifications among pediatric cases diagnosed during 2014. Before implementation of the 2014 revised case definition, an OI
diagnosis was required for a pediatric case to meet
the criteria for stage 3 classification.
In this report, the term diagnosis of HIV infection
is defined as a diagnosis of HIV infection regardless
of the stage of disease (stage 0, 1, 2, 3 [AIDS], or
unknown) and refers to all persons with a diagnosis of
HIV infection. The term HIV infection, stage 3 (AIDS),
and its condensed version—stage 3 (AIDS)—refer
specifically to persons with diagnosed HIV whose
infection was classified as stage 3 (AIDS) during a
given year (for diagnoses) or whose infection has
ever been classified as stage 3 (AIDS) (for prevalence
and deaths).
• Section 3 (Tables 18a/b–21a/b): numbers (statistically adjusted and unadjusted) and rates
(adjusted) of prevalence (i.e., data on persons
living with diagnosed HIV infection [any stage]
and data on persons living with infection ever
classified as stage 3 [AIDS])
• Section 4 (Tables 22–27): numbers (statistically
adjusted and unadjusted) and rates (adjusted) of
diagnoses and prevalence of HIV infection (any
stage) and diagnoses and prevalence of infection
classified as stage 3 (AIDS), presented by state
and metropolitan statistical area (MSA)
Many tables in the 2014 report present data in 2 formats. Tables in the first format—labeled “a”—exclude
data from the dependent areas (American Samoa,
Guam, the Northern Mariana Islands, Puerto Rico, the
Republic of Palau, and the U.S. Virgin Islands). Tables
in the second format—labeled “b”—include data from
the dependent areas.
Please use caution when interpreting reported numbers less than 12, as well as estimated numbers and
accompanying rates and trends based on these numbers: the underlying relative standard errors are greater
than 30%, so the numbers are considered unreliable.
Diagnoses of HIV Infection and of Infection
Classified as Stage 3 (AIDS)
This report is based on diagnoses of HIV infection
that the 50 states, the District of Columbia, and 6 U.S.
dependent areas reported to CDC as of July 31, 2015.
Data from all areas are included in tables displaying
numbers (unadjusted), estimated numbers, and estimated rates of diagnoses of HIV infection and of
diagnoses of infection classified as stage 3 (AIDS), by
selected characteristics, area of residence, and MSA
(Tables 1a/b–11, 16a/b, 17a/b, 22, 23, 26, and 27).
TABULATION AND PRESENTATION OF DATA
The data in this report include information received
by CDC through July 31, 2015. The data are organized into 4 sections.
• Section 1 (Tables 1a/b–11): numbers (statistically adjusted [estimated] and unadjusted) and
rates (adjusted) of diagnoses of HIV infection
(any stage) and diagnoses of infection classified
as stage 3 (AIDS)
• Section 2 (Tables 12a/b–17a/b): numbers (statistically adjusted and unadjusted) and rates
(adjusted) of deaths and proportions (unadjusted)
of survival among persons with diagnosed HIV
infection (any stage) and persons with infection
ever classified as stage 3 (AIDS)
HIV Surveillance Report
Deaths
Persons reported to the National HIV Surveillance
System are assumed alive unless their deaths have
been reported to CDC. Death data include deaths of
persons with diagnosed HIV infection (Tables 12a/b
and 14a/b) or with infection ever classified as stage 3
(AIDS) (Tables 13a/b and 15a/b) regardless of the
cause of death. Because of delays in the reporting of
deaths, 4 years (2010–2013) of death data are displayed. The exclusion of data from the most recent
13
Vol. 26
year allowed at least 18 months for deaths to be
reported to CDC. The estimated numbers and rates
of deaths resulted from statistical adjustment for
delays in reporting. Please use caution when interpreting trend data on the estimated numbers of
deaths: the estimates for the most recent year are
most subject to uncertainty.
Survival Analyses
The Kaplan-Meier method was used to estimate the
probability of survival for 12, 24, and 36 months after
a diagnosis of HIV infection (Tables 16a/b) or after a
diagnosis of infection classified as stage 3 (AIDS)
(Tables 17a/b). To allow at least 3 years from the time
of diagnosis to deaths occurring through December
31, 2013 (reported to CDC by July 31, 2015), table
data were limited to persons whose diagnosis was
made during 2005–2010. Data for each HIV reporting
area were included in the survival tables beginning
with the first full calendar year after implementation
of code-based or name-based HIV infection reporting.
Prevalence: Persons Living with
Diagnosed HIV Infection and
Persons Living with Infection Ever
Classified as Stage 3 (AIDS)
Because of delays in the reporting of deaths, 4 years
of prevalence data are displayed. The data reflect persons living with diagnosed HIV infection, regardless
of stage of disease, (Tables 18a/b, 20a/b, 24, and 26)
and persons living with infection ever classified as
stage 3 (AIDS) (Tables 19a/b, 21a/b, 25, and 27) at
the end of a given year during 2010–2013. The exclusion of data from the most recent year allowed at least
18 months for deaths to be reported and for these
deaths to be factored into calculations of prevalence.
Age
The designation “adults and adolescents” refers to
persons aged 13 years and older; the designation
“children” refers to persons aged less than 13 years.
For presentations of data on persons living with diagnosed HIV infection (Tables 18a/b, 20a/b, and 24)
and presentations of data on persons living with infection classified as stage 3 (AIDS) (Tables 19a/b, 21a/b,
and 25), the age-group assignment (e.g., 20–24 years)
or the age designation (e.g., “adults and adolescents”)
is based on the person’s age as of December 31 of the
HIV Surveillance Report
14
specified year. For presentations of data on deaths of
persons with diagnosed HIV infection (Tables 12a/b
and 14a/b) and deaths of persons with infection classified as stage 3 (AIDS) (Tables 13a/b and 15a/b), agegroup assignment is determined by the person’s age at
the time of death. For all other tables, the age designation or the specific age-group assignment is based on
the person’s age at the time of diagnosis (HIV infection or infection classified as stage 3 [AIDS]).
Age-group designations for transmission categories
in tables displaying data on prevalence and on deaths
are based on a person’s age at the end of the specified
year or age at death, respectively. That is, the transmission categories among “adults and adolescents” in
these tables include persons who were children at the
time of diagnosis but who were aged 13 years and
older during the specified year or at death.
Sex
Sex designations in this report are based on a person’s sex at birth. Transgender is an umbrella term
that is used to identify persons whose sex assigned at
birth does not match current gender identity or
expression. Data for transgender persons are not presented in this report because information on gender
identity (a person’s internal understanding of his or
her gender or the gender with which a person identifies) is not consistently collected or documented in
the data sources used by HIV reporting jurisdictions.
HIV surveillance personnel collect this information,
when available, from sources such as case report
forms submitted by health care or HIV testing providers and medical records, or by matching with
other databases (e.g., Ryan White program data) in
the health department. In May 2012, CDC issued
guidance to state and local programs on methods for
collecting data on transgender persons and working
with transgender-specific data. However, characterization of HIV infection among transgender persons
may require supplemental data from special studies.
Race and Ethnicity
In the Federal Register [4] for October 30, 1997, the
Office of Management and Budget (OMB) announced
the Revisions to the Standards for the Classification of
Federal Data on Race and Ethnicity. Implementation by
January 1, 2003, was mandated. At a minimum, data on
the following race categories should be collected:
Vol. 26
• American Indian or Alaska Native
• Asian
• black or African American
• Native Hawaiian or other Pacific Islander
• white
Additionally, systems must be able to retain information when multiple race categories are reported. In
addition to data on race, data on 2 categories of ethnicity should be collected:
• Hispanic or Latino
• not Hispanic or Latino
The Asian or Pacific Islander category displayed in
annual surveillance reports published prior to the 2007
surveillance report was split into 2 categories:
(1) Asian and (2) Native Hawaiian or other Pacific
Islander. The Asian category (in tables where footnoted) includes the cases in Asians/Pacific Islanders
(referred to as legacy cases) that were reported before
the implementation of the new race categories in 2003
(e.g., cases of HIV infection that were diagnosed and
reported to CDC before 2003 but that progressed to
AIDS after 2003) and a small percentage of cases that
were reported after 2003 but that were reported
according to the old race category (Asian/Pacific
Islander). In tables of diagnoses of HIV infection
during 2010–2014, the Asian category does not
include Asian/Pacific Islander cases because these
cases were diagnosed after 2003 and were reported to
CDC in accordance with OMB’s Revisions to the
Standards for the Classification of Federal Data on
Race and Ethnicity [4].
This report also presents data for persons for whom
multiple race categories are reported. In this report,
persons categorized by race were not Hispanic or
Latino. The number of persons reported in each race
category may, however, include persons whose ethnicity was not reported.
Northeast: Connecticut, Maine, Massachusetts,
New Hampshire, New Jersey, New York,
Pennsylvania, Rhode Island, and Vermont
Midwest: Illinois, Indiana, Iowa, Kansas,
Michigan, Minnesota, Missouri, Nebraska, North
Dakota, Ohio, South Dakota, and Wisconsin
South: Alabama, Arkansas, Delaware, District of
Columbia, Florida, Georgia, Kentucky, Louisiana,
Maryland, Mississippi, North Carolina, Oklahoma,
South Carolina, Tennessee, Texas, Virginia, and West
Virginia
West: Alaska, Arizona, California, Colorado,
Hawaii, Idaho, Montana, Nevada, New Mexico,
Oregon, Utah, Washington, and Wyoming
U.S. dependent areas: American Samoa, Guam,
the Northern Mariana Islands, Puerto Rico, the Republic of Palau, and the U.S. Virgin Islands
Metropolitan Statistical Areas
In the Federal Register for June 28, 2010, the OMB
published revised standards for defining MSAs in federal statistical activities [5]. These standards, which
provided for the identification of MSAs in the United
States and Puerto Rico, replaced the 2000 standards.
The adoption of the new standards was effective as of
June 28, 2010. On February 28, 2013, the OMB
announced new MSA delineations based on the new
standards and Census 2010 data [6]. Tables 26 (data
on diagnosed HIV infection) and 27 (data on stage 3
[AIDS]) present numbers and rates of diagnoses and
of prevalence, by MSA, for areas with populations of
500,000 or more. The MSAs listed in these tables
were defined according to the OMB’s most recent
update (February 2013) of statistical areas [6].
Transmission Categories
Transmission category is the term for the classification of cases that summarizes a person’s possible HIV
risk factors; the summary classification results from
selecting, from the presumed hierarchical order of
probability, the 1 (single) risk factor most likely to
have been responsible for transmission. For surveillance purposes, a diagnosis of HIV infection is
counted only once in the hierarchy of transmission
categories. Persons with more than 1 reported risk
factor for HIV infection are classified in the transmission category listed first in the hierarchy. The exception is men who had sexual contact with other men
Geographic Designations
Geographic designations reflect the area of residence
at the time of diagnosis of HIV infection or at the
time of stage 3 (AIDS) classification. The 4 regions
of residence used in this report are defined by the
U.S. Census Bureau as follows:
HIV Surveillance Report
15
Vol. 26
and injected drugs; this group makes up a separate
transmission category.
Persons whose transmission category is classified as
male-to-male sexual contact include men who have
ever had sexual contact with other men (i.e., homosexual contact) and men who have ever had sexual contact
with both men and women (i.e., bisexual contact). Persons whose transmission category is classified as heterosexual contact are persons who have ever had
heterosexual contact with a person known to have,
or to be at high risk for, HIV infection (e.g., an injection drug user). The heterosexual contact category
excludes men who have ever had sexual contact with
both men and women.
Tables of prevalence data and tables of death data
include a separate transmission category of adults and
adolescents with HIV infection attributed to perinatal
transmission. The category includes persons infected
through perinatal transmission but aged 13 years and
older during the specified year or at death.
Cases of HIV infection reported without a risk factor
listed in the hierarchy of transmission categories are
classified as “no identified risk (NIR)” [7]. Cases classified as NIR include cases that are being followed up
by local health department staff; cases in persons
whose risk-factor information is missing because they
died, declined to be interviewed, or were lost to followup; and cases in persons who were interviewed or for
whom other follow-up information was available but
for whom no risk factor was identified.
Because a substantial proportion of cases of HIV
infection are reported to CDC without an identified
risk factor, multiple imputation is used to assign a
transmission category [8]. Multiple imputation is a statistical approach in which each missing transmission
category is replaced with a set of plausible values that
represent the uncertainty about the true, but missing,
value [9]. The plausible values are analyzed by using
standard procedures, and the results from these analyses are then combined to produce the final results. In
tables displaying transmission categories, multiple
imputation was used for adults and adolescents, but
not for children (because the number of cases in children is small, missing transmission categories were
not imputed).
HIV Surveillance Report
16
Reporting Delays
Reporting delays (time between diagnosis or death
and the reporting of diagnosis or death to CDC) may
differ among demographic and geographic categories;
for some, delays in reporting have been as long as
several years. The statistical adjustment of the data on
diagnoses and deaths is based on estimates of
reporting-delay distributions, which are calculated by
using a modified semiparametric life-table statistical
procedure. This procedure takes into account differences in reporting delays due to sex, race/ethnicity,
HIV transmission categories, geographic area (i.e.,
reporting city, state, or dependent area; region of residence), the size of the MSA, and the type of facility
where the diagnosis was made or death occurred [10].
The statistical adjustment of data on diagnoses takes
into consideration the information reported from the
state or dependent area where the diagnosis was
made; the statistical adjustment of data on deaths
takes into consideration the information from the state
where the death occurred. No adjustments are made
for incomplete reporting.
Rates
Rates per 100,000 population were calculated for
(1) the numbers of diagnoses of HIV infection and
the numbers of infections classified as stage 3
(AIDS), (2) the numbers of deaths of persons with
diagnosed HIV infection and deaths of persons with
infection ever classified as stage 3 (AIDS), and
(3) the numbers of persons living with diagnosed
HIV infection and persons living with infection ever
classified as stage 3 (AIDS).
The population denominators used to compute the
rates for the 50 states, the District of Columbia, and
Puerto Rico were based on the Vintage 2014 postcensal estimates file (for years 2010–2014) from the
U.S. Census Bureau [11]. The population denominators for American Samoa, Guam, the Northern
Mariana Islands, the Republic of Palau, and the U.S.
Virgin Islands were based on estimates and projections from the U.S. Census Bureau’s International
Data Base [12]. Each rate was calculated by dividing
the estimated total number of diagnoses (or deaths or
prevalence) for the calendar year by the population
for that calendar year and then multiplying the result
by 100,000. The denominators used for calculating
the rates specific to age, sex, and race/ethnicity were
Vol. 26
computed by applying the appropriate vintage estimates for age, sex, and race/ethnicity for the 50 states
and the District of Columbia [11]. The same method
was used to calculate the denominators for Puerto
Rico, with the exception of race/ethnicity estimates;
these data are not available for Puerto Rico (see next
paragraph). For the other 5 U.S. dependent areas,
estimates from the U.S. Census Bureau’s International Data Base were used for age- and sex-specific
population denominators [12].
CDC currently does not provide subpopulation
rates by race/ethnicity for the 6 U.S. dependent areas
because the U.S. Census Bureau does not collect
information from all dependent areas. Rates for
transmission categories are not provided in this
report because of the absence of denominator data
from the U.S. Census Bureau, the source of data used
for calculating all rates in this report.
7. CDC. Current Trends: Heterosexually acquired AIDS—
United States, 1993. MMWR 1994;43(9):158, Fig 3.
8. Harrison KM, Kajese T, Hall HI, Song R. Risk factor
redistribution of the national HIV/AIDS surveillance
data: an alternative approach. Public Health Rep
2008;123(5):618–627.
9. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York: John Wiley & Sons Inc; 1987.
10. Song R, Green TA. An improved approach to accounting for reporting delay in case surveillance systems. JP
J Biostat 2012;7(1):1–14.
11. U.S. Census Bureau. Population estimates [entire data
set]. http://www.census.gov/popest/data/. Updated July
1, 2014. Accessed October 15, 2015.
12. U.S. Census Bureau. International Data Base.
http://go.usa.gov/vSUj. Updated December 2013.
Accessed October 15, 2015.
REFERENCES
1. Hall HI, Song R, Gerstle JE III, Lee LM; on behalf of
HIV/AIDS Reporting System Evaluation Group.
Assessing the completeness of reporting of human
immunodeficiency virus diagnoses in 2002–2003:
capture-recapture methods. Am J Epidemiol
2006;164(4):391–397.
2. CDC. Revised surveillance case definitions for HIV
infection among adults, adolescents, and children aged
<18 months and for HIV infection and AIDS among
children aged 18 months to <13 years—United States,
2008. MMWR 2008;57(RR-10):1–12.
3. CDC. Revised surveillance case definition for HIV
infection—United States, 2014. MMWR 2014;63(RR03):1–10.
4. Office of Management and Budget. Revisions to the
standards for the classification of federal data on race
and ethnicity. Federal Register 1997;62:58781–58790.
http://go.usa.gov/vSdR. Accessed October 15, 2015.
5. Office of Management and Budget. 2010 Standards for
defining metropolitan and micropolitan statistical
areas. Federal Register 2010;75(123):37246–39052.
http://go.usa.gov/vSpG. Accessed October 15, 2015.
6. Office of Management and Budget. Revised definitions
of metropolitan statistical areas, new definitions of micropolitan statistical areas and combined statistical areas,
and guidance on uses of the delineations of these areas.
OMB Bulletin 13-01. http://go.usa.gov/vSyB. Published February 28, 2013. Accessed October 15, 2015.
HIV Surveillance Report
17
Vol. 26
HIV Surveillance Report
Table 1a. Diagnoses of HIV infection, by year of diagnosis and selected characteristics, 2010–2014—United States
2010
2011
Estimateda
No.
No.
Rate
2012
Estimateda
No.
No.
Rate
2013
Estimateda
No.
No.
Rate
2014
Estimateda
No.
No.
Rate
Estimateda
No.
No.
Rate
Age at diagnosis (yr)
<13
232
238
0.4
192
198
0.4
240
250
0.5
180
191
0.4
159
174
0.3
13–14
42
43
0.5
43
45
0.5
44
46
0.6
40
43
0.5
33
35
0.4
15–19
2,071
2,118
9.6
2,002
2,068
9.5
1,875
1,964
9.2
1,689
1,792
8.5
1,664
1,828
8.7
20–24
7,079
7,245
33.4
7,069
7,311
33.0
7,157
7,489
33.1
7,035
7,483
32.7
7,144
7,868
34.3
25–29
6,366
6,520
30.8
6,346
6,563
30.8
6,470
6,777
31.7
6,711
7,151
33.1
7,114
7,870
35.8
30–34
5,504
5,639
28.1
5,272
5,455
26.6
5,472
5,729
27.4
5,235
5,574
26.2
5,449
6,026
28.0
35–39
5,046
5,171
25.8
4,463
4,622
23.6
4,176
4,374
22.4
4,031
4,288
21.8
4,212
4,662
23.4
40–44
5,230
5,361
25.6
4,800
4,971
23.6
4,433
4,646
22.1
3,997
4,257
20.4
3,799
4,196
20.4
45–49
4,851
4,972
22.0
4,595
4,758
21.5
4,317
4,527
20.8
3,995
4,268
20.1
3,647
4,021
19.3
50–54
3,510
3,602
16.1
3,364
3,487
15.4
3,219
3,377
14.9
3,024
3,235
14.3
2,928
3,242
14.4
55–59
2,077
2,132
10.8
1,999
2,072
10.2
1,923
2,019
9.7
2,047
2,184
10.3
1,949
2,166
10.1
60–64
1,064
1,091
6.4
1,072
1,111
6.2
1,052
1,106
6.2
1,098
1,170
6.5
960
1,069
5.8
790
810
2.0
816
848
2.0
819
861
2.0
867
930
2.1
819
914
2.0
American Indian/Alaska Native
174
177
7.8
159
163
7.1
187
193
8.4
178
186
8.0
208
222
9.5
Asian
708
727
4.9
774
802
5.3
809
848
5.4
809
859
5.3
941
1,046
6.2
20,461
20,987
55.2
19,345
20,064
52.3
18,632
19,581
50.5
17,993
19,252
49.2
17,592
19,540
49.4
9,072
9,291
18.3
8,919
9,230
17.8
8,954
9,372
17.7
8,829
9,386
17.3
9,227
10,201
18.4
57
58
11.7
56
58
11.4
58
60
11.6
54
56
10.6
53
58
10.6
11,864
12,135
6.1
11,376
11,738
5.9
11,259
11,752
5.9
10,914
11,581
5.9
10,967
12,025
6.1
1,526
1,565
27.7
1,404
1,456
25.0
1,298
1,358
22.6
1,172
1,246
20.1
889
982
15.4
21,834
27,031
—
21,828
27,001
—
21,758
27,588
—
21,594
27,642
—
21,566
29,418
—
Injection drug use
1,307
2,115
—
1,080
1,819
—
916
1,642
—
874
1,575
—
809
1,590
—
Male-to-male sexual contact and
injection drug use
1,238
1,562
—
1,100
1,393
—
1,036
1,342
—
924
1,216
—
870
1,217
—
Heterosexual contactc
2,891
4,111
—
2,739
3,883
—
2,500
3,617
—
2,398
3,545
—
2,049
3,285
—
Otherd
6,771
52
—
6,245
50
—
6,491
69
—
6,163
57
—
6,891
60
—
34,041
34,871
27.9
32,992
34,146
27.0
32,701
34,259
26.9
31,953
34,034
26.4
32,185
35,571
27.4
65
18
Race/ethnicity
Black/African American
Hispanic/Latinob
Native Hawaiian/Other Pacific Islander
White
Multiple races
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Subtotal
Vol. 26
HIV Surveillance Report
Table 1a. Diagnoses of HIV infection, by year of diagnosis and selected characteristics, 2010–2014—United States (cont)
2010
2011
a
No.
Rate
No.
No.
Rate
2013
a
Estimated
Estimated
No.
2012
a
Estimated
No.
No.
Rate
2014
Estimated
No.
No.
a
Rate
Estimateda
No.
No.
Rate
Female adult or adolescent
Injection drug use
803
1,455
—
672
1,284
—
617
1,178
—
559
1,073
—
495
1,045
—
Heterosexual contactc
4,740
8,340
—
4,307
7,833
—
3,905
7,439
—
3,782
7,213
—
3,282
7,242
—
Otherd
4,046
36
—
3,870
49
—
3,734
39
—
3,475
55
—
3,756
41
—
Subtotal
9,589
9,831
7.5
8,849
9,166
6.9
8,256
8,656
6.5
7,816
8,340
6.2
7,533
8,328
6.1
181
185
—
142
147
—
168
175
—
119
127
—
115
127
—
Child (<13 yrs at diagnosis)
Perinatal
Othere
51
53
—
50
51
—
72
75
—
61
64
—
44
48
—
232
238
0.4
192
198
0.4
240
250
0.5
180
191
0.4
159
174
0.3
Northeast
8,381
8,597
15.5
7,800
8,087
14.5
7,646
8,039
14.4
7,236
7,750
13.8
7,137
7,953
14.2
Midwest
5,554
5,664
8.5
5,424
5,580
8.3
5,507
5,717
8.5
5,376
5,654
8.4
5,099
5,529
8.2
South
21,997
22,550
19.6
21,316
22,079
19.0
20,469
21,480
18.3
20,131
21,508
18.1
20,065
22,196
18.5
West
7,930
8,129
11.3
7,493
7,764
10.7
7,575
7,929
10.8
7,206
7,654
10.3
7,576
8,395
11.2
Totalf
43,862
44,940
14.5
42,033
43,510
14.0
41,197
43,165
13.7
39,949
42,566
13.4
39,877
44,073
13.8
Subtotal
Region of residence
19
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting. Rates are per 100,000 population. Rates are not calculated by transmission category
because of the lack of denominator data.
b Hispanics/Latinos can be of any race.
c Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
d Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
e Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
f Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Vol. 26
HIV Surveillance Report
Table 1b. Diagnoses of HIV infection, by year of diagnosis and selected characteristics, 2010–2014—United States and 6 dependent areas
2010
2011
Estimated
No.
No.
a
Rate
2012
Estimated
No.
No.
a
Rate
2013
Estimated
No.
No.
a
Rate
2014
Estimated
No.
No.
a
Rate
Estimateda
No.
No.
Rate
Age at diagnosis (yr)
<13
236
242
0.5
194
200
0.4
240
250
0.5
180
191
0.4
160
176
0.3
13–14
42
43
0.5
44
46
0.5
45
47
0.6
41
44
0.5
33
35
0.4
15–19
2,100
2,148
9.6
2,023
2,090
9.5
1,894
1,984
9.2
1,707
1,811
8.4
1,686
1,854
8.7
20–24
7,155
7,324
33.3
7,147
7,393
32.9
7,263
7,603
33.2
7,123
7,578
32.7
7,245
7,983
34.4
25–29
6,462
6,620
30.9
6,443
6,665
30.9
6,566
6,880
31.8
6,791
7,238
33.1
7,195
7,963
35.8
30–34
5,616
5,755
28.3
5,361
5,549
26.7
5,571
5,835
27.5
5,322
5,669
26.3
5,507
6,093
28.0
35–39
5,144
5,273
25.9
4,547
4,711
23.7
4,243
4,445
22.5
4,098
4,362
21.9
4,288
4,750
23.5
40–44
5,351
5,487
25.9
4,903
5,080
23.8
4,529
4,749
22.3
4,065
4,331
20.5
3,878
4,288
20.6
45–49
4,964
5,090
22.2
4,701
4,870
21.7
4,415
4,632
21.1
4,078
4,358
20.3
3,716
4,101
19.4
50–54
3,580
3,674
16.2
3,452
3,580
15.7
3,292
3,455
15.1
3,104
3,323
14.5
2,973
3,294
14.4
55–59
2,123
2,179
10.9
2,047
2,123
10.3
1,960
2,059
9.8
2,092
2,234
10.4
1,991
2,215
10.2
60–64
1,100
1,129
6.6
1,097
1,138
6.3
1,075
1,131
6.3
1,134
1,210
6.6
986
1,099
5.8
819
840
2.0
841
874
2.1
857
902
2.1
893
959
2.1
835
933
2.0
American Indian/Alaska Native
174
177
—
159
163
—
187
193
—
178
186
—
208
222
—
Asian
709
728
—
774
802
—
809
848
—
809
859
—
942
1,047
—
20,475
21,001
—
19,361
20,081
—
18,636
19,585
—
18,006
19,266
—
17,607
19,557
—
9,882
10,133
—
9,668
10,020
—
9,700
10,171
—
9,492
10,110
—
9,822
10,887
—
65
20
Race/ethnicity
Black/African American
Hispanic/Latinob
Native Hawaiian/Other Pacific Islander
White
Multiple races
60
61
—
57
59
—
59
61
—
54
56
—
53
58
—
11,866
12,137
—
11,377
11,739
—
11,260
11,753
—
10,917
11,584
—
10,971
12,029
—
1,526
1,565
—
1,404
1,456
—
1,299
1,360
—
1,172
1,246
—
890
983
—
Transmission category
Male adult or adolescent
Male-to-male sexual contact
22,110
27,335
—
22,085
27,291
—
22,046
27,909
—
21,868
27,956
—
21,842
29,771
—
Injection drug use
1,429
2,257
—
1,178
1,940
—
999
1,742
—
947
1,667
—
859
1,672
—
Male-to-male sexual contact and
injection drug use
1,264
1,592
—
1,116
1,412
—
1,054
1,363
—
939
1,232
—
873
1,222
—
Heterosexual contactc
3,032
4,268
—
2,875
4,038
—
2,635
3,769
—
2,514
3,680
—
2,144
3,412
—
Otherd
Subtotal
6,815
52
—
6,294
51
—
6,521
69
—
6,196
57
—
6,959
61
—
34,650
35,504
28.0
33,548
34,733
27.2
33,255
34,853
27.0
32,464
34,592
26.5
32,677
36,138
27.5
Vol. 26
HIV Surveillance Report
Table 1b. Diagnoses of HIV infection, by year of diagnosis and selected characteristics, 2010–2014—United States and 6 dependent areas (cont)
2010
2011
Estimateda
No.
No.
2012
Estimateda
Rate
No.
No.
Rate
2013
Estimateda
No.
No.
Rate
2014
Estimateda
No.
No.
Rate
Estimateda
No.
No.
Rate
Female adult or adolescent
Injection drug use
824
1,479
—
704
1,319
—
638
1,204
—
585
1,105
—
507
1,060
—
Heterosexual contactc
4,918
8,541
—
4,472
8,018
—
4,061
7,626
—
3,892
7,363
—
3,376
7,369
—
Otherd
4,064
37
—
3,882
49
—
3,756
39
—
3,507
56
—
3,773
42
—
Subtotal
9,806
10,057
7.6
9,058
9,386
7.0
8,455
8,869
6.5
7,984
8,524
6.2
7,656
8,471
6.1
184
188
—
143
148
—
168
175
—
119
127
—
116
128
—
52
54
—
51
52
—
72
75
—
61
64
—
44
48
—
236
242
0.5
194
200
0.4
240
250
0.5
180
191
0.4
160
176
0.3
8,381
8,597
15.5
7,800
8,087
14.5
7,646
8,039
14.4
7,236
7,750
13.8
7,137
7,953
14.2
Child (<13 yrs at diagnosis)
Perinatal
Othere
Subtotal
Region of residence
Northeast
Midwest
21
5,554
5,664
8.5
5,424
5,580
8.3
5,507
5,717
8.5
5,376
5,654
8.4
5,099
5,529
8.2
South
21,997
22,550
19.6
21,316
22,079
19.0
20,469
21,480
18.3
20,131
21,508
18.1
20,065
22,196
18.5
West
7,930
8,129
11.3
7,493
7,764
10.7
7,575
7,929
10.8
7,206
7,654
10.3
7,576
8,395
11.2
830
863
21.0
767
810
19.8
753
807
20.0
679
741
18.6
616
711
18.0
44,692
45,802
14.6
42,800
44,320
14.0
41,950
43,972
13.8
40,628
43,307
13.5
40,493
44,784
13.9
U.S. dependent areas
Totalf
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting. Rates are per 100,000 population. Rates by race/ethnicity are not provided because
U.S. census information for U.S. dependent areas is limited. Rates are not calculated by transmission category because of the lack of denominator data.
b Hispanics/Latinos can be of any race.
c Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
d Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
e Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
f Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Vol. 26
HIV Surveillance Report
Table 2a. Stage 3 (AIDS), by year of diagnosis and selected characteristics, 2010–2014 and cumulative—United States
2010
2011
Estimateda
No.
No.
Rate
2012
Estimateda
No.
No.
Rate
2013
Estimateda
No.
No.
Rate
2014
Estimateda
No.
No.
Rate
Estimateda
No.
No.
Rate
Cumulativeb
No.
Est. No.a
Age at diagnosis (yr)
<13c
21
21
0.0
15
15
0.0
10
10
0.0
8
8
0.0
94
104
0.2
9,561
9,588
13–14
49
50
0.6
40
42
0.5
30
31
0.4
28
30
0.4
20
22
0.3
1,462
1,477
22
15–19
451
461
2.1
426
440
2.0
349
363
1.7
401
423
2.0
207
227
1.1
8,909
9,027
20–24
1,989
2,038
9.4
1,970
2,042
9.2
1,895
1,981
8.8
2,001
2,112
9.2
1,339
1,467
6.4
51,371
51,986
25–29
2,886
2,956
14.0
2,776
2,877
13.5
2,730
2,853
13.3
2,809
2,974
13.8
2,303
2,531
11.5
141,002
142,069
30–34
3,305
3,382
16.9
3,133
3,242
15.8
3,236
3,377
16.1
2,931
3,099
14.6
2,368
2,598
12.1
224,940
226,254
35–39
3,717
3,804
18.9
3,205
3,318
16.9
2,919
3,047
15.6
2,848
3,010
15.3
2,330
2,556
12.8
243,597
245,042
40–44
4,324
4,425
21.2
3,776
3,909
18.6
3,431
3,577
17.0
3,095
3,270
15.7
2,424
2,659
12.9
204,493
205,990
45–49
4,292
4,392
19.4
3,965
4,107
18.5
3,650
3,805
17.5
3,344
3,534
16.6
2,611
2,866
13.7
139,973
141,345
50–54
3,168
3,240
14.5
2,908
3,009
13.3
2,888
3,010
13.3
2,807
2,963
13.1
2,253
2,468
10.9
83,736
84,738
55–59
1,761
1,801
9.1
1,802
1,863
9.2
1,771
1,848
8.9
1,796
1,893
8.9
1,548
1,702
7.9
46,497
47,105
60–64
936
957
5.6
906
936
5.3
991
1,033
5.8
1,031
1,087
6.0
835
913
4.9
24,762
25,078
65
742
759
1.9
721
744
1.8
722
751
1.7
769
811
1.8
713
784
1.7
20,882
21,137
116
118
5.2
103
105
4.6
94
96
4.2
91
94
4.0
90
95
4.0
3,498
3,523
Race/ethnicity
American Indian/Alaska Native
d
Asian
363
372
2.5
362
375
2.5
354
369
2.3
358
379
2.3
323
352
2.1
9,689
9,815
13,419
13,745
36.2
12,363
12,816
33.4
12,030
12,574
32.4
11,548
12,219
31.2
9,119
10,045
25.4
499,734
504,354
5,617
5,745
11.3
5,237
5,415
10.4
5,015
5,222
9.8
4,868
5,132
9.5
3,924
4,279
7.7
217,650
219,578
39
40
8.0
31
32
6.3
26
27
5.2
27
28
5.2
18
19
3.5
842
850
White
6,953
7,102
3.6
6,483
6,693
3.4
6,111
6,354
3.2
6,005
6,328
3.2
4,850
5,303
2.7
436,952
439,455
Multiple races
1,134
1,165
20.6
1,064
1,108
19.0
992
1,044
17.4
971
1,034
16.7
721
803
12.6
32,820
33,260
11,695
14,448
—
11,238
13,863
—
10,826
13,664
—
10,781
13,785
—
8,180
11,277
—
529,245
586,385
Injection drug use
1,485
2,072
—
1,240
1,773
—
1,116
1,649
—
957
1,477
—
812
1,268
—
165,386
187,372
Male-to-male sexual contact
and injection drug use
1,177
1,431
—
1,018
1,242
—
929
1,166
—
774
1,005
—
555
782
—
78,824
85,290
Heterosexual contactf
2,255
3,092
—
2,112
2,896
—
1,946
2,728
—
1,891
2,730
—
1,453
2,211
—
66,501
84,200
Black/African American
Hispanic/Latinoe
Native Hawaiian/
Other Pacific Islander
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Vol. 26
Otherg
Subtotal
4,063
118
—
3,613
127
—
3,699
117
—
3,696
133
—
3,243
85
—
107,624
11,627
20,675
21,161
16.9
19,221
19,901
15.8
18,516
19,324
15.2
18,099
19,130
14.9
14,243
15,624
12.0
947,580
954,875
HIV Surveillance Report
Table 2a. Stage 3 (AIDS), by year of diagnosis and selected characteristics, 2010–2014 and cumulative—United States (cont)
2010
2011
a
Estimated
No.
No.
Rate
2012
a
Estimated
No.
No.
Rate
2013
Estimated
No.
No.
a
Rate
2014
Estimated
No.
No.
a
Rate
Estimateda
No.
No.
Rate
Cumulativeb
No.
Est. No.a
Female adult or adolescent
Injection drug use
981
1,469
—
864
1,302
—
781
1,205
—
671
1,089
—
523
913
—
75,745
90,413
Heterosexual contactf
3,603
5,502
—
3,316
5,195
—
3,113
5,039
—
2,899
4,839
—
2,203
4,150
—
114,383
149,980
Otherg
2,361
133
—
2,227
131
—
2,202
109
—
2,191
147
—
1,982
106
—
53,916
5,979
Subtotal
6,945
7,105
5.4
6,407
6,628
5.0
6,096
6,353
4.8
5,761
6,075
4.5
4,708
5,168
3.8
244,044
246,372
15
15
—
12
12
—
8
8
—
8
8
—
83
92
—
8,690
8,715
6
6
—
3
3
—
2
2
—
0
0
—
11
12
—
871
874
21
21
0.0
15
15
0.0
10
10
0.0
8
8
0.0
94
104
0.2
9,561
9,588
Northeast
5,631
5,782
10.4
5,153
5,356
9.6
4,765
4,992
8.9
4,360
4,636
8.3
3,409
3,793
6.8
351,863
354,392
Midwest
3,365
3,431
5.1
3,248
3,341
5.0
3,106
3,215
4.8
2,952
3,087
4.6
2,431
2,627
3.9
127,677
128,670
South
13,747
14,059
12.2
12,949
13,402
11.5
12,608
13,155
11.2
12,667
13,376
11.3
10,003
10,965
9.2
483,173
487,539
West
4,898
5,016
7.0
4,293
4,445
6.1
4,143
4,325
5.9
3,889
4,115
5.5
3,202
3,511
4.7
238,472
240,235
Totali
27,641
28,287
9.1
25,643
26,545
8.5
24,622
25,687
8.2
23,868
25,214
8.0
19,045
20,896
6.6
Child (<13 yrs at diagnosis)
Perinatal
Otherh
Subtotal
Region of residence
23
1,201,185 1,210,835
Note. Reported numbers less than 12, as well as estimated numbers (and accompanying rates and trends) based on these numbers, should be interpreted with caution because the numbers have underlying relative standard errors greater than
30% and are considered unreliable.
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting. Rates are per 100,000 population. Rates are not calculated by transmission category
because of the lack of denominator data.
b From the beginning of the epidemic through 2014.
c The criteria for stage 3 (AIDS) classification among pediatric cases were expanded in 2014 (see Technical Notes).
d Includes Asian/Pacific Islander legacy cases (see Technical Notes).
e Hispanics/Latinos can be of any race.
f Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
g Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
h Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
i Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Vol. 26
HIV Surveillance Report
Table 2b. Stage 3 (AIDS), by year of diagnosis and selected characteristics, 2010–2014 and cumulative—United States and 6 dependent areas
2010
2011
a
Estimated
No.
No.
Rate
2012
a
Estimated
No.
No.
Rate
2013
a
Estimated
No.
No.
Rate
2014
a
Estimateda
Estimated
No.
No.
Rate
No.
No.
Rate
Cumulativeb
No.
Est. No.a
Age at diagnosis (yr)
24
<13c
21
21
0.0
15
15
0.0
10
10
0.0
8
8
0.0
94
104
0.2
9,986
10,014
13–14
49
50
0.6
41
43
0.5
31
32
0.4
29
31
0.4
20
22
0.3
1,520
1,536
15–19
455
465
2.1
434
449
2.0
350
364
1.7
405
427
2.0
211
233
1.1
9,147
9,268
20–24
2,007
2,056
9.3
1,986
2,059
9.2
1,914
2,001
8.7
2,025
2,138
9.2
1,353
1,485
6.4
52,793
53,421
25–29
2,919
2,990
14.0
2,810
2,913
13.5
2,762
2,887
13.3
2,838
3,005
13.7
2,321
2,555
11.5
145,224
146,317
30–34
3,356
3,435
16.9
3,179
3,290
15.8
3,276
3,419
16.1
2,974
3,145
14.6
2,400
2,641
12.1
231,855
233,212
35–39
3,791
3,880
19.1
3,277
3,393
17.1
2,973
3,103
15.7
2,899
3,064
15.4
2,375
2,615
13.0
250,834
252,332
40–44
4,416
4,520
21.3
3,847
3,983
18.7
3,502
3,651
17.1
3,151
3,330
15.7
2,474
2,726
13.1
210,319
211,872
45–49
4,399
4,502
19.6
4,060
4,205
18.7
3,731
3,890
17.7
3,418
3,614
16.8
2,659
2,928
13.8
143,924
145,345
50–54
3,240
3,314
14.7
2,989
3,093
13.5
2,947
3,072
13.4
2,874
3,034
13.3
2,293
2,520
11.0
86,093
87,132
55–59
1,802
1,843
9.2
1,834
1,896
9.2
1,810
1,889
9.0
1,841
1,942
9.0
1,583
1,749
8.0
47,907
48,541
60–64
966
988
5.7
921
952
5.3
1,011
1,054
5.8
1,056
1,114
6.1
853
938
5.0
25,555
25,886
65
762
779
1.9
753
777
1.9
752
783
1.8
791
834
1.8
728
803
1.7
21,837
22,105
American Indian/Alaska Native
116
118
—
103
105
—
94
96
—
91
94
—
90
95
—
3,499
3,524
Asiand
363
372
—
363
376
—
354
369
—
358
379
—
324
353
—
9,747
9,873
13,428
13,755
—
12,369
12,823
—
12,040
12,585
—
11,552
12,223
—
9,126
10,053
—
500,208
504,833
6,146
6,288
—
5,731
5,928
—
5,448
5,676
—
5,304
5,599
—
4,233
4,689
—
252,778
255,036
41
42
—
32
33
—
27
28
—
27
28
—
18
19
—
858
867
White
6,955
7,104
—
6,483
6,693
—
6,114
6,357
—
6,006
6,330
—
4,851
5,305
—
437,071
439,575
Multiple races
1,134
1,165
—
1,065
1,109
—
992
1,044
—
971
1,034
—
722
804
—
32,833
33,274
Race/ethnicity
Black/African American
Hispanic/Latinoe
Native Hawaiian/
Other Pacific Islander
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Vol. 26
11,811
14,570
—
11,355
13,988
—
10,946
13,792
—
10,910
13,926
—
8,266
11,394
—
535,337
592,621
Injection drug use
1,614
2,207
—
1,340
1,881
—
1,208
1,748
—
1,031
1,560
—
869
1,346
—
178,756
201,009
Male-to-male sexual contact
and injection drug use
1,205
1,460
—
1,037
1,263
—
946
1,185
—
785
1,017
—
564
794
—
81,355
87,850
Heterosexual contactf
2,354
3,196
—
2,217
3,007
—
2,019
2,807
—
1,985
2,833
—
1,516
2,301
—
70,522
88,352
Otherg
4,074
121
—
3,625
130
—
3,709
120
—
3,706
135
—
3,253
85
—
108,156
11,828
21,058
21,554
17.0
19,574
20,268
15.9
18,828
19,651
15.2
18,417
19,471
14.9
14,468
15,920
12.1
974,126
981,660
Subtotal
HIV Surveillance Report
Table 2b. Stage 3 (AIDS), by year of diagnosis and selected characteristics, 2010–2014 and cumulative—United States and 6 dependent areas (cont)
2010
2011
Estimateda
Rate
2012
Estimateda
No.
No.
Rate
2013
Estimateda
No.
No.
Rate
2014
Estimateda
No.
No.
Rate
Estimateda
No.
No.
Rate
Cumulativeb
No.
Est. No.a
No.
No.
Injection drug use
1,012
1,501
—
891
1,331
—
804
1,230
—
697
1,118
—
546
944
—
78,776
93,515
Heterosexual contactf
3,728
5,632
—
3,432
5,318
—
3,218
5,154
—
2,989
4,940
—
2,264
4,241
—
119,886
155,667
Otherg
2,364
134
—
2,234
135
—
2,209
111
—
2,198
150
—
1,992
108
—
54,220
6,125
Subtotal
7,104
7,268
5.5
6,557
6,784
5.1
6,231
6,494
4.8
5,884
6,207
4.5
4,802
5,293
3.8
252,882
255,307
15
15
—
12
12
—
8
8
—
8
8
—
83
92
—
9,089
9,115
Female adult or adolescent
Child (<13 yrs at diagnosis)
Perinatal
Otherh
Subtotal
6
6
—
3
3
—
2
2
—
0
0
—
11
12
—
897
900
21
21
0.0
15
15
0.0
10
10
0.0
8
8
0.0
94
104
0.2
9,986
10,014
5,631
5,782
10.4
5,153
5,356
9.6
4,765
4,992
8.9
4,360
4,636
8.3
3,409
3,793
6.8
351,863
354,392
Region of residence
Northeast
Midwest
25
3,365
3,431
5.1
3,248
3,341
5.0
3,106
3,215
4.8
2,952
3,087
4.6
2,431
2,627
3.9
127,677
128,670
South
13,747
14,059
12.2
12,949
13,402
11.5
12,608
13,155
11.2
12,667
13,376
11.3
10,003
10,965
9.2
483,173
487,539
West
4,898
5,016
7.0
4,293
4,445
6.1
4,143
4,325
5.9
3,889
4,115
5.5
3,202
3,511
4.7
238,472
240,235
542
556
13.5
503
523
12.8
447
469
11.6
441
473
11.9
319
422
10.7
35,809
36,146
28,183
28,844
9.2
26,146
27,067
8.6
25,069
26,156
8.2
24,309
25,687
8.0
19,364
21,318
6.6
U.S. dependent areas
Totali
1,236,994 1,246,981
Note. Reported numbers less than 12, as well as estimated numbers (and accompanying rates and trends) based on these numbers, should be interpreted with caution because the numbers have underlying relative standard errors greater than
30% and are considered unreliable.
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting. Rates are per 100,000 population. Rates by race/ethnicity are not provided because
U.S. census information for U.S. dependent areas is limited. Rates are not calculated by transmission category because of the lack of denominator data.
b From the beginning of the epidemic through 2014.
c The criteria for stage 3 (AIDS) classification among pediatric cases were expanded in 2014 (see Technical Notes).
d Includes Asian/Pacific Islander legacy cases (see Technical Notes).
e Hispanics/Latinos can be of any race.
f Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
g Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
h Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
i Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Vol. 26
HIV Surveillance Report
Table 3a. Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2014—United States
American Indian/
Alaska Native
Asian
Estimatedb
Black/African American
Estimatedb
No.
Rate
Hispanic/Latinoa
Estimatedb
No.
No.
Rate
Native Hawaiian/
Other Pacific Islander
Estimatedb
26
No.
No.
Rate
No.
No.
<13
3
3
0.7
10
11
0.4
98
108
1.5
16
13–14
0
0
0.0
3
3
0.9
17
18
1.5
15–19
8
9
4.7
20
22
2.2
1,044
1,148
20–24
37
39
19.4
141
157
12.7
25–29
46
49
27.7
171
190
30–34
32
34
21.3
163
35–39
12
13
8.8
40–44
23
25
45–49
20
50–54
No.
White
Estimatedb
Multiple races
Estimatedb
Rate
No.
No.
Rate
No.
No.
18
0.1
1
1
1.0
26
5
5
0.3
0
0
0.0
38.2
330
364
7.8
2
2
3,896
4,296 124.8
1,574
1,740
36.4
8
13.5
3,280
3,646 122.6
1,711
1,893
42.6
182
12.6
2,104
2,345
85.1
1,527
1,687
137
152
11.1
1,568
1,744
68.9
1,194
16.9
116
129
9.4
1,397
1,556
60.0
21
14.2
78
85
7.1
1,338
1,490
19
20
12.5
52
58
5.2
1,114
55–59
6
7
4.6
25
28
2.8
60–64
1
1
0.9
11
12
65
1
1
0.5
14
120
142
—
Injection drug use
9
11
Male-to-male sexual contact
and injection drug use
5
Heterosexual contactd
Total
Estimatedb
Estimatedb
No.
No.c
Rate
No.
No.
Rate
Rate
28
0.1
5
5
0.2
159
174
0.3
8
8
0.2
0
0
0.0
33
35
0.4
5.9
203
221
1.9
57
62
9.4
1,664
1,828
8.7
9
18.6
1,295
1,416
11.2
193
211
36.7
7,144
7,868
34.3
6
7
13.1
1,738
1,904
15.2
162
180
41.5
7,114
7,870
35.8
38.0
8
9
17.9
1,510
1,654
13.4
105
116
31.0
5,449
6,026
28.0
1,326
32.1
10
11
26.2
1,198
1,314
11.5
93
103
33.4
4,212
4,662
23.4
967
1,070
27.7
7
8
20.8
1,198
1,309
10.6
91
100
36.2
3,799
4,196
20.4
57.3
813
893
26.3
5
6
16.1
1,315
1,440
10.8
78
86
35.6
3,647
4,021
19.3
1,242
45.6
515
569
19.4
2
2
6.3
1,171
1,289
8.4
55
61
25.5
2,928
3,242
14.4
908
1,014
40.6
297
330
14.2
1
1
3.6
682
753
4.9
30
33
15.8
1,949
2,166
10.1
1.4
443
501
25.2
158
173
10.0
2
2
10.4
335
368
2.7
10
11
7.0
960
1,069
5.8
16
0.8
385
431
10.7
120
133
3.7
1
1
2.5
288
321
0.9
10
11
3.5
819
914
2.0
586
798
—
7,777 11,201
—
5,737
7,552
—
33
45
—
6,791
9,008
—
522
672
—
21,566 29,418
—
—
13
20
—
208
679
—
202
395
—
1
2
—
358
455
—
18
27
—
809
1,590
—
7
—
13
17
—
137
288
—
172
251
—
1
1
—
511
611
—
31
40
—
870
1,217
—
8
10
—
37
60
—
1,212
2,108
—
441
623
—
0
1
—
305
422
—
46
63
—
2,049
3,285
—
17
0
—
159
3
—
3,537
29
—
1,439
11
—
10
0
—
1,621
17
—
108
1
—
6,891
60
—
159
170
18.3
808
898
13.4
12,871 14,305
94.0
7,991
8,832
41.5
45
49
22.0
9,586 10,513
12.6
725
803
40.6
32,185 35,571
27.4
Age at diagnosis (yr)
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Othere
Subtotal
Vol. 26
HIV Surveillance Report
Table 3a. Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2014—United States (cont)
American Indian/
Alaska Native
Asian
Estimatedb
Black/African American
Estimatedb
No.
Rate
Hispanic/Latinoa
Estimatedb
No.
No.
Rate
Native Hawaiian/
Other Pacific Islander
Estimatedb
No.
No.
Rate
No.
No.
9
13
—
1
7
—
134
451
—
87
21
36
—
59
129
—
1,988
4,654
—
Other
16
0
—
63
1
—
2,501
23
Subtotal
46
49
5.1
123
137
1.8
4,623
2
2
—
9
10
—
Other
1
1
—
1
1
Subtotal
3
3
0.7
10
Northeast
10
11
8.5
Midwest
25
26
South
56
West
Totalg
No.
White
Estimatedb
Multiple races
Estimatedb
Rate
No.
No.
Rate
No.
183
—
0
1
—
247
564
1,159
—
3
7
—
—
569
9
—
4
0
5,128
30.0
1,220
1,350
6.5
7
75
83
—
12
13
—
—
23
25
—
4
4
11
0.4
98
108
1.5
16
182
205
5.8
3,055
3,385
53.6
6.6
88
97
4.8
2,467
2,677
61
7.9
210
231
6.0
10,798 12,068
117
124
11.9
461
513
7.0
208
222
9.5
941
1,046
6.2
No.
Total
Estimatedb
Estimatedb
No.
No.c
Rate
No.
No.
Rate
Rate
360
—
17
31
—
495
1,045
—
570
1,115
—
77
142
—
3,282
7,242
—
—
538
8
—
65
1
—
3,756
41
—
8
3.5
1,355
1,483
1.7
159
174
8.2
7,533
8,328
6.1
1
1
—
13
14
—
3
3
—
115
127
—
—
0
0
—
13
14
—
2
2
—
44
48
—
18
0.1
1
1
1.0
26
28
0.1
5
5
0.2
159
174
0.3
1,952
2,190
28.3
4
5
21.9
1,720
1,922
5.1
214
236
26.7
7,137
7,953
14.2
38.2
617
680
13.3
3
3
10.5
1,773
1,910
3.7
126
136
11.2
5,099
5,529
8.2
53.0
3,767
4,097
20.1
13
15
17.5
4,818
5,276
7.6
403
449
21.5
20,065 22,196
18.5
1,411
41.2
2,891
3,234
14.6
33
35
8.6
2,656
2,917
7.6
146
161
7.3
17,592 19,540
49.4
9,227 10,201
18.4
53
58
10.6
10,967 12,025
6.1
889
982
15.4
Female adult or adolescent
Injection drug use
d
Heterosexual contact
e
Child (<13 yrs at diagnosis)
Perinatal
f
Region of residence
27
1,272
7,576
8,395
11.2
39,877 44,073
13.8
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
Reported numbers less than 12, as well as estimated numbers (and accompanying rates and trends) based on these numbers, should be interpreted with caution because the numbers have underlying relative standard errors greater than 30% and
are considered unreliable.
a Hispanics/Latinos can be of any race.
b Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting. Rates are per 100,000 population. Rates are not calculated by transmission category
because of the lack of denominator data.
c Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
d Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
e
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
f
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
g Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Vol. 26
HIV Surveillance Report
Table 3b. Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2014—United States and 6 dependent areas
American Indian/
Alaska Native
No.
Est. No.b
Black/
African American
Asian
No.
Est. No.b
No.
Est. No.b
Hispanic/Latinoa
No.
Est. No.b
Native Hawaiian/
Other Pacific Islander
No.
Est. No.b
White
Multiple races
Est. No.b
No.
No.
Est. No.b
Total
No.
Est. No.b,c
Age at diagnosis (yr)
28
<13
3
3
10
11
98
108
17
19
1
1
26
28
5
5
160
176
13–14
0
0
3
3
17
18
5
5
0
0
8
8
0
0
33
35
15–19
8
9
20
22
1,045
1,150
351
388
2
2
203
221
57
62
1,686
1,854
20–24
37
39
141
157
3,896
4,296
1,674
1,854
8
9
1,296
1,418
193
211
7,245
7,983
25–29
46
49
171
190
3,281
3,648
1,790
1,984
6
7
1,739
1,905
162
180
7,195
7,963
30–34
32
34
163
182
2,106
2,347
1,582
1,750
8
9
1,511
1,655
105
116
5,507
6,093
35–39
12
13
137
152
1,569
1,745
1,269
1,412
10
11
1,198
1,314
93
103
4,288
4,750
40–44
23
25
116
129
1,398
1,557
1,045
1,161
7
8
1,198
1,309
91
100
3,878
4,288
45–49
20
21
78
85
1,339
1,491
881
971
5
6
1,315
1,440
78
86
3,716
4,101
50–54
19
20
53
59
1,118
1,247
554
614
2
2
1,172
1,290
55
61
2,973
3,294
55–59
6
7
25
28
910
1,016
336
376
1
1
682
753
31
35
1,991
2,215
60–64
1
1
11
12
444
502
183
202
2
2
335
368
10
11
986
1,099
65
1
1
14
16
386
432
135
150
1
1
288
321
10
11
835
933
120
142
587
799
7,781
11,207
6,003
7,893
33
45
6,795
9,012
523
674
21,842
29,771
Injection drug use
9
11
13
20
208
682
252
474
1
2
358
455
18
27
859
1,672
Male-to-male sexual contact
and injection drug use
5
7
13
17
137
289
175
257
1
1
511
611
31
40
873
1,222
Heterosexual contactd
8
10
37
60
1,215
2,113
533
744
0
1
305
422
46
63
2,144
3,412
17
0
159
3
3,542
29
1,502
11
10
0
1,621
17
108
1
6,959
61
159
170
809
900
12,883
14,319
8,465
9,379
45
49
9,590
10,518
726
804
32,677
36,138
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Othere
Subtotal
Vol. 26
HIV Surveillance Report
Table 3b. Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2014—United States and 6 dependent areas (cont)
American Indian/
Alaska Native
No.
Est. No.b
Black/
African American
Asian
No.
Est. No.b
No.
Est. No.b
Hispanic/Latinoa
No.
Est. No.b
Native Hawaiian/
Other Pacific Islander
No.
Est. No.b
White
Multiple races
Est. No.b
No.
No.
Est. No.b
Total
No.
Est. No.b,c
Female adult or adolescent
Injection drug use
9
13
1
7
134
451
99
198
0
1
247
360
17
31
507
1,060
21
36
59
129
1,989
4,657
657
1,282
3
7
570
1,115
77
142
3,376
7,369
Other
16
0
63
1
2,503
23
584
9
4
0
538
8
65
1
3,773
42
Subtotal
46
49
123
137
4,626
5,131
1,340
1,490
7
8
1,355
1,483
159
174
7,656
8,471
2
2
9
10
75
83
13
15
1
1
13
14
3
3
116
128
Other
1
1
1
1
23
25
4
4
0
0
13
14
2
2
44
48
Subtotal
3
3
10
11
98
108
17
19
1
1
26
28
5
5
160
176
Northeast
10
11
182
205
3,055
3,385
1,952
2,190
4
5
1,720
1,922
214
236
7,137
7,953
Midwest
25
26
88
97
2,467
2,677
617
680
3
3
1,773
1,910
126
136
5,099
5,529
South
56
61
210
231
10,798
12,068
3,767
4,097
13
15
4,818
5,276
403
449
20,065
22,196
West
117
124
461
513
1,272
1,411
2,891
3,234
33
35
2,656
2,917
146
161
7,576
8,395
0
0
1
1
15
17
595
687
0
0
4
5
1
1
616
711
208
222
942
1,047
17,607
19,557
9,822
10,887
53
58
10,971
12,029
890
983
40,493
44,784
Heterosexual contactd
e
Child (<13 yrs at diagnosis)
Perinatal
f
Region of residence
29
U.S. dependent areas
Totalg
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
Reported numbers less than 12, as well as estimated numbers (and accompanying rates and trends) based on these numbers, should be interpreted with caution because the numbers have underlying relative standard errors greater than 30% and
are considered unreliable.
a Hispanics/Latinos can be of any race.
b Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting.
c Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
d
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
e Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
f Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
Vol. 26
g
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
HIV Surveillance Report
Table 4a. Stage 3 (AIDS), by race/ethnicity and selected characteristics, 2014—United States
American Indian/
Alaska Native
Asiana
Estimatedc
Black/African American
Estimatedc
Hispanic/Latinob
Estimatedc
Native Hawaiian/
Other Pacific Islander
Estimatedc
White
Estimatedc
Multiple races
Estimatedc
Total
Estimatedc
Estimatedc
30
No.d
Rate
94
104
0.2
0.7
20
22
0.3
20
3.0
207
227
1.1
59
65
11.3
1,339
1,467
6.4
3.4
89
99
22.8
2,303
2,531 11.5
550
4.5
71
79
21.2
2,368
2,598 12.1
512
561
4.9
88
97
31.3
2,330
2,556 12.8
5.7
650
709
5.8
87
98
35.4
2,424
2,659 12.9
3
9.1
826
907
6.8
95
106
43.8
2,611
2,866 13.7
1
1
3.2
774
844
5.5
82
93
38.5
2,253
2,468 10.9
10.8
1
1
3.7
492
540
3.5
60
67
31.5
1,548
1,702
7.9
139
8.0
2
2
9.3
258
281
2.0
27
30
18.3
835
913
4.9
95
103
2.9
0
0
0.0
238
263
0.7
24
27
8.3
713
784
1.7
—
1,973
2,665
—
11
13
—
2,656
3,564
—
303
412
—
8,180 11,277
—
587
—
200
313
—
0
0
—
246
300
—
33
47
—
812
1,268
—
135
233
—
100
144
—
1
1
—
269
335
—
36
51
—
555
782
—
—
899
1,451
—
279
388
—
1
1
—
203
268
—
47
67
—
1,453
2,211
—
2
—
1,644
36
—
689
20
—
2
0
—
731
23
—
101
5
—
3,243
85
—
289
4.3
6,031
6,649 43.7
3,241
3,530
16.6
15
16
7.2
4,105
4,489
5.4
520
582
29.4
No.
No.
Rate
No.
No.
Rate
No.
No.
Rate
No.
<13
1
1
0.2
1
1
0.0
56
62
0.9
11
13–14
0
0
0.0
1
1
0.3
13
15
1.2
15–19
0
0
0.0
0
0
0.0
145
159
20–24
4
4
2.1
20
21
1.7
25–29
10
10
5.9
38
41
30–34
14
15
9.1
46
35–39
8
9
5.9
40–44
19
20
45–49
11
50–54
No.
Rate
No.
No.
Rate
No.
12
0.1
0
0
0.0
6
4
4
0.2
0
0
0.0
5.3
27
30
0.6
0
0
798
878 25.5
274
299
6.3
0
2.9
1,240
1,372 46.1
534
582
13.1
50
3.5
1,130
1,245 45.2
600
653
57
63
4.6
1,036
1,140 45.0
626
13.7
58
64
4.6
1,073
1,182 45.6
12
7.9
53
57
4.8
1,120
14
15
9.0
21
23
2.1
55–59
5
5
3.5
15
16
60–64
3
3
2.6
4
65
1
1
0.5
Male-to-male sexual contact
38
46
Injection drug use
10
Male-to-male sexual contact
and injection drug use
Heterosexual contacte
No.
Rate
No.
No.
Rate
6
0.0
19
21
0.9
0
0
0.0
2
2
0.0
17
19
0.2
18
0
0.0
184
199
1.6
1
1
2.2
391
425
14.7
5
5
11.3
502
684
16.5
3
3
7.9
535
584
15.1
2
2
1,232 47.4
503
549
16.2
3
1,004
1,103 40.5
357
389
13.2
1.6
745
821 32.9
230
251
4
0.5
413
454 22.8
128
9
10
0.5
346
380
9.5
—
163
234
—
3,036
4,343
11
—
6
10
—
317
5
7
—
9
11
—
4
5
—
20
31
9
0
—
67
66
69
7.5
265
No.
Age at diagnosis (yr)
Transmission category
Male adult or adolescent
f
Other
Subtotal
14,243 15,624 12.0
Vol. 26
HIV Surveillance Report
Table 4a. Stage 3 (AIDS), by race/ethnicity and selected characteristics, 2014—United States (cont)
American Indian/
Alaska Native
Asiana
Estimatedc
Black/African American
Estimatedc
Rate
Hispanic/Latinob
Estimatedc
No.
No.
Rate
Native Hawaiian/
Other Pacific Islander
Estimatedc
No.
No.
Rate
No.
No.
No.
7
9
—
2
4
—
220
462
—
87
10
15
—
32
58
—
1,442
2,809
—
6
0
—
23
1
—
1,370
62
23
24
2.5
57
62
0.8
3,032
Perinatal
0
0
—
0
0
—
52
58
Otherg
1
1
—
1
1
—
4
Subtotal
1
1
0.2
1
1
0.0
56
Northeast
2
2
1.6
54
60
1.7
Midwest
10
10
2.6
44
46
South
22
24
3.1
76
West
56
59
5.6
Totalh
90
95
4.0
No.
White
Estimatedc
Multiple races
Estimatedc
Total
Estimatedc
Estimatedc
No.d
Rate
523
913
—
—
2,203
4,150
—
8
—
1,982
106
—
182
200
9.4
4,708
5,168
3.8
—
18
20
—
83
92
—
0
—
1
1
—
11
12
—
6
6
0.0
19
21
0.9
94
104
0.2
0.0
716
801
2.1
160
181
20.4
3,409
3,793
6.8
1
3.4
829
889
1.7
107
118
9.7
2,431
2,627
3.9
4
4
4.9
2,134
2,333
3.3
360
398
19.1
10,003 10,965
9.2
5.7
13
14
3.4
1,171
1,280
3.3
94
105
4.8
7.7
18
19
3.5
4,850
5,303
2.7
721
803
12.6
Rate
No.
No.
Rate
No.
144
—
0
0
—
178
313
568
—
1
3
—
—
272
25
—
2
0
3,334 19.5
672
737
3.5
3
—
7
8
—
4
—
4
4
62
0.9
11
1,569
1,739 27.5
2.3
1,181
83
2.2
149
163
2.2
323
352
2.1
No.
Rate
No.
No.
Rate
247
—
29
46
—
315
550
—
90
146
—
246
10
—
63
3
1.4
739
808
0.9
0
0
—
6
6
—
0
0
—
0
12
0.1
0
0
0.0
908
1,011
13.1
0
0
1,280 18.3
259
282
5.5
1
5,804
6,402 28.1
1,603
1,721
8.5
565
624 18.2
1,154
1,266
9,119 10,045 25.4
3,924
4,279
No.
Female adult or adolescent
Injection drug use
e
Heterosexual contact
Otherf
Subtotal
Child (<13 yrs at diagnosis)
31
Region of residence
3,202
3,511
4.7
19,045 20,896
6.6
Note. Reported numbers less than 12, as well as estimated numbers (and accompanying rates and trends) based on these numbers, should be interpreted with caution because the numbers have underlying relative standard errors greater than
30% and are considered unreliable.
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanics/Latinos can be of any race.
c Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting. Rates are per 100,000 population. Rates are not calculated by transmission category
because of the lack of denominator data.
d Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
Vol. 26
e
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
f
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
g
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
h
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
HIV Surveillance Report
Table 4b. Stage 3 (AIDS), by race/ethnicity and selected characteristics, 2014—United States and 6 dependent areas
American Indian/
Alaska Native
No.
Est. No.
Asian
c
No.
Black/
African American
a
Est. No.
c
No.
Est. No.
Hispanic/Latino
c
No.
b
c
Est. No.
Native Hawaiian/
Other Pacific Islander
No.
Est. No.
c
White
No.
Multiple races
Est. No.
c
No.
c
Est. No.
Total
No.
Est. No.
c,d
Age at diagnosis (yr)
32
<13
1
1
1
1
56
62
11
12
0
0
6
6
19
21
94
104
13–14
0
0
1
1
13
15
4
4
0
0
0
0
2
2
20
22
15–19
0
0
0
0
145
159
31
36
0
0
17
19
18
20
211
233
20–24
4
4
20
21
798
878
288
317
0
0
184
199
59
65
1,353
1,485
25–29
10
10
38
41
1,240
1,372
552
606
1
1
391
425
89
99
2,321
2,555
30–34
14
15
46
50
1,130
1,245
632
696
5
5
502
550
71
79
2,400
2,641
35–39
8
9
57
63
1,036
1,140
671
743
3
3
512
561
88
97
2,375
2,615
40–44
19
20
58
64
1,074
1,183
584
650
2
2
650
709
87
98
2,474
2,726
45–49
11
12
53
57
1,121
1,234
550
609
3
3
826
907
95
106
2,659
2,928
50–54
14
15
22
24
1,008
1,108
391
434
1
1
775
845
82
93
2,293
2,520
55–59
5
5
15
16
745
821
264
297
1
1
492
540
61
68
1,583
1,749
60–64
3
3
4
4
414
456
145
163
2
2
258
281
27
30
853
938
65
1
1
9
10
346
380
110
122
0
0
238
263
24
27
728
803
Male-to-male sexual contact
38
46
164
235
3,037
4,344
2,055
2,776
11
13
2,657
3,565
304
414
8,266
11,394
Injection drug use
10
11
6
10
317
589
257
390
0
0
246
300
33
47
869
1,346
5
7
9
11
135
233
109
156
1
1
269
335
36
51
564
794
e
Heterosexual contact
4
5
20
31
901
1,455
340
474
1
1
203
268
47
67
1,516
2,301
Otherf
9
0
67
2
1,647
36
696
20
2
0
731
23
101
5
3,253
85
66
69
266
290
6,037
6,656
3,457
3,815
15
16
4,106
4,490
521
583
14,468
15,920
Transmission category
Male adult or adolescent
Male-to-male sexual contact
and injection drug use
Subtotal
Vol. 26
HIV Surveillance Report
Table 4b. Stage 3 (AIDS), by race/ethnicity and selected characteristics, 2014—United States and 6 dependent areas (cont)
American Indian/
Alaska Native
Black/
African American
Asiana
No.
c
Est. No.
7
9
2
10
15
6
c
Multiple races
No.
175
0
0
178
247
29
46
546
944
374
658
1
3
315
550
90
146
2,264
4,241
62
281
27
2
0
246
10
63
8
1,992
108
3,033
3,335
765
861
3
3
739
808
182
200
4,802
5,293
0
52
58
7
8
0
0
6
6
18
20
83
92
1
1
4
4
4
4
0
0
0
0
1
1
11
12
1
1
1
56
62
11
12
0
0
6
6
19
21
94
104
2
2
54
60
1,569
1,739
908
1,011
0
0
716
801
160
181
3,409
3,793
Midwest
10
10
44
46
1,181
1,280
259
282
1
1
829
889
107
118
2,431
2,627
South
22
24
76
83
5,804
6,402
1,603
1,721
4
4
2,134
2,333
360
398
10,003
10,965
West
56
59
149
163
565
624
1,154
1,266
13
14
1,171
1,280
94
105
3,202
3,511
0
0
1
1
7
9
309
409
0
0
1
1
1
2
319
422
90
95
324
353
9,126
10,053
4,233
4,689
18
19
4,851
5,305
722
804
19,364
21,318
Est. No.
No.
4
220
462
110
32
58
1,442
2,811
0
23
1
1,371
23
24
57
62
Perinatal
0
0
0
Otherg
1
1
Subtotal
1
Northeast
Est. No.
Est. No.
c
Total
c
Est. No.
No.
c
White
No.
No.
c
Est. No.
Native Hawaiian/
Other Pacific Islander
Hispanic/Latinob
No.
Est. No.
c
No.
c,d
Est. No.
Female adult or adolescent
Injection drug use
e
Heterosexual contact
Otherf
Subtotal
Child (<13 yrs at diagnosis)
Region of residence
33
U.S. dependent areas
h
Total
Note. Reported numbers less than 12, as well as estimated numbers (and accompanying rates and trends) based on these numbers, should be interpreted with caution because the numbers have underlying relative standard errors greater than
30% and are considered unreliable.
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanics/Latinos can be of any race.
c Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting.
d Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
Vol. 26
e
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
f
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
g
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
h
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Table 5a. Diagnoses of HIV infection, by transmission category, race/ethnicity, and selected characteristics, 2014—United States
Male-to-male
sexual contact
No.
Est. No.
Male-to-male sexual
contact and IDU
IDU
c
No.
Est. No.
c
No.
c
Est. No.
Heterosexual
contacta
No.
Est. No.
Otherb
c
Total
No.
Est. No.
c
No.
Est. No.c,d
American Indian/Alaska Native
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
0
5
32
33
18
6
9
9
7
1
0
0
0
5
36
36
22
6
13
12
8
2
0
1
0
0
1
2
0
0
3
0
3
0
0
0
0
0
1
2
0
0
4
0
3
0
0
0
0
0
1
0
0
0
0
2
2
0
0
0
0
0
1
0
1
0
1
2
2
0
0
0
0
0
0
0
3
1
1
2
0
1
0
0
0
0
0
0
3
1
2
2
0
1
0
0
0
0
2
1
3
0
5
3
1
1
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
5
36
36
24
7
18
16
13
3
0
1
0
5
38
38
26
7
19
17
14
4
0
1
Region of residence
Northeast
Midwest
South
West
6
11
29
74
6
13
37
84
0
1
4
4
0
1
5
5
0
3
0
2
0
3
1
3
2
0
0
6
2
0
1
7
0
2
7
8
0
0
0
0
8
17
40
94
8
18
44
100
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
0
0
1
3
1
1
1
1
0
1
0
0
0
0
2
3
1
1
1
1
0
1
0
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
2
0
5
2
2
2
2
4
2
0
0
0
3
1
8
5
4
4
3
5
3
0
0
0
1
1
4
3
2
2
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
1
10
8
5
5
4
6
3
1
0
0
3
1
11
8
5
5
4
6
3
1
0
Region of residence
Northeast
Midwest
South
West
—
—
—
—
—
—
—
—
0
1
3
5
0
2
5
6
—
—
—
—
—
—
—
—
0
3
4
14
2
7
12
16
2
4
9
1
0
0
0
0
2
8
16
20
2
9
17
21
120
142
18
24
5
7
29
46
33
1
205
219
Female adult or adolescent
Subtotale
HIV Surveillance Report
34
Vol. 26
Table 5a. Diagnoses of HIV infection, by transmission category, race/ethnicity, and selected characteristics, 2014—United States (cont)
Male-to-male
sexual contact
No.
Est. No.c
Male-to-male sexual
contact and IDU
IDU
No.
Est. No.c
No.
Est. No.c
Heterosexual
contacta
No.
Est. No.c
Otherb
Total
No.
Est. No.c
No.
Est. No.c,d
Asian
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
2
14
117
121
106
82
65
44
25
6
2
2
2
18
141
162
139
111
92
66
39
13
7
9
0
1
0
0
4
4
2
1
1
0
0
0
0
1
0
0
5
5
3
3
2
0
0
1
0
1
2
1
2
3
4
0
0
0
0
0
0
1
3
2
3
4
5
0
0
0
0
0
0
1
1
5
12
5
3
4
4
1
0
1
0
1
1
7
14
9
6
6
6
4
1
5
1
2
11
26
20
21
21
20
13
8
5
11
1
0
0
0
0
0
0
0
0
0
0
1
3
19
131
153
144
115
95
69
43
15
7
14
3
21
145
171
161
128
106
75
48
17
8
16
Region of residence
Northeast
Midwest
South
West
118
42
104
322
157
63
159
420
3
1
7
2
6
2
9
3
0
4
2
7
0
5
3
9
11
7
6
13
16
10
13
21
28
19
49
63
1
0
1
1
160
73
168
407
180
80
185
453
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
1
1
1
1
1
2
0
0
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
1
5
9
10
13
9
5
4
1
2
0
0
1
11
19
20
23
22
9
9
9
4
0
0
0
5
9
9
9
12
4
5
8
2
0
0
0
0
0
0
0
0
0
0
1
0
0
0
1
10
18
19
22
21
9
9
10
4
0
0
1
11
19
22
24
24
10
10
11
4
0
Region of residence
Northeast
Midwest
South
West
—
—
—
—
—
—
—
—
0
1
0
0
1
1
1
3
—
—
—
—
—
—
—
—
13
8
20
18
23
13
38
54
9
4
16
34
0
0
0
1
22
13
36
52
25
14
39
58
586
798
14
27
13
17
96
188
222
5
931
1,035
Female adult or adolescent
Subtotale
HIV Surveillance Report
35
Vol. 26
Table 5a. Diagnoses of HIV infection, by transmission category, race/ethnicity, and selected characteristics, 2014—United States (cont)
Male-to-male
sexual contact
No.
Est. No.c
Male-to-male sexual
contact and IDU
IDU
No.
Est. No.c
No.
Est. No.c
Heterosexual
contacta
No.
Est. No.c
Otherb
Total
No.
Est. No.c
No.
Est. No.c,d
Black/African American
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
2
658
2,677
1,955
909
462
334
327
207
139
60
47
5
856
3,460
2,628
1,367
791
622
585
404
276
119
91
0
1
10
16
12
11
17
29
30
39
24
19
0
8
52
63
57
59
67
89
84
97
52
48
0
7
26
24
24
11
11
9
10
8
5
2
0
17
60
53
44
26
23
19
20
15
8
4
1
21
108
140
149
139
159
138
151
98
54
54
1
35
175
213
227
220
264
257
264
205
121
126
6
153
581
527
423
358
355
349
295
247
123
120
3
6
7
2
1
1
1
1
2
1
2
2
9
840
3,402
2,662
1,517
981
876
852
693
531
266
242
10
923
3,754
2,959
1,696
1,097
978
951
773
594
301
271
Region of residence
Northeast
Midwest
South
West
1,158
1,344
4,630
645
1,575
1,781
6,934
912
49
20
119
20
229
51
361
38
31
17
62
27
49
34
164
42
275
126
752
59
461
189
1,356
100
582
401
2,321
233
2
15
10
1
2,095
1,908
7,884
984
2,316
2,070
8,825
1,093
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
2
6
11
11
10
12
23
22
21
11
5
0
11
30
48
44
47
50
59
58
55
29
20
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
2
74
241
252
266
258
239
200
173
156
70
57
4
205
509
638
604
599
528
480
411
365
171
140
6
128
247
355
310
319
270
263
226
200
96
81
4
10
3
2
1
1
0
0
0
0
0
0
8
204
494
618
587
587
521
486
421
377
177
143
9
226
542
688
649
647
578
539
470
420
200
160
Region of residence
Northeast
Midwest
South
West
—
—
—
—
—
—
—
—
31
15
73
15
127
47
239
38
—
—
—
—
—
—
—
—
323
233
1,343
89
921
533
2,938
262
594
289
1,446
172
7
2
9
4
948
537
2,862
276
1,055
582
3,185
304
7,777
11,201
342
1,130
137
288
3,200
6,761
6,038
52
17,494
19,433
Female adult or adolescent
Subtotale
HIV Surveillance Report
36
Vol. 26
Table 5a. Diagnoses of HIV infection, by transmission category, race/ethnicity, and selected characteristics, 2014—United States (cont)
Male-to-male
sexual contact
No.
Est. No.c
Male-to-male sexual
contact and IDU
IDU
No.
Est. No.c
No.
Est. No.c
Heterosexual
contacta
No.
Est. No.c
Otherb
Total
No.
Est. No.c
No.
Est. No.c,d
Hispanic/Latinof
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
2
226
1,224
1,274
996
692
506
417
219
92
52
37
2
287
1,497
1,589
1,309
942
729
583
324
153
82
56
0
0
12
21
32
29
31
25
22
20
8
2
0
3
22
35
55
57
60
52
45
40
17
10
0
8
25
35
38
23
16
15
4
6
1
1
0
12
36
49
52
34
26
21
8
9
2
2
0
3
29
49
67
72
69
64
44
22
9
13
0
4
35
63
87
95
98
92
69
35
20
23
0
43
154
189
228
200
205
160
115
74
41
30
0
2
4
1
1
0
0
0
0
0
0
1
2
280
1,444
1,568
1,361
1,016
827
681
404
214
111
83
2
309
1,594
1,736
1,504
1,128
914
748
446
237
121
91
Region of residence
Northeast
Midwest
South
West
1,070
411
2,311
1,945
1,429
536
3,010
2,578
53
5
67
77
153
12
125
105
24
7
59
82
36
12
93
111
101
26
240
74
150
36
330
107
329
92
601
417
0
2
7
2
1,577
541
3,278
2,595
1,769
598
3,564
2,902
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
2
12
7
12
13
14
6
10
6
3
2
0
7
19
17
23
26
25
15
21
16
7
7
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
17
59
66
86
87
60
70
51
34
19
15
1
45
126
139
159
172
131
130
102
77
45
34
3
31
59
70
68
78
66
56
50
43
25
20
2
4
0
2
0
0
0
0
0
0
0
0
3
50
130
143
166
178
140
132
111
83
47
37
3
55
145
157
183
198
156
145
123
93
52
41
Region of residence
Northeast
Midwest
South
West
—
—
—
—
—
—
—
—
33
7
26
21
80
12
53
39
—
—
—
—
—
—
—
—
133
41
267
123
339
70
464
286
209
28
186
146
2
1
4
1
375
76
479
290
421
83
521
325
5,737
7,552
289
579
172
251
1,005
1,782
2,008
19
9,211
10,183
Female adult or adolescent
Subtotale
HIV Surveillance Report
37
Vol. 26
Table 5a. Diagnoses of HIV infection, by transmission category, race/ethnicity, and selected characteristics, 2014—United States (cont)
Male-to-male
sexual contact
No.
Est. No.c
Male-to-male sexual
contact and IDU
IDU
No.
Est. No.c
No.
Est. No.c
Heterosexual
contacta
No.
Est. No.c
Otherb
Total
No.
Est. No.c
No.
Est. No.c,d
Native Hawaiian/Other Pacific Islander
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
0
1
5
6
5
6
3
5
1
0
0
1
0
1
8
7
6
9
6
6
1
0
1
1
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
1
3
3
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
7
6
7
9
6
5
1
0
2
1
0
1
8
7
7
10
7
6
1
0
2
1
Region of residence
Northeast
Midwest
South
West
1
3
5
24
2
3
12
28
1
0
0
0
2
0
0
0
0
0
0
1
0
0
0
1
0
0
0
0
0
0
1
0
1
0
6
3
0
0
0
0
3
3
11
28
3
3
13
30
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
0
1
0
0
0
1
0
1
0
0
0
0
1
1
0
1
1
1
0
1
1
0
0
0
1
0
0
1
1
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
1
1
1
0
1
1
0
0
0
1
1
0
1
1
1
0
1
1
0
0
Region of residence
Northeast
Midwest
South
West
—
—
—
—
—
—
—
—
0
0
0
0
0
0
0
0
—
—
—
—
—
—
—
—
0
0
1
2
1
0
1
5
1
0
0
3
0
0
0
0
1
0
1
5
1
0
1
6
33
45
1
3
1
1
3
7
14
0
52
57
Female adult or adolescent
Subtotale
HIV Surveillance Report
38
Vol. 26
Table 5a. Diagnoses of HIV infection, by transmission category, race/ethnicity, and selected characteristics, 2014—United States (cont)
Male-to-male
sexual contact
No.
Est. No.c
Male-to-male sexual
contact and IDU
IDU
No.
Est. No.c
No.
Est. No.c
Heterosexual
contacta
No.
Est. No.c
Otherb
Total
No.
Est. No.c
No.
Est. No.c,d
White
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
2
126
914
1,175
942
738
698
794
693
372
194
143
3
158
1,130
1,474
1,220
983
950
1,091
955
540
271
234
0
2
30
46
55
43
57
41
45
22
14
3
0
2
34
54
63
51
69
53
61
34
20
14
0
9
56
118
90
68
61
48
35
17
9
0
0
10
65
133
105
80
72
63
46
23
12
3
0
3
14
29
32
22
43
49
52
25
17
19
0
3
18
35
39
30
54
68
71
44
24
36
2
20
127
181
186
171
189
234
205
144
65
97
1
0
3
1
2
1
0
3
1
1
1
4
4
160
1,141
1,549
1,305
1,042
1,048
1,166
1,030
580
299
262
4
173
1,249
1,696
1,429
1,144
1,145
1,279
1,133
641
328
291
Region of residence
Northeast
Midwest
South
West
1,082
1,142
2,885
1,682
1,430
1,473
3,920
2,184
51
49
141
117
89
59
172
135
48
83
192
188
63
98
234
217
54
43
138
70
80
56
199
86
254
255
781
331
1
8
7
1
1,489
1,572
4,137
2,388
1,663
1,694
4,532
2,623
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
10
24
44
43
36
28
29
18
10
3
2
0
13
36
59
60
46
41
43
29
19
7
6
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
2
16
63
75
89
68
66
55
65
48
15
8
3
34
130
148
163
123
122
118
125
93
32
24
2
17
67
70
73
52
56
65
58
44
18
16
1
0
1
1
2
0
0
0
1
0
0
0
4
43
154
189
205
156
150
149
141
102
36
26
4
47
167
208
225
169
163
162
156
112
40
30
Region of residence
Northeast
Midwest
South
West
—
—
—
—
—
—
—
—
40
28
118
61
71
41
161
87
—
—
—
—
—
—
—
—
87
90
300
93
184
166
568
197
102
78
251
107
2
2
2
2
229
196
669
261
256
210
731
286
6,791
9,008
605
815
511
611
875
1,537
2,159
25
10,941
11,996
Female adult or adolescent
Subtotale
HIV Surveillance Report
39
Vol. 26
Table 5a. Diagnoses of HIV infection, by transmission category, race/ethnicity, and selected characteristics, 2014—United States (cont)
Male-to-male
sexual contact
No.
Est. No.c
Male-to-male sexual
contact and IDU
IDU
No.
Est. No.c
No.
Est. No.c
Heterosexual
contacta
No.
Est. No.c
Otherb
Total
No.
Est. No.c
No.
Est. No.c,d
Multiple races
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
0
42
149
116
60
43
41
33
23
13
0
2
0
50
170
140
78
65
55
46
41
20
3
5
0
0
1
5
2
3
2
1
1
2
1
0
0
0
1
5
3
4
3
3
3
3
2
1
0
1
9
6
4
3
4
3
0
1
0
0
0
1
10
7
6
4
5
4
1
1
0
0
0
1
3
6
6
9
3
11
3
3
0
1
0
1
3
7
8
11
4
14
4
5
1
3
0
4
7
10
13
17
11
13
17
7
4
5
0
0
0
0
0
0
0
0
0
0
0
0
0
48
169
143
85
75
61
61
44
26
5
8
0
53
185
159
94
84
67
67
49
29
6
9
Region of residence
Northeast
Midwest
South
West
121
77
233
91
154
95
309
114
4
2
5
7
9
2
8
8
4
2
8
17
5
3
12
19
17
5
19
5
23
7
26
7
28
14
52
14
0
0
0
0
174
100
317
134
192
108
355
148
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
1
0
1
1
1
4
4
2
2
0
1
0
1
1
2
2
2
7
7
4
3
0
1
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
5
14
10
13
10
13
6
3
0
2
1
0
8
24
19
19
18
27
12
8
2
5
1
0
3
10
8
6
7
13
7
6
2
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9
24
19
20
18
30
17
11
4
5
2
0
9
26
21
22
20
33
19
12
4
5
2
Region of residence
Northeast
Midwest
South
West
—
—
—
—
—
—
—
—
5
0
9
3
12
1
14
4
—
—
—
—
—
—
—
—
16
15
42
4
31
25
77
9
18
9
33
5
0
0
0
0
39
24
84
12
43
26
91
13
522
672
35
58
31
40
123
205
173
1
884
976
Female adult or adolescent
Subtotale
HIV Surveillance Report
40
Vol. 26
Table 5a. Diagnoses of HIV infection, by transmission category, race/ethnicity, and selected characteristics, 2014—United States (cont)
Male-to-male
sexual contact
No.
Est. No.c
Male-to-male sexual
contact and IDU
IDU
No.
Est. No.c
No.
Est. No.c
Heterosexual
contacta
No.
Est. No.c
Otherb
No.
Total
Est. No.c
No.
Est. No.c,d
Total
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
8
1,072
5,118
4,680
3,036
2,029
1,656
1,629
1,175
623
308
232
12
1,374
6,442
6,034
4,141
2,905
2,467
2,389
1,772
1,004
483
396
0
4
54
90
105
90
112
97
102
83
48
24
0
15
112
159
183
177
206
200
198
173
92
74
0
26
119
184
159
108
96
77
51
32
15
3
0
43
174
244
211
148
133
109
77
48
22
8
1
29
155
229
269
248
278
268
254
150
80
88
1
45
233
325
378
366
428
440
415
294
166
193
9
222
884
934
874
770
789
779
646
481
239
264
5
9
14
4
4
2
2
4
3
2
3
8
18
1,353
6,330
6,117
4,443
3,245
2,931
2,850
2,228
1,369
690
611
19
1,485
6,974
6,766
4,917
3,598
3,236
3,142
2,464
1,521
766
680
Region of residence
Northeast
Midwest
South
West
3,556
3,030
10,197
4,783
4,753
3,966
14,380
6,320
161
78
343
227
488
128
680
294
107
116
323
324
153
155
507
402
460
207
1,155
227
733
298
1,925
328
1,222
783
3,817
1,069
5
25
26
4
5,506
4,214
15,835
6,630
6,132
4,572
17,518
7,348
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
15
42
64
70
61
59
63
53
40
18
10
0
32
87
128
135
123
125
127
114
95
45
34
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
4
115
383
417
466
438
390
338
301
241
108
81
8
297
802
971
972
940
835
752
662
549
257
199
11
181
389
516
470
468
419
396
346
299
144
117
7
14
5
5
3
1
1
1
2
1
1
1
15
311
814
997
1,006
967
868
797
700
580
270
208
16
343
894
1,104
1,109
1,064
960
879
778
645
303
233
Region of residence
Northeast
Midwest
South
West
—
—
—
—
—
—
—
—
109
52
229
105
291
104
473
177
—
—
—
—
—
—
—
—
572
390
1,977
343
1,502
814
4,098
828
935
412
1,941
468
12
6
16
8
1,616
854
4,147
916
1,804
924
4,587
1,013
21,566
29,418
1,304
2,635
870
1,217
5,331
10,527
10,647
102
39,718
43,899
Female adult or adolescent
Totale
Abbreviation: IDU, injection drug use.
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
Reported numbers less than 12, as well as estimated numbers (and accompanying trends) based on these numbers, should be interpreted with caution because the numbers have underlying
relative standard errors greater than 30% and are considered unreliable.
a Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
b Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
c Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting.
d Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
e Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
f Hispanics/Latinos can be of any race.
HIV Surveillance Report
41
Vol. 26
Table 5b. Diagnoses of HIV infection, by transmission category, race/ethnicity, and selected characteristics, 2014—United States and 6 dependent areas
Male-to-male
sexual contact
No.
Est. No.
Male-to-male sexual
contact and IDU
IDU
c
No.
Est. No.
c
No.
c
Est. No.
Heterosexual
contacta
No.
Est. No.
Otherb
c
Total
No.
Est. No.
c
No.
Est. No.c,d
American Indian/Alaska Native
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
0
5
32
33
18
6
9
9
7
1
0
0
0
5
36
36
22
6
13
12
8
2
0
1
0
0
1
2
0
0
3
0
3
0
0
0
0
0
1
2
0
0
4
0
3
0
0
0
0
0
1
0
0
0
0
2
2
0
0
0
0
0
1
0
1
0
1
2
2
0
0
0
0
0
0
0
3
1
1
2
0
1
0
0
0
0
0
0
3
1
2
2
0
1
0
0
0
0
2
1
3
0
5
3
1
1
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
5
36
36
24
7
18
16
13
3
0
1
0
5
38
38
26
7
19
17
14
4
0
1
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
6
11
29
74
0
6
13
37
84
0
0
1
4
4
0
0
1
5
5
0
0
3
0
2
0
0
3
1
3
0
2
0
0
6
0
2
0
1
7
0
0
2
7
8
0
0
0
0
0
0
8
17
40
94
0
8
18
44
100
0
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
0
0
1
3
1
1
1
1
0
1
0
0
0
0
2
3
1
1
1
1
0
1
0
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
2
0
5
2
2
2
2
4
2
0
0
0
3
1
8
5
4
4
3
5
3
0
0
0
1
1
4
3
2
2
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
1
10
8
5
5
4
6
3
1
0
0
3
1
11
8
5
5
4
6
3
1
0
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
—
—
—
—
—
—
—
—
—
—
0
1
3
5
0
0
2
5
6
0
—
—
—
—
—
—
—
—
—
—
0
3
4
14
0
2
7
12
16
0
2
4
9
1
0
0
0
0
0
0
2
8
16
20
0
2
9
17
21
0
120
142
18
24
5
7
29
46
33
1
205
219
Female adult or adolescent
Subtotale
HIV Surveillance Report
42
Vol. 26
Table 5b. Diagnoses of HIV infection, by transmission category, race/ethnicity, and selected characteristics, 2014—United States and 6 dependent areas (cont)
Male-to-male
sexual contact
No.
Male-to-male sexual
contact and IDU
IDU
c
Est. No.
No.
Est. No.
c
No.
c
Est. No.
Heterosexual
contacta
No.
Est. No.
Otherb
c
Total
No.
Est. No.
c
No.
Est. No.c,d
Asian
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
2
14
117
121
106
82
65
44
26
6
2
2
2
18
141
162
139
111
92
66
40
13
7
9
0
1
0
0
4
4
2
1
1
0
0
0
0
1
0
0
5
5
3
3
2
0
0
1
0
1
2
1
2
3
4
0
0
0
0
0
0
1
3
2
3
4
5
0
0
0
0
0
0
1
1
5
12
5
3
4
4
1
0
1
0
1
1
7
14
9
6
6
6
4
1
5
1
2
11
26
20
21
21
20
13
8
5
11
1
0
0
0
0
0
0
0
0
0
0
1
3
19
131
153
144
115
95
69
44
15
7
14
3
21
145
171
161
128
106
75
49
17
8
16
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
118
42
104
322
1
157
63
159
420
1
3
1
7
2
0
6
2
9
3
0
0
4
2
7
0
0
5
3
9
0
11
7
6
13
0
16
10
13
21
0
28
19
49
63
0
1
0
1
1
0
160
73
168
407
1
180
80
185
453
1
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
1
1
1
1
1
2
0
0
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
1
5
9
10
13
9
5
4
1
2
0
0
1
11
19
20
23
22
9
9
9
4
0
0
0
5
9
9
9
12
4
5
8
2
0
0
0
0
0
0
0
0
0
0
1
0
0
0
1
10
18
19
22
21
9
9
10
4
0
0
1
11
19
22
24
24
10
10
11
4
0
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
—
—
—
—
—
—
—
—
—
—
0
1
0
0
0
1
1
1
3
0
—
—
—
—
—
—
—
—
—
—
13
8
20
18
0
23
13
38
54
0
9
4
16
34
0
0
0
0
1
0
22
13
36
52
0
25
14
39
58
0
587
799
14
27
13
17
96
188
222
5
932
1,036
Female adult or adolescent
Subtotale
HIV Surveillance Report
43
Vol. 26
Table 5b. Diagnoses of HIV infection, by transmission category, race/ethnicity, and selected characteristics, 2014—United States and 6 dependent areas (cont)
Male-to-male
sexual contact
No.
Male-to-male sexual
contact and IDU
IDU
c
Est. No.
No.
Est. No.
c
No.
c
Est. No.
Heterosexual
contacta
No.
Est. No.
Otherb
c
Total
No.
Est. No.
c
No.
Est. No.c,d
Black/African American
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
2
659
2,677
1,955
910
463
334
328
207
139
60
47
5
857
3,460
2,628
1,368
792
622
586
404
276
119
91
0
1
10
16
12
11
17
29
30
39
24
19
0
8
52
64
57
59
68
89
84
98
53
48
0
7
26
24
24
11
11
9
10
8
5
2
0
17
60
53
44
26
23
19
20
15
8
4
1
21
108
140
149
139
159
138
153
98
54
55
1
35
175
213
227
220
265
257
267
205
121
127
6
153
581
528
423
358
356
349
296
248
124
120
3
6
7
2
1
1
1
1
2
1
2
2
9
841
3,402
2,663
1,518
982
877
853
696
532
267
243
10
924
3,754
2,960
1,697
1,099
979
952
776
595
302
272
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
1,158
1,344
4,630
645
4
1,575
1,781
6,934
912
5
49
20
119
20
0
229
51
361
38
3
31
17
62
27
0
49
34
164
42
0
275
126
752
59
3
461
189
1,356
100
5
582
401
2,321
233
5
2
15
10
1
0
2,095
1,908
7,884
984
12
2,316
2,070
8,825
1,093
14
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
2
6
11
11
10
12
23
22
21
11
5
0
11
30
48
44
47
50
59
58
55
29
20
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
2
74
241
252
266
258
239
200
174
156
70
57
4
205
509
638
605
599
528
480
413
366
171
140
6
128
247
355
311
319
270
263
226
201
96
81
4
10
3
2
1
1
0
0
0
0
0
0
8
204
494
618
588
587
521
486
422
378
177
143
9
226
542
688
650
647
578
539
471
422
200
160
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
—
—
—
—
—
—
—
—
—
—
31
15
73
15
0
127
47
239
38
0
—
—
—
—
—
—
—
—
—
—
323
233
1,343
89
1
921
533
2,938
262
3
594
289
1,446
172
2
7
2
9
4
0
948
537
2,862
276
3
1,055
582
3,185
304
3
7,781
11,207
342
1,133
137
289
3,204
6,770
6,045
52
17,509
19,450
Female adult or adolescent
Subtotale
HIV Surveillance Report
44
Vol. 26
Table 5b. Diagnoses of HIV infection, by transmission category, race/ethnicity, and selected characteristics, 2014—United States and 6 dependent areas (cont)
Male-to-male
sexual contact
No.
Male-to-male sexual
contact and IDU
IDU
c
Est. No.
No.
Est. No.
c
No.
c
Est. No.
Heterosexual
contacta
No.
Est. No.
Otherb
c
Total
No.
Est. No.
c
No.
Est. No.c,d
Hispanic/Latinof
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
2
240
1,300
1,324
1,021
723
532
434
231
98
58
40
2
305
1,591
1,652
1,342
979
765
606
340
161
90
59
0
0
13
27
37
33
37
37
25
27
11
5
0
4
25
43
63
63
71
70
50
49
22
13
0
8
25
36
38
24
16
15
4
7
1
1
0
12
36
50
52
35
27
21
8
10
3
2
0
3
36
58
74
85
81
74
53
34
17
18
0
4
45
75
96
111
115
107
81
51
31
29
0
45
164
197
235
203
216
170
120
77
45
30
0
2
4
1
1
0
0
0
0
0
0
1
2
296
1,538
1,642
1,405
1,068
882
730
433
243
132
94
2
327
1,702
1,821
1,555
1,188
978
805
480
271
145
104
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
1,070
411
2,311
1,945
266
1,429
536
3,010
2,578
341
53
5
67
77
50
153
12
125
105
79
24
7
59
82
3
36
12
93
111
6
101
26
240
74
92
150
36
330
107
121
329
92
601
417
63
0
2
7
2
0
1,577
541
3,278
2,595
474
1,769
598
3,564
2,902
546
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
2
13
7
13
17
17
7
11
7
3
2
0
7
21
17
24
31
29
16
22
17
7
7
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
19
63
70
95
104
78
84
59
43
23
19
1
50
131
144
171
194
154
150
112
87
49
39
3
34
60
71
69
80
68
60
51
43
25
20
2
4
1
2
0
0
0
0
0
0
0
0
3
55
136
148
177
201
163
151
121
93
51
41
3
61
152
163
195
224
183
167
134
104
57
46
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
—
—
—
—
—
—
—
—
—
—
33
7
26
21
12
80
12
53
39
15
—
—
—
—
—
—
—
—
—
—
133
41
267
123
93
339
70
464
286
123
209
28
186
146
15
2
1
4
1
1
375
76
479
290
120
421
83
521
325
139
6,003
7,893
351
672
175
257
1,190
2,026
2,086
20
9,805
10,868
Female adult or adolescent
Subtotale
HIV Surveillance Report
45
Vol. 26
Table 5b. Diagnoses of HIV infection, by transmission category, race/ethnicity, and selected characteristics, 2014—United States and 6 dependent areas (cont)
Male-to-male
sexual contact
No.
Male-to-male sexual
contact and IDU
IDU
c
Est. No.
No.
Est. No.
c
No.
c
Est. No.
Heterosexual
contacta
No.
Est. No.
Otherb
c
Total
No.
Est. No.
c
No.
Est. No.c,d
Native Hawaiian/Other Pacific Islander
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
0
1
5
6
5
6
3
5
1
0
0
1
0
1
8
7
6
9
6
6
1
0
1
1
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
1
3
3
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
7
6
7
9
6
5
1
0
2
1
0
1
8
7
7
10
7
6
1
0
2
1
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
1
3
5
24
0
2
3
12
28
0
1
0
0
0
0
2
0
0
0
0
0
0
0
1
0
0
0
0
1
0
0
0
0
0
0
0
0
1
0
0
1
0
6
3
0
0
0
0
0
0
3
3
11
28
0
3
3
13
30
0
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
0
1
0
0
0
1
0
1
0
0
0
0
1
1
0
1
1
1
0
1
1
0
0
0
1
0
0
1
1
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
1
1
1
0
1
1
0
0
0
1
1
0
1
1
1
0
1
1
0
0
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
—
—
—
—
—
—
—
—
—
—
0
0
0
0
0
0
0
0
0
0
—
—
—
—
—
—
—
—
—
—
0
0
1
2
0
1
0
1
5
0
1
0
0
3
0
0
0
0
0
0
1
0
1
5
0
1
0
1
6
0
33
45
1
3
1
1
3
7
14
0
52
57
Female adult or adolescent
Subtotale
HIV Surveillance Report
46
Vol. 26
Table 5b. Diagnoses of HIV infection, by transmission category, race/ethnicity, and selected characteristics, 2014—United States and 6 dependent areas (cont)
Male-to-male
sexual contact
No.
Male-to-male sexual
contact and IDU
IDU
c
Est. No.
No.
Est. No.
c
No.
c
Est. No.
Heterosexual
contacta
No.
Est. No.
Otherb
c
Total
No.
Est. No.
c
No.
Est. No.c,d
White
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
2
126
915
1,176
943
738
698
794
694
372
194
143
3
158
1,131
1,475
1,221
983
950
1,091
956
540
271
234
0
2
30
46
55
43
57
41
45
22
14
3
0
2
34
54
63
51
69
53
61
34
20
14
0
9
56
118
90
68
61
48
35
17
9
0
0
10
65
133
105
80
72
63
46
23
12
3
0
3
14
29
32
22
43
49
52
25
17
19
0
3
18
35
39
30
54
68
71
44
24
36
2
20
127
181
186
171
189
234
205
144
65
97
1
0
3
1
2
1
0
3
1
1
1
4
4
160
1,142
1,550
1,306
1,042
1,048
1,166
1,031
580
299
262
4
173
1,251
1,697
1,430
1,144
1,145
1,279
1,134
641
328
291
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
1,082
1,142
2,885
1,682
4
1,430
1,473
3,920
2,184
5
51
49
141
117
0
89
59
172
135
0
48
83
192
188
0
63
98
234
217
0
54
43
138
70
0
80
56
199
86
0
254
255
781
331
0
1
8
7
1
0
1,489
1,572
4,137
2,388
4
1,663
1,694
4,532
2,623
5
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
10
24
44
43
36
28
29
18
10
3
2
0
13
36
59
60
46
41
43
29
19
7
6
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
2
16
63
75
89
68
66
55
65
48
15
8
3
34
130
148
163
123
122
118
125
93
32
24
2
17
67
70
73
52
56
65
58
44
18
16
1
0
1
1
2
0
0
0
1
0
0
0
4
43
154
189
205
156
150
149
141
102
36
26
4
47
167
208
225
169
163
162
156
112
40
30
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
—
—
—
—
—
—
—
—
—
—
40
28
118
61
0
71
41
161
87
0
—
—
—
—
—
—
—
—
—
—
87
90
300
93
0
184
166
568
197
0
102
78
251
107
0
2
2
2
2
0
229
196
669
261
0
256
210
731
286
0
6,795
9,012
605
815
511
611
875
1,537
2,159
25
10,945
12,001
Female adult or adolescent
Subtotale
HIV Surveillance Report
47
Vol. 26
Table 5b. Diagnoses of HIV infection, by transmission category, race/ethnicity, and selected characteristics, 2014—United States and 6 dependent areas (cont)
Male-to-male
sexual contact
No.
Male-to-male sexual
contact and IDU
IDU
c
Est. No.
No.
Est. No.
c
No.
c
Est. No.
Heterosexual
contacta
No.
Est. No.
Otherb
c
Total
No.
Est. No.
c
No.
Est. No.c,d
Multiple races
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
0
42
149
116
60
43
41
33
23
14
0
2
0
50
170
140
78
65
55
46
41
22
3
5
0
0
1
5
2
3
2
1
1
2
1
0
0
0
1
5
3
4
3
3
3
3
2
1
0
1
9
6
4
3
4
3
0
1
0
0
0
1
10
7
6
4
5
4
1
1
0
0
0
1
3
6
6
9
3
11
3
3
0
1
0
1
3
7
8
11
4
14
4
5
1
3
0
4
7
10
13
17
11
13
17
7
4
5
0
0
0
0
0
0
0
0
0
0
0
0
0
48
169
143
85
75
61
61
44
27
5
8
0
53
185
159
94
84
67
67
49
30
6
9
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
121
77
233
91
1
154
95
309
114
1
4
2
5
7
0
9
2
8
8
0
4
2
8
17
0
5
3
12
19
0
17
5
19
5
0
23
7
26
7
0
28
14
52
14
0
0
0
0
0
0
174
100
317
134
1
192
108
355
148
1
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
1
0
1
1
1
4
4
2
2
0
1
0
1
1
2
2
2
7
7
4
3
0
1
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
5
14
10
13
10
13
6
3
0
2
1
0
8
24
19
19
18
27
12
8
2
5
1
0
3
10
8
6
7
13
7
6
2
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9
24
19
20
18
30
17
11
4
5
2
0
9
26
21
22
20
33
19
12
4
5
2
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
—
—
—
—
—
—
—
—
—
—
5
0
9
3
0
12
1
14
4
0
—
—
—
—
—
—
—
—
—
—
16
15
42
4
0
31
25
77
9
0
18
9
33
5
0
0
0
0
0
0
39
24
84
12
0
43
26
91
13
0
523
674
35
58
31
40
123
205
173
1
885
977
Female adult or adolescent
Subtotale
HIV Surveillance Report
48
Vol. 26
Table 5b. Diagnoses of HIV infection, by transmission category, race/ethnicity, and selected characteristics, 2014—United States and 6 dependent areas (cont)
Male-to-male
sexual contact
No.
Male-to-male sexual
contact and IDU
IDU
c
Est. No.
No.
Est. No.
c
No.
c
Est. No.
Heterosexual
contacta
No.
Est. No.
Otherb
c
No.
Total
Est. No.
c
No.
Est. No.c,d
Total
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
8
1,087
5,195
4,731
3,063
2,061
1,682
1,647
1,189
630
314
235
12
1,393
6,537
6,099
4,176
2,944
2,503
2,413
1,790
1,013
490
400
0
4
55
96
110
94
118
109
105
90
51
27
0
16
115
168
190
182
218
218
204
183
98
78
0
26
119
185
159
109
96
77
51
33
15
3
0
43
174
246
211
150
133
109
77
49
22
8
1
29
162
238
276
261
290
278
265
162
88
94
1
45
242
337
388
382
445
455
430
309
178
200
9
224
894
943
881
773
801
789
652
485
244
264
5
9
14
4
4
2
2
4
3
2
3
8
18
1,370
6,425
6,193
4,489
3,298
2,987
2,900
2,262
1,400
712
623
19
1,505
7,083
6,853
4,970
3,659
3,301
3,200
2,504
1,558
792
694
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
3,556
3,030
10,197
4,783
276
4,753
3,966
14,380
6,320
353
161
78
343
227
50
488
128
680
294
82
107
116
323
324
3
153
155
507
402
6
460
207
1,155
227
95
733
298
1,925
328
127
1,222
783
3,817
1,069
68
5
25
26
4
0
5,506
4,214
15,835
6,630
492
6,132
4,572
17,518
7,348
567
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
15
43
64
71
65
62
64
54
41
18
10
0
33
89
128
136
128
128
128
115
97
45
34
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
4
117
387
421
475
455
408
352
310
250
112
85
8
302
807
977
984
962
858
772
674
560
261
203
11
184
390
517
472
470
421
400
347
300
144
117
7
14
5
5
3
1
1
1
2
1
1
1
15
316
820
1,002
1,018
990
891
816
711
591
274
212
16
349
901
1,110
1,123
1,091
987
901
791
658
307
238
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
—
—
—
—
—
—
—
—
—
—
109
52
229
105
12
291
104
473
177
15
—
—
—
—
—
—
—
—
—
—
572
390
1,977
343
94
1,502
814
4,098
828
127
935
412
1,941
468
17
12
6
16
8
1
1,616
854
4,147
916
123
1,804
924
4,587
1,013
143
21,842
29,771
1,366
2,732
873
1,222
5,520
10,781
10,732
103
40,333
44,608
Female adult or adolescent
Totale
Abbreviation: IDU, injection drug use.
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
Reported numbers less than 12, as well as estimated numbers (and accompanying trends) based on these numbers, should be interpreted with caution because the numbers have underlying
relative standard errors greater than 30% and are considered unreliable.
a Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
b Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
c Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting.
d Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
e Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
f Hispanics/Latinos can be of any race.
HIV Surveillance Report
49
Vol. 26
Table 6a. Stage 3 (AIDS), by transmission category, race/ethnicity, and selected characteristics, 2014—United States
Male-to-male
sexual contact
No.
Est. No.
Male-to-male sexual
contact and IDU
IDU
c
No.
Est. No.
c
No.
c
Est. No.
Heterosexual
contacta
No.
Est. No.
Otherb
c
Total
No.
Est. No.
c
No.
Est. No.c,d
American Indian/Alaska Native
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
0
0
4
5
6
3
7
6
5
2
0
0
0
0
4
6
7
4
10
8
5
2
0
1
0
0
0
2
1
0
4
0
2
1
0
0
0
0
0
2
1
0
4
0
2
1
0
0
0
0
0
0
1
0
0
2
2
0
0
0
0
0
0
0
1
0
0
2
2
0
0
0
0
0
0
0
2
0
1
0
0
1
0
0
0
0
0
0
2
0
1
1
0
1
0
0
0
0
0
1
1
1
3
2
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
8
11
4
15
10
9
4
0
1
0
0
4
8
11
4
16
11
10
4
0
1
Region of residence
Northeast
Midwest
South
West
0
3
8
27
0
4
11
32
0
1
4
5
0
1
5
5
0
2
1
2
0
2
1
3
1
0
0
3
1
0
1
3
0
1
3
5
0
0
0
0
1
7
16
42
1
7
17
44
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
0
0
0
1
2
2
0
1
0
1
0
0
0
0
0
1
3
3
0
1
0
1
0
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
0
0
1
0
0
1
1
4
1
2
0
0
0
0
2
2
2
2
1
4
1
2
0
0
0
0
1
2
2
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
3
4
4
1
5
1
3
0
0
0
0
2
3
4
4
1
5
1
3
0
Region of residence
Northeast
Midwest
South
West
—
—
—
—
—
—
—
—
0
0
3
4
0
0
4
5
—
—
—
—
—
—
—
—
1
2
1
6
1
3
3
9
0
1
2
3
0
0
0
0
1
3
6
13
1
3
6
14
38
46
17
20
5
7
14
20
15
0
89
94
Female adult or adolescent
Subtotale
HIV Surveillance Report
50
Vol. 26
Table 6a. Stage 3 (AIDS), by transmission category, race/ethnicity, and selected characteristics, 2014—United States (cont)
Male-to-male
sexual contact
No.
Male-to-male sexual
contact and IDU
IDU
c
Est. No.
No.
Est. No.
c
No.
c
Est. No.
Heterosexual
contacta
No.
Est. No.
Otherb
c
Total
No.
Est. No.
c
No.
Est. No.c,d
Asianf
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
0
0
13
23
28
27
31
28
7
3
1
2
0
0
16
28
38
41
43
42
13
5
2
6
0
0
0
0
1
1
2
1
1
0
0
0
0
0
0
0
1
2
2
2
2
0
0
1
0
0
0
2
0
2
5
0
0
0
0
0
0
0
0
2
1
3
6
0
0
0
0
0
0
0
0
2
4
2
3
4
3
2
0
0
0
0
0
2
4
4
5
5
4
3
0
2
1
0
2
3
8
13
11
13
6
3
1
6
1
0
0
0
0
0
0
0
0
0
0
0
1
0
15
30
41
45
52
46
17
8
2
8
1
0
16
32
45
50
57
50
19
9
2
9
Region of residence
Northeast
Midwest
South
West
32
18
30
83
45
26
53
109
1
0
3
2
3
1
4
3
0
2
0
7
0
2
0
8
2
7
4
7
5
10
7
10
13
10
22
22
0
0
0
1
48
37
59
121
53
39
65
132
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
0
0
1
1
0
0
0
0
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
0
3
4
4
8
2
5
1
2
2
1
0
0
5
9
5
13
6
7
4
7
2
1
0
0
2
4
1
4
3
1
3
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
8
5
12
6
7
4
7
2
1
0
0
5
9
5
13
7
8
4
8
2
1
Region of residence
Northeast
Midwest
South
West
—
—
—
—
—
—
—
—
0
0
0
2
0
0
0
3
—
—
—
—
—
—
—
—
3
7
10
12
6
7
17
27
3
0
6
14
0
0
0
1
6
7
16
28
7
7
17
31
163
234
8
14
9
11
52
89
90
2
322
351
Female adult or adolescent
Subtotale
HIV Surveillance Report
51
Vol. 26
Table 6a. Stage 3 (AIDS), by transmission category, race/ethnicity, and selected characteristics, 2014—United States (cont)
Male-to-male
sexual contact
No.
Male-to-male sexual
contact and IDU
IDU
c
Est. No.
No.
Est. No.
c
No.
c
Est. No.
Heterosexual
contacta
No.
Est. No.
Otherb
c
Total
No.
Est. No.
c
No.
Est. No.c,d
Black/African American
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
0
82
511
734
456
306
276
255
187
130
62
37
1
103
643
941
650
458
442
415
309
216
100
64
0
0
1
3
11
26
24
47
60
64
49
32
0
1
8
19
30
50
55
91
101
104
74
54
0
2
7
16
11
7
13
21
23
22
8
5
0
3
13
28
24
19
25
35
34
30
13
8
1
3
29
56
93
109
124
147
144
92
46
55
1
5
45
83
132
159
188
231
230
170
96
110
4
23
105
161
188
176
208
230
204
164
92
89
3
9
9
3
2
2
1
1
2
1
0
3
5
110
653
970
759
624
645
700
618
472
257
218
5
120
718
1,075
839
688
710
772
677
521
283
239
Region of residence
Northeast
Midwest
South
West
425
524
1,826
261
593
683
2,716
351
74
24
196
23
168
44
343
31
19
20
71
25
30
30
139
33
171
78
622
28
280
121
1,003
47
287
170
1,104
83
10
6
17
2
976
816
3,819
420
1,081
885
4,219
464
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
1
2
4
5
10
34
46
55
42
12
9
0
2
10
22
25
40
74
84
90
67
26
21
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
8
57
135
206
206
204
197
177
115
79
58
1
20
124
269
379
411
397
375
335
233
145
120
8
26
86
131
160
196
190
177
154
116
65
61
8
17
26
7
2
0
0
1
0
0
0
1
8
35
145
270
371
412
428
420
386
273
156
128
9
39
160
298
406
451
472
460
426
301
171
141
Region of residence
Northeast
Midwest
South
West
—
—
—
—
—
—
—
—
57
35
116
12
125
64
249
24
—
—
—
—
—
—
—
—
244
141
1,000
57
512
313
1,855
129
287
179
831
73
14
8
37
4
588
355
1,947
142
652
385
2,141
156
3,036
4,343
537
1,050
135
233
2,341
4,260
3,014
98
9,063
9,982
Female adult or adolescent
Subtotale
HIV Surveillance Report
52
Vol. 26
Table 6a. Stage 3 (AIDS), by transmission category, race/ethnicity, and selected characteristics, 2014—United States (cont)
Male-to-male
sexual contact
No.
Male-to-male sexual
contact and IDU
IDU
c
Est. No.
No.
Est. No.
c
No.
c
Est. No.
Heterosexual
contacta
No.
Est. No.
Otherb
c
Total
No.
Est. No.
c
No.
Est. No.c,d
Hispanic/Latinog
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
0
12
193
365
352
314
242
227
139
71
32
26
0
13
237
446
464
440
346
319
194
110
58
38
0
0
2
10
19
32
27
26
42
26
10
6
0
0
4
15
29
48
41
44
58
40
20
13
0
0
5
13
20
14
13
13
8
6
5
3
0
0
8
18
27
21
21
18
11
8
8
4
0
0
8
30
33
40
44
47
31
21
9
16
0
0
9
37
41
56
59
64
43
32
21
26
1
4
37
57
93
119
103
96
63
50
42
24
1
4
8
1
2
0
1
0
1
0
0
0
1
16
245
475
517
519
429
409
283
174
98
75
1
17
267
518
563
565
468
446
308
190
106
81
Region of residence
Northeast
Midwest
South
West
321
139
799
714
466
194
1,075
929
77
8
61
54
138
13
93
70
16
7
35
42
24
11
52
57
75
14
143
47
109
21
192
67
184
52
285
168
12
2
6
0
673
220
1,323
1,025
749
240
1,418
1,123
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
0
2
8
10
10
14
12
20
8
3
0
0
1
3
13
15
18
21
23
27
13
6
3
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
3
10
21
48
56
60
39
29
27
14
6
1
6
17
47
75
101
94
80
54
49
27
18
3
8
17
30
25
41
32
43
25
21
13
14
2
5
11
5
0
0
1
0
0
0
0
0
3
11
29
59
83
107
106
94
74
56
30
20
3
12
32
64
90
119
116
103
81
61
33
22
Region of residence
Northeast
Midwest
South
West
—
—
—
—
—
—
—
—
40
4
27
16
69
7
45
24
—
—
—
—
—
—
—
—
86
23
152
52
184
34
244
107
109
12
94
57
10
1
7
7
235
39
273
125
262
42
295
138
1,973
2,665
287
457
100
144
592
956
961
45
3,913
4,267
Female adult or adolescent
Subtotale
HIV Surveillance Report
53
Vol. 26
Table 6a. Stage 3 (AIDS), by transmission category, race/ethnicity, and selected characteristics, 2014—United States (cont)
Male-to-male
sexual contact
No.
Male-to-male sexual
contact and IDU
IDU
c
Est. No.
No.
Est. No.
c
No.
c
Est. No.
Heterosexual
contacta
No.
Est. No.
Otherb
c
Total
No.
Est. No.
c
No.
Est. No.c,d
Native Hawaiian/Other Pacific Islander
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
0
0
0
1
3
2
1
3
1
0
0
0
0
0
0
1
3
3
1
3
1
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
4
3
2
3
1
0
1
0
0
0
0
1
4
3
2
3
1
0
1
0
Region of residence
Northeast
Midwest
South
West
0
1
1
9
0
1
2
10
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
1
0
0
1
0
0
0
1
0
0
0
1
1
0
0
0
0
0
1
3
11
0
1
3
12
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
1
0
0
0
0
1
1
0
0
0
0
0
1
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
1
1
0
0
0
0
0
1
0
0
0
0
1
1
0
Region of residence
Northeast
Midwest
South
West
—
—
—
—
—
—
—
—
0
0
0
0
0
0
0
0
—
—
—
—
—
—
—
—
0
0
1
0
0
0
1
2
0
0
0
2
0
0
0
0
0
0
1
2
0
0
1
2
11
13
0
0
1
1
2
4
4
0
18
19
Female adult or adolescent
Subtotale
HIV Surveillance Report
54
Vol. 26
Table 6a. Stage 3 (AIDS), by transmission category, race/ethnicity, and selected characteristics, 2014—United States (cont)
Male-to-male
sexual contact
No.
Male-to-male sexual
contact and IDU
IDU
c
Est. No.
No.
Est. No.
c
No.
c
Est. No.
Heterosexual
contacta
No.
Est. No.
Otherb
c
Total
No.
Est. No.
c
No.
Est. No.c,d
White
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
0
7
108
232
304
271
332
474
407
254
147
120
0
10
128
292
392
363
457
631
563
353
194
181
0
1
7
11
19
30
40
47
39
29
12
11
0
1
8
13
22
34
46
56
49
38
15
19
0
1
15
26
29
29
44
46
47
20
9
3
0
1
17
31
36
36
53
59
59
25
11
5
0
0
4
13
14
18
26
36
44
19
18
11
0
0
4
15
17
22
31
47
55
31
25
21
0
5
16
44
60
69
99
119
131
85
41
62
0
3
4
3
1
1
2
1
3
0
2
2
0
14
150
326
426
417
541
722
668
407
227
207
0
15
162
355
466
456
590
793
729
447
247
228
Region of residence
Northeast
Midwest
South
West
374
479
1,138
665
509
639
1,541
875
34
29
100
83
52
35
118
94
28
40
101
100
36
51
129
119
47
28
87
41
62
35
120
51
111
139
328
153
5
6
11
1
594
715
1,754
1,042
664
766
1,919
1,140
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
0
9
19
9
25
29
29
30
17
10
1
0
0
12
23
15
33
40
39
40
27
14
4
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
1
11
33
42
47
41
36
42
36
9
17
0
2
21
47
69
72
79
74
75
65
19
29
0
2
14
13
25
23
39
39
34
32
12
13
0
1
5
0
0
0
0
0
0
1
0
2
0
3
34
65
76
95
109
104
106
85
31
31
0
3
38
70
84
104
119
113
115
93
34
35
Region of residence
Northeast
Midwest
South
West
—
—
—
—
—
—
—
—
29
17
87
45
48
25
116
59
—
—
—
—
—
—
—
—
43
55
174
43
85
94
290
81
50
39
116
41
4
1
5
1
122
111
377
129
137
120
411
140
2,656
3,564
424
547
269
335
518
818
977
33
4,844
5,297
Female adult or adolescent
Subtotale
HIV Surveillance Report
55
Vol. 26
Table 6a. Stage 3 (AIDS), by transmission category, race/ethnicity, and selected characteristics, 2014—United States (cont)
Male-to-male
sexual contact
No.
Male-to-male sexual
contact and IDU
IDU
c
Est. No.
No.
Est. No.
c
No.
c
Est. No.
Heterosexual
contacta
No.
Est. No.
Otherb
c
Total
No.
Est. No.
c
No.
Est. No.c,d
Multiple races
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
0
8
43
59
30
31
37
38
31
18
3
5
0
9
49
70
43
47
50
51
48
28
7
9
0
0
1
1
2
5
1
4
5
10
3
1
0
0
1
1
2
6
3
5
8
13
4
3
0
0
2
5
6
4
2
5
5
5
2
0
0
0
2
6
8
6
3
7
7
7
3
1
0
1
0
2
5
5
9
11
4
9
0
1
0
1
0
2
6
6
11
15
7
12
2
4
2
1
2
5
12
13
10
13
17
11
6
9
2
1
0
0
1
0
0
0
0
0
0
0
2
10
48
72
55
58
59
71
62
53
14
16
2
11
53
80
61
65
67
80
69
59
16
18
Region of residence
Northeast
Midwest
South
West
52
54
151
46
74
70
206
62
13
2
10
8
21
3
14
9
5
6
9
16
8
8
16
19
12
9
26
0
20
11
35
1
28
13
49
11
1
1
2
0
110
84
245
81
124
93
274
91
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
0
0
3
3
0
3
7
5
3
3
2
0
0
0
5
4
3
5
11
8
4
3
3
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
4
8
7
9
15
17
8
8
2
8
4
0
4
10
13
13
29
26
16
15
4
10
6
0
4
3
7
4
15
8
9
7
2
2
2
0
4
1
1
1
0
0
0
0
0
0
0
0
8
11
17
16
30
28
24
20
7
13
8
0
9
12
19
18
32
31
26
23
8
14
9
Region of residence
Northeast
Midwest
South
West
—
—
—
—
—
—
—
—
14
2
9
4
20
4
17
6
—
—
—
—
—
—
—
—
19
12
53
6
31
19
87
9
16
8
36
3
5
1
2
0
49
22
98
13
55
24
106
15
303
412
62
93
36
51
137
213
164
13
702
782
Female adult or adolescent
Subtotale
HIV Surveillance Report
56
Vol. 26
Table 6a. Stage 3 (AIDS), by transmission category, race/ethnicity, and selected characteristics, 2014—United States (cont)
Male-to-male
sexual contact
No.
Male-to-male sexual
contact and IDU
IDU
c
Est. No.
No.
Est. No.
c
No.
c
Est. No.
Heterosexual
contacta
No.
Est. No.
Otherb
c
Total
No.
Est. No.
c
No.
Est. No.c,d
Total
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
0
109
872
1,419
1,179
954
926
1,031
777
478
245
190
1
134
1,078
1,785
1,598
1,356
1,349
1,470
1,133
713
361
299
0
1
11
27
53
94
98
125
149
130
74
50
0
2
21
50
86
141
151
198
220
195
113
91
0
3
29
62
68
56
77
87
85
53
24
11
0
4
40
87
98
86
109
121
114
70
35
18
1
4
41
103
151
174
208
245
226
144
73
83
1
6
59
140
202
246
296
364
340
249
144
163
8
33
162
271
362
392
434
473
421
313
183
191
8
18
22
8
5
3
4
1
6
1
2
6
9
150
1,115
1,882
1,813
1,670
1,743
1,961
1,658
1,118
599
525
10
164
1,221
2,070
1,990
1,832
1,910
2,155
1,813
1,229
655
576
Region of residence
Northeast
Midwest
South
West
1,204
1,218
3,953
1,805
1,687
1,617
5,605
2,369
199
64
374
175
382
96
577
212
68
77
217
193
99
104
338
241
308
136
883
126
477
197
1,359
179
623
385
1,792
443
28
16
36
5
2,402
1,880
7,219
2,742
2,672
2,031
7,915
3,006
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
1
13
34
28
47
83
95
111
70
29
12
0
4
26
63
61
96
144
159
167
111
51
32
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
16
89
201
309
332
325
286
261
183
115
86
2
32
178
386
543
627
604
551
487
360
206
174
11
40
122
186
218
281
273
269
223
177
92
90
10
27
43
13
4
0
2
2
0
2
1
2
11
57
224
421
555
660
681
650
595
430
236
188
12
63
246
461
608
723
749
712
655
473
258
208
Region of residence
Northeast
Midwest
South
West
—
—
—
—
—
—
—
—
140
58
242
83
262
100
430
121
—
—
—
—
—
—
—
—
396
240
1,391
176
819
470
2,497
363
465
239
1,085
193
32
11
50
12
1,001
537
2,718
452
1,114
581
2,977
496
8,180
11,277
1,335
2,181
555
782
3,656
6,361
5,225
191
18,951
20,792
Female adult or adolescent
Totale
Abbreviation: IDU, injection drug use.
Note. Reported numbers less than 12, as well as estimated numbers (and accompanying trends) based on these numbers, should be interpreted with caution because the numbers have
underlying relative standard errors greater than 30% and are considered unreliable.
a Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
b Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
c Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting.
d Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
e Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
f Includes Asian/Pacific Islander legacy cases (see Technical Notes).
g Hispanics/Latinos can be of any race.
HIV Surveillance Report
57
Vol. 26
Table 6b. Stage 3 (AIDS), by transmission category, race/ethnicity, and selected characteristics, 2014—United States and 6 dependent areas
Male-to-male
sexual contact
No.
Est. No.c
Male-to-male sexual
contact and IDU
IDU
No.
Est. No.c
No.
Est. No.c
Heterosexual
contacta
No.
Est. No.c
Otherb
Total
No.
Est. No.c
No.
Est. No.c,d
American Indian/Alaska Native
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
0
0
4
5
6
3
7
6
5
2
0
0
0
0
4
6
7
4
10
8
5
2
0
1
0
0
0
2
1
0
4
0
2
1
0
0
0
0
0
2
1
0
4
0
2
1
0
0
0
0
0
0
1
0
0
2
2
0
0
0
0
0
0
0
1
0
0
2
2
0
0
0
0
0
0
0
2
0
1
0
0
1
0
0
0
0
0
0
2
0
1
1
0
1
0
0
0
0
0
1
1
1
3
2
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
8
11
4
15
10
9
4
0
1
0
0
4
8
11
4
16
11
10
4
0
1
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
0
3
8
27
0
0
4
11
32
0
0
1
4
5
0
0
1
5
5
0
0
2
1
2
0
0
2
1
3
0
1
0
0
3
0
1
0
1
3
0
0
1
3
5
0
0
0
0
0
0
1
7
16
42
0
1
7
17
44
0
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
0
0
0
1
2
2
0
1
0
1
0
0
0
0
0
1
3
3
0
1
0
1
0
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
0
0
1
0
0
1
1
4
1
2
0
0
0
0
2
2
2
2
1
4
1
2
0
0
0
0
1
2
2
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
3
4
4
1
5
1
3
0
0
0
0
2
3
4
4
1
5
1
3
0
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
0
0
0
0
0
0
0
0
0
0
0
0
3
4
0
0
0
4
5
0
0
0
0
0
0
0
0
0
0
0
1
2
1
6
0
1
3
3
9
0
0
1
2
3
0
0
0
0
0
0
1
3
6
13
0
1
3
6
14
0
38
46
17
20
5
7
14
20
15
0
89
94
Female adult or adolescent
Subtotale
HIV Surveillance Report
58
Vol. 26
Table 6b. Stage 3 (AIDS), by transmission category, race/ethnicity, and selected characteristics, 2014—United States and 6 dependent areas (cont)
Male-to-male
sexual contact
No.
Male-to-male sexual
contact and IDU
IDU
c
Est. No.
No.
Est. No.
c
No.
c
Est. No.
Heterosexual
contacta
No.
Est. No.
Otherb
c
Total
No.
Est. No.
c
No.
Est. No.c,d
Asianf
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
0
0
13
23
28
27
31
28
8
3
1
2
0
0
16
28
38
41
43
42
14
5
2
6
0
0
0
0
1
1
2
1
1
0
0
0
0
0
0
0
1
2
2
2
2
0
0
1
0
0
0
2
0
2
5
0
0
0
0
0
0
0
0
2
1
3
6
0
0
0
0
0
0
0
0
2
4
2
3
4
3
2
0
0
0
0
0
2
4
4
5
5
4
3
0
2
1
0
2
3
8
13
11
13
6
3
1
6
1
0
0
0
0
0
0
0
0
0
0
0
1
0
15
30
41
45
52
46
18
8
2
8
1
0
16
32
45
50
57
50
20
9
2
9
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
32
18
30
83
1
45
26
53
109
1
1
0
3
2
0
3
1
4
3
0
0
2
0
7
0
0
2
0
8
0
2
7
4
7
0
5
10
7
10
0
13
10
22
22
0
0
0
0
1
0
48
37
59
121
1
53
39
65
132
1
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
0
0
1
1
0
0
0
0
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
0
3
4
4
8
2
5
1
2
2
1
0
0
5
9
5
13
6
7
4
7
2
1
0
0
2
4
1
4
3
1
3
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
8
5
12
6
7
4
7
2
1
0
0
5
9
5
13
7
8
4
8
2
1
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
—
—
—
—
—
—
—
—
—
—
0
0
0
2
0
0
0
0
3
0
—
—
—
—
—
—
—
—
—
—
3
7
10
12
0
6
7
17
27
0
3
0
6
14
0
0
0
0
1
0
6
7
16
28
0
7
7
17
31
0
164
235
8
14
9
11
52
89
90
2
323
352
Female adult or adolescent
Subtotale
HIV Surveillance Report
59
Vol. 26
Table 6b. Stage 3 (AIDS), by transmission category, race/ethnicity, and selected characteristics, 2014—United States and 6 dependent areas (cont)
Male-to-male
sexual contact
No.
Male-to-male sexual
contact and IDU
IDU
c
Est. No.
No.
Est. No.
c
No.
c
Est. No.
Heterosexual
contacta
No.
Est. No.
Otherb
c
Total
No.
Est. No.
c
No.
Est. No.c,d
Black/African American
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
0
82
511
734
456
306
276
256
187
130
62
37
1
103
643
941
650
458
442
416
309
216
101
64
0
0
1
3
11
26
24
47
60
64
49
32
0
1
8
19
30
50
55
91
102
104
74
54
0
2
7
16
11
7
13
21
23
22
8
5
0
3
13
28
24
19
25
35
34
30
13
8
1
3
29
56
93
109
124
147
146
92
46
55
1
5
45
83
132
159
188
231
233
170
96
110
4
23
105
161
188
176
209
230
205
164
93
89
3
9
9
3
2
2
1
1
2
1
0
3
5
110
653
970
759
624
646
701
621
472
258
218
5
120
718
1,075
839
688
712
773
681
521
284
239
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
425
524
1,826
261
1
593
683
2,716
351
2
74
24
196
23
0
168
44
343
31
1
19
20
71
25
0
30
30
139
33
0
171
78
622
28
2
280
121
1,003
47
4
287
170
1,104
83
3
10
6
17
2
0
976
816
3,819
420
6
1,081
885
4,219
464
7
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
1
2
4
5
10
34
46
55
42
12
9
0
2
10
22
25
40
74
84
90
67
26
21
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
8
57
135
206
206
204
197
177
115
79
58
1
20
124
269
379
411
397
375
336
233
145
120
8
26
86
131
160
196
190
177
155
116
65
61
8
17
26
7
2
0
0
1
0
0
0
1
8
35
145
270
371
412
428
420
387
273
156
128
9
39
160
298
406
451
472
460
427
301
171
141
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
—
—
—
—
—
—
—
—
—
—
57
35
116
12
0
125
64
249
24
0
—
—
—
—
—
—
—
—
—
—
244
141
1,000
57
0
512
313
1,855
129
1
287
179
831
73
1
14
8
37
4
0
588
355
1,947
142
1
652
385
2,141
156
1
3,037
4,344
537
1,051
135
233
2,343
4,265
3,018
98
9,070
9,991
Female adult or adolescent
Subtotale
HIV Surveillance Report
60
Vol. 26
Table 6b. Stage 3 (AIDS), by transmission category, race/ethnicity, and selected characteristics, 2014—United States and 6 dependent areas (cont)
Male-to-male
sexual contact
No.
Male-to-male sexual
contact and IDU
IDU
c
Est. No.
No.
Est. No.
c
No.
c
Est. No.
Heterosexual
contacta
No.
Est. No.
Otherb
c
Total
No.
Est. No.
c
No.
Est. No.c,d
Hispanic/Latinog
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
0
13
205
376
363
322
252
239
145
75
36
29
0
15
252
462
479
451
359
335
202
115
63
42
0
0
2
11
21
45
36
39
51
34
11
7
0
0
4
16
33
65
54
60
70
51
22
14
0
0
5
13
20
16
15
16
10
6
5
3
0
0
8
18
27
23
24
22
14
8
8
4
0
0
8
33
36
51
52
56
34
30
17
23
0
0
9
41
45
71
70
77
48
44
34
35
1
4
37
57
94
120
104
97
64
50
44
24
1
4
8
1
2
0
1
0
1
0
0
0
1
17
257
490
534
554
459
447
304
195
113
86
1
19
282
538
586
611
508
494
335
219
128
95
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
321
139
799
714
82
466
194
1,075
929
111
77
8
61
54
57
138
13
93
70
76
16
7
35
42
9
24
11
52
57
12
75
14
143
47
61
109
21
192
67
86
184
52
285
168
7
12
2
6
0
0
673
220
1,323
1,025
216
749
240
1,418
1,123
285
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
0
2
9
15
12
18
15
24
12
3
0
0
1
3
14
21
21
27
28
33
18
6
3
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
4
11
23
57
64
72
44
37
36
16
10
1
9
19
49
88
112
114
88
66
60
29
23
3
10
18
30
26
41
35
44
26
21
13
14
2
6
12
5
0
0
1
0
0
0
0
0
3
14
31
62
98
117
125
103
87
69
32
24
3
17
35
68
110
133
142
116
99
78
35
26
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
—
—
—
—
—
—
—
—
—
—
40
4
27
16
23
69
7
45
24
31
—
—
—
—
—
—
—
—
—
—
86
23
152
52
61
184
34
244
107
90
109
12
94
57
9
10
1
7
7
3
235
39
273
125
93
262
42
295
138
124
2,055
2,776
367
565
109
156
714
1,132
977
47
4,222
4,676
Female adult or adolescent
Subtotale
HIV Surveillance Report
61
Vol. 26
Table 6b. Stage 3 (AIDS), by transmission category, race/ethnicity, and selected characteristics, 2014—United States and 6 dependent areas (cont)
Male-to-male
sexual contact
No.
Male-to-male sexual
contact and IDU
IDU
c
Est. No.
No.
Est. No.
c
No.
c
Est. No.
Heterosexual
contacta
No.
Est. No.
Otherb
c
Total
No.
Est. No.
c
No.
Est. No.c,d
Native Hawaiian/Other Pacific Islander
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
0
0
0
1
3
2
1
3
1
0
0
0
0
0
0
1
3
3
1
3
1
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
4
3
2
3
1
0
1
0
0
0
0
1
4
3
2
3
1
0
1
0
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
0
1
1
9
0
0
1
2
10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
1
0
0
0
1
0
0
0
0
1
0
0
0
0
1
1
0
0
0
0
0
0
0
1
3
11
0
0
1
3
12
0
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
1
0
0
0
0
1
1
0
0
0
0
0
1
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
1
1
0
0
0
0
0
1
0
0
0
0
1
1
0
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
—
—
—
—
—
—
—
—
—
—
0
0
0
0
0
0
0
0
0
0
—
—
—
—
—
—
—
—
—
—
0
0
1
0
0
0
0
1
2
0
0
0
0
2
0
0
0
0
0
0
0
0
1
2
0
0
0
1
2
0
11
13
0
0
1
1
2
4
4
0
18
19
Female adult or adolescent
Subtotale
HIV Surveillance Report
62
Vol. 26
Table 6b. Stage 3 (AIDS), by transmission category, race/ethnicity, and selected characteristics, 2014—United States and 6 dependent areas (cont)
Male-to-male
sexual contact
No.
Male-to-male sexual
contact and IDU
IDU
c
Est. No.
No.
Est. No.
c
No.
c
Est. No.
Heterosexual
contacta
No.
Est. No.
Otherb
c
Total
No.
Est. No.
c
No.
Est. No.c,d
White
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
0
7
108
232
304
271
332
474
408
254
147
120
0
10
128
292
392
363
457
631
564
353
194
181
0
1
7
11
19
30
40
47
39
29
12
11
0
1
8
13
22
34
46
56
49
38
15
19
0
1
15
26
29
29
44
46
47
20
9
3
0
1
17
31
36
36
53
59
59
25
11
5
0
0
4
13
14
18
26
36
44
19
18
11
0
0
4
15
17
22
31
47
55
31
25
21
0
5
16
44
60
69
99
119
131
85
41
62
0
3
4
3
1
1
2
1
3
0
2
2
0
14
150
326
426
417
541
722
669
407
227
207
0
15
162
355
466
456
590
793
731
447
247
228
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
374
479
1,138
665
1
509
639
1,541
875
1
34
29
100
83
0
52
35
118
94
0
28
40
101
100
0
36
51
129
119
0
47
28
87
41
0
62
35
120
51
0
111
139
328
153
0
5
6
11
1
0
594
715
1,754
1,042
1
664
766
1,919
1,140
1
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
0
9
19
9
25
29
29
30
17
10
1
0
0
12
23
15
33
40
39
40
27
14
4
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
1
11
33
42
47
41
36
42
36
9
17
0
2
21
47
69
72
79
74
75
65
19
29
0
2
14
13
25
23
39
39
34
32
12
13
0
1
5
0
0
0
0
0
0
1
0
2
0
3
34
65
76
95
109
104
106
85
31
31
0
3
38
70
84
104
119
113
115
93
34
35
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
—
—
—
—
—
—
—
—
—
—
29
17
87
45
0
48
25
116
59
0
—
—
—
—
—
—
—
—
—
—
43
55
174
43
0
85
94
290
81
0
50
39
116
41
0
4
1
5
1
0
122
111
377
129
0
137
120
411
140
0
2,657
3,565
424
547
269
335
518
818
977
33
4,845
5,298
Female adult or adolescent
Subtotale
HIV Surveillance Report
63
Vol. 26
Table 6b. Stage 3 (AIDS), by transmission category, race/ethnicity, and selected characteristics, 2014—United States and 6 dependent areas (cont)
Male-to-male
sexual contact
No.
Male-to-male sexual
contact and IDU
IDU
c
Est. No.
No.
Est. No.
c
No.
c
Est. No.
Heterosexual
contacta
No.
Est. No.
Otherb
c
Total
No.
Est. No.
c
No.
Est. No.c,d
Multiple races
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
0
8
43
59
30
31
37
38
31
19
3
5
0
9
49
70
43
47
50
51
48
29
7
9
0
0
1
1
2
5
1
4
5
10
3
1
0
0
1
1
2
6
3
5
8
13
4
3
0
0
2
5
6
4
2
5
5
5
2
0
0
0
2
6
8
6
3
7
7
7
3
1
0
1
0
2
5
5
9
11
4
9
0
1
0
1
0
2
6
6
11
15
7
12
2
4
2
1
2
5
12
13
10
13
17
11
6
9
2
1
0
0
1
0
0
0
0
0
0
0
2
10
48
72
55
58
59
71
62
54
14
16
2
11
53
80
61
65
67
80
69
61
16
18
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
52
54
151
46
1
74
70
206
62
2
13
2
10
8
0
21
3
14
9
0
5
6
9
16
0
8
8
16
19
0
12
9
26
0
0
20
11
35
1
0
28
13
49
11
0
1
1
2
0
0
110
84
245
81
1
124
93
274
91
2
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
0
0
3
3
0
3
7
5
3
3
2
0
0
0
5
4
3
5
11
8
4
3
3
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
4
8
7
9
15
17
8
8
2
8
4
0
4
10
13
13
29
26
16
15
4
10
6
0
4
3
7
4
15
8
9
7
2
2
2
0
4
1
1
1
0
0
0
0
0
0
0
0
8
11
17
16
30
28
24
20
7
13
8
0
9
12
19
18
32
31
26
23
8
14
9
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
—
—
—
—
—
—
—
—
—
—
14
2
9
4
0
20
4
17
6
0
—
—
—
—
—
—
—
—
—
—
19
12
53
6
0
31
19
87
9
0
16
8
36
3
0
5
1
2
0
0
49
22
98
13
0
55
24
106
15
0
304
414
62
93
36
51
137
213
164
13
703
783
Female adult or adolescent
Subtotale
HIV Surveillance Report
64
Vol. 26
Table 6b. Stage 3 (AIDS), by transmission category, race/ethnicity, and selected characteristics, 2014—United States and 6 dependent areas (cont)
Male-to-male
sexual contact
No.
Male-to-male sexual
contact and IDU
IDU
c
Est. No.
No.
Est. No.
c
No.
c
Est. No.
Heterosexual
contacta
No.
Est. No.
Otherb
c
Total
No.
Est. No.
c
No.
Est. No.c,d
Total
Male adult or adolescent
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
0
110
884
1,430
1,190
962
936
1,044
785
483
249
193
1
136
1,093
1,801
1,613
1,367
1,363
1,487
1,143
720
368
303
0
1
11
28
55
107
107
138
158
138
75
51
0
2
21
51
90
158
164
214
232
206
116
92
0
3
29
62
68
58
79
90
87
53
24
11
0
4
40
87
98
88
112
125
117
70
35
18
1
4
41
106
154
185
216
254
231
153
81
90
1
6
59
144
207
262
308
376
347
262
157
172
8
33
162
271
363
393
436
474
423
313
186
191
8
18
22
8
5
3
4
1
6
1
2
6
9
151
1,127
1,897
1,830
1,705
1,774
2,000
1,684
1,140
615
536
10
166
1,236
2,090
2,013
1,878
1,951
2,204
1,846
1,259
678
590
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
1,204
1,218
3,953
1,805
86
1,687
1,617
5,605
2,369
117
199
64
374
175
57
382
96
577
212
78
68
77
217
193
9
99
104
338
241
12
308
136
883
126
63
477
197
1,359
179
90
623
385
1,792
443
10
28
16
36
5
0
2,402
1,880
7,219
2,742
225
2,672
2,031
7,915
3,006
297
Age at diagnosis (yr)
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
1
13
35
33
49
87
98
115
74
29
12
0
4
26
64
67
99
149
163
173
116
51
32
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
0
17
90
203
318
340
337
291
269
192
117
90
2
35
179
388
557
638
624
559
500
371
209
179
11
42
123
186
219
281
276
270
225
177
92
90
10
29
44
13
4
0
2
2
0
2
1
2
11
60
226
424
570
670
700
659
609
443
238
192
12
68
249
465
628
737
775
724
673
489
260
213
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
—
—
—
—
—
—
—
—
—
—
140
58
242
83
23
262
100
430
121
31
—
—
—
—
—
—
—
—
—
—
396
240
1,391
176
61
819
470
2,497
363
91
465
239
1,085
193
10
32
11
50
12
3
1,001
537
2,718
452
94
1,114
581
2,977
496
125
8,266
11,394
1,415
2,290
564
794
3,780
6,542
5,245
193
19,270
21,214
Female adult or adolescent
Totale
Abbreviation: IDU, injection drug use.
Note. Reported numbers less than 12, as well as estimated numbers (and accompanying trends) based on these numbers, should be interpreted with caution because the numbers have
underlying relative standard errors greater than 30% and are considered unreliable.
a Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
b Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
c Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting.
d Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
e Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
f Includes Asian/Pacific Islander legacy cases (see Technical Notes).
g Hispanics/Latinos can be of any race.
HIV Surveillance Report
65
Vol. 26
HIV Surveillance Report
Table 7a. Diagnoses of HIV infection among children aged <13 years, by race/ethnicity, 2010–2014—United States
2010
2011
Estimated
Race/ethnicity
a
2012
Estimated
a
No.
No.
Rate
No.
No.
Rate
American Indian/Alaska Native
0
0
0.0
1
1
0.2
Asian
3
3
0.1
6
6
0.3
147
150
2.1
117
121
1.7
37
38
0.3
22
23
0
0
0.0
0
0
White
31
32
0.1
34
Multiple races
14
14
0.7
232
238
0.4
Black/African American
Hispanic/Latinob
Native Hawaiian/Other Pacific Islander
Totalc
2013
a
Estimated
No.
No.
Rate
0
0
0.0
13
14
0.6
168
175
2.4
0.2
15
16
0.0
1
1
35
0.1
32
12
13
0.6
192
198
0.4
2014
Estimated
No.
a
No.
Rate
0
0
0.0
15
16
0.6
120
127
1.8
0.1
10
11
1.0
0
0
33
0.1
23
11
12
0.5
240
250
0.5
Estimateda
No.
No.
Rate
3
3
0.7
10
11
0.4
98
108
1.5
0.1
16
18
0.1
0.0
1
1
1.0
24
0.1
26
28
0.1
12
13
0.6
5
5
0.2
180
191
0.4
159
174
0.3
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
Reported numbers less than 12, as well as estimated numbers (and accompanying rates and trends) based on these numbers, should be interpreted with caution because the numbers have underlying
relative standard errors greater than 30% and are considered unreliable.
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting. Rates are per 100,000 population.
b Hispanics/Latinos can be of any race.
66
c Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Table 7b. Diagnoses of HIV infection among children aged <13 years, by race/ethnicity, 2010–2014—United States and 6 dependent areas
2010
Race/ethnicity
No.
2011
Est. No.
a
No.
2012
Est. No.
a
No.
2013
Est. No.
a
No.
2014
Est. No.
a
No.
Est. No.a
American Indian/Alaska Native
0
0
1
1
0
0
0
0
3
3
Asian
3
3
6
6
13
14
15
16
10
11
147
150
117
121
168
175
120
127
98
108
41
42
24
25
15
16
10
11
17
19
0
0
0
0
1
1
0
0
1
1
White
31
32
34
35
32
33
23
24
26
28
Multiple races
14
14
12
13
11
12
12
13
5
5
236
242
194
200
240
250
180
191
160
176
Black/African American
Hispanic/Latinob
Native Hawaiian/Other Pacific Islander
Totalc
Vol. 26
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
Reported numbers less than 12, as well as estimated numbers (and accompanying trends) based on these numbers, should be interpreted with caution because the numbers have
underlying relative standard errors greater than 30% and are considered unreliable.
a
Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting.
b
Hispanics/Latinos can be of any race.
c
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
HIV Surveillance Report
Table 8a. Stage 3 (AIDS) among children aged <13 years, by race/ethnicity, 2010–2014 and cumulative—United States
2010
2011
Estimateda
Race/ethnicity
No.
2012
Estimateda
No.
Rate
No.
No.
Rate
No.
American Indian/Alaska Native
0
Asianc
1
Black/African American
13
Hispanic/Latinod
4
Native Hawaiian/Other Pacific Islander 0
White
3
Multiple races
0
0
1
13
4
0
3
0
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0
0
11
2
0
2
0
0
0
11
2
0
2
0
0.0
0.0
0.2
0.0
0.0
0.0
0.0
0
0
9
0
0
1
0
Totale
21
0.0
15
15
0.0
10
21
2013
Estimateda
2014
Estimateda
Estimateda
Cumulativeb
Rate
No.
No.
Rate
No.
No.
Rate
No.
Est. No.a
0
0
9
0
0
1
0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0
0
4
2
0
0
2
0
0
4
2
0
0
2
0.0
0.0
0.1
0.0
0.0
0.0
0.1
1
1
56
11
0
6
19
1
1
62
12
0
6
21
0.2
0.0
0.9
0.1
0.0
0.0
0.9
27
46
5,674
1,988
6
1,554
266
27
46
5,691
1,993
6
1,556
269
10
0.0
8
8
0.0
94
104
0.2
9,561
9,588
No.
Note. Reported numbers less than 12, as well as estimated numbers (and accompanying rates and trends) based on these numbers, should be interpreted with caution because the numbers have
underlying relative standard errors greater than 30% and are considered unreliable.
The criteria for stage 3 (AIDS) classification among pediatric cases were expanded in 2014 (see Technical Notes).
a
Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting. Rates are per 100,000 population.
b
From the beginning of the epidemic through 2014.
c Includes Asian/Pacific Islander legacy cases (see Technical Notes).
d Hispanics/Latinos can be of any race.
e Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
67
Table 8b. Stage 3 (AIDS) among children aged <13 years, by race/ethnicity, 2010–2014 and cumulative—United States and 6 dependent areas
2010
2011
No.
Est. No.b
No.
Est. No.b
American Indian/Alaska Native
Asianc
Black/African American
Hispanic/Latinod
Native Hawaiian/Other Pacific Islander
White
Multiple races
0
1
13
4
0
3
0
0
1
13
4
0
3
0
0
0
11
2
0
2
0
0
0
11
2
0
2
0
Totale
21
21
15
15
Race/ethnicity
2012
2013
2014
Cumulativea
Est. No.b
No.
Est. No.b
No.
Est. No.b
No.
Est. No.b
0
0
9
0
0
1
0
0
0
9
0
0
1
0
0
0
4
2
0
0
2
0
0
4
2
0
0
2
1
1
56
11
0
6
19
1
1
62
12
0
6
21
27
47
5,686
2,400
6
1,554
266
27
47
5,703
2,406
6
1,556
269
10
10
8
8
94
104
9,986
10,014
No.
Vol. 26
Note. Reported numbers less than 12, as well as estimated numbers (and accompanying trends) based on these numbers, should be interpreted with caution because the numbers have underlying
relative standard errors greater than 30% and are considered unreliable.
The criteria for stage 3 (AIDS) classification among pediatric cases were expanded in 2014 (see Technical Notes).
a
From the beginning of the epidemic through 2014.
b
Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting.
c
Includes Asian/Pacific Islander legacy cases (see Technical Notes).
d
Hispanics/Latinos can be of any race.
e
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Table 9. Stage 3 (AIDS) among children aged <13 years, by year of diagnosis,
1992–2014—United States and 6 dependent areas
United States and
dependent areas
United States
Year of diagnosis
No.
Est. No.a
No.
Est. No.a
1992
908
909
957
958
1993
894
895
932
933
1994
819
820
845
846
1995
675
676
697
698
1996
528
529
541
542
1997
341
342
353
354
1998
250
251
257
258
1999
202
203
206
207
2000
137
137
140
140
2001
132
133
134
135
2002
109
109
116
116
2003
76
76
78
78
2004
59
59
60
60
2005
55
55
55
55
2006
40
41
43
44
2007
35
35
36
36
2008
40
40
41
41
2009
17
17
17
17
2010
21
21
21
21
2011
15
15
15
15
2012
10
10
10
10
2013
8
8
8
8
2014
94
104
94
104
Note. The criteria for stage 3 (AIDS) classification among pediatric cases were expanded in 2014 (see
Technical Notes).
a
Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for
incomplete reporting.
HIV Surveillance Report
68
Vol. 26
HIV Surveillance Report
Table 10. Diagnoses of HIV infection among adult and adolescent Hispanics/Latinos, by transmission category and place of birth, 2014—United States and 6 dependent areas
Central America
No.
Est.
No.a
289
Injection drug use
Male-to-male sexual contact and
injection drug use
Cuba
Mexico
%
No.
Est.
No.a
436
78.9
328
369
88.2
6
21
3.9
2
5
1.3
32
5
11
1.9
3
4
0.9
54
82
14.9
33
40
Otherd
145
2
0.4
28
0
Subtotal
499
553
394
418
0
5
3.6
4
5
13.2
4
10
Heterosexual contactc
68
140
96.2
26
32
86.8
74
Otherd
65
0
0.2
5
0
0.0
Subtotal
133
146
100
35
37
100
Totale
632
698
100
429
455
100
Transmission category
%
Est.
No.a
No.
Puerto Rico
%
No.
Est.
No.a
531
65.7
395
85
123
15.2
1.8
8
12
125
9.1
104
0
0.0
%
No.
85.2
418
53
3.9
13
25
9.6
75
0.0
226
Est.
No.a
South America
United States
Est.
No.a
Total
%
No.b
Est.
No.a,b
86.6
6,003
7,893
84.2
152
4.2
252
474
5.1
111
144
3.9
175
257
2.7
5.1
153
190
5.2
533
744
7.9
0.0
404
5
0.1
1,502
11
0.1
%
No.
%
465
91.4
2,554 3,176
2
6
1.1
89
1.5
10
12
2.4
141
17.4
18
26
95
1
0.2
39
0
710
808
464
509
6.1
17
26
11.3
0
2
4.3
59
103
20.3
99
198
13.3
146
93.6
128
200
88.0
20
36
92.7
219
403
79.0
657
1,282
86.1
63
0
0.2
54
2
0.7
16
1
3.0
183
4
0.8
584
9
0.6
141
156
100
199
228
100
36
39
100
461
510
100
1,340
1,383 1,528
100
909
1,035
100
500
548
100
3,772 4,177
100
9,805 10,868 100
Male adult or adolescent
Male-to-male sexual contact
Heterosexual contactc
100
100
896 1,169
1,242 1,373
100
100
100
3,311 3,667
100
8,465
9,379 100
Female adult or adolescent
69
Injection drug use
1,490 100
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
Reported numbers less than 12, as well as estimated numbers (and accompanying trends) based on these numbers, should be interpreted with caution because the numbers have underlying relative standard errors greater than 30% and are
considered unreliable.
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting.
b Entries include persons whose place of birth is not among those listed and persons whose place of birth is unknown.
c Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
d Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
e Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Vol. 26
HIV Surveillance Report
Table 11. Stage 3 (AIDS) among adult and adolescent Hispanics/Latinos, by transmission category and place of birth, 2014—United States and 6 dependent areas
Central America
No.
Est.
No.a
123
197
Injection drug use
5
Male-to-male sexual contact and
injection drug use
Cuba
No.
Est.
No.a
71.0
95
15
5.4
2
5
Heterosexual contactc
42
Otherd
Mexico
%
No.
Est.
No.a
108
77.7
381
2
4
3.0
1.7
3
4
60
21.5
18
80
1
0.5
252
277
1
6
Heterosexual contactc
39
Otherd
Subtotal
Transmission category
Puerto Rico
%
No.
Est.
No.a
525
77.7
125
164
24
41
6.0
96
2.7
9
18
2.6
23
16.5
56
93
12
0
0.0
153
0
130
139
623
676
7.1
1
1
13.3
3
7
74
92.8
5
8
86.7
47
33
0
0.1
3
0
0.0
73
80
100
9
10
325
357
100
139
149
%
South America
United States
No.
Est.
No.a
40.2
95
112
82.8
123
30.3
3
4
3.1
101
144
9.9
257
390
10.2
17
22
5.3
4
5
3.6
65
85
5.9
109
156
4.1
13.7
68
96
23.6
11
14
10.5
91
111
7.7
340
474
12.4
0.0
22
2
0.6
10
0
0.0
201
15
1.0
696
20
0.5
328
407
123
135
7.2
30
41
22.7
3
4
19.3
63
91
28.2
110
175
20.3
85
91.4
85
134
74.6
10
15
70.0
137
215
66.8
374
658
76.5
36
1
1.4
29
5
2.7
6
2
10.7
93
16
5.0
281
27
3.2
100
86
93
100
144
180
100
19
21
100
293
322
100
765
861
100
100
709
769
100
472
587
100
142
156
100
1,620 1,766
100
4,222 4,676
100
%
%
No.
Est.
No.a
Total
Est.
No.a,b
%
No.b
75.5
2,055 2,776
%
Male adult or adolescent
Male-to-male sexual contact
Subtotal
100
100
100
100
100
869 1,090
1,327 1,444
100
3,457 3,815
72.8
100
Female adult or adolescent
70
Injection drug use
Totale
Note. Reported numbers less than 12, as well as estimated numbers (and accompanying trends) based on these numbers, should be interpreted with caution because the numbers have underlying relative standard errors greater than 30% and are
considered unreliable.
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting.
b Entries include persons whose place of birth is not among those listed and persons whose place of birth is unknown.
c Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
d Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
e Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Vol. 26
HIV Surveillance Report
Table 12a. Deaths of persons with diagnosed HIV infection, by year of death and selected characteristics, 2010–2013—United States
No.
No.
Rate
No.
No.
Rate
No.
No.
Rate
No.
No.
Rate
Age at death (yr)
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
7
3
39
195
420
757
1,192
2,113
3,211
3,181
2,563
1,689
1,690
8
3
41
205
443
795
1,248
2,213
3,361
3,327
2,682
1,767
1,773
0.0
0.0
0.2
0.9
2.1
4.0
6.2
10.6
14.8
14.9
13.6
10.4
4.4
0
1
25
198
413
688
1,051
1,826
2,921
3,144
2,651
1,727
1,825
0
1
27
211
443
735
1,117
1,943
3,111
3,345
2,818
1,837
1,947
0.0
0.0
0.1
1.0
2.1
3.6
5.7
9.2
14.0
14.8
13.9
10.3
4.7
4
2
23
176
417
693
943
1,610
2,609
3,105
2,640
1,868
1,973
5
2
25
193
457
756
1,029
1,751
2,833
3,370
2,862
2,032
2,144
0.0
0.0
0.1
0.9
2.1
3.6
5.3
8.3
13.0
14.9
13.8
11.4
5.0
1
1
11
153
391
572
763
1,298
2,104
2,708
2,386
1,715
1,950
1
1
14
182
468
667
882
1,509
2,422
3,127
2,757
1,985
2,265
0.0
0.0
0.1
0.8
2.2
3.1
4.5
7.2
11.4
13.8
13.0
10.9
5.1
71
Race/ethnicity
American Indian/Alaska Native
Asianb
Black/African American
Hispanic/Latinoc
Native Hawaiian/Other Pacific Islander
White
Multiple races
75
73
8,257
2,703
7
5,135
810
79
76
8,642
2,812
7
5,405
846
3.5
0.5
22.7
5.5
1.4
2.7
15.0
58
86
7,928
2,673
10
4,972
743
61
91
8,434
2,825
10
5,322
789
2.7
0.6
22.0
5.4
2.0
2.7
13.5
54
72
7,682
2,418
7
5,039
791
59
78
8,352
2,594
7
5,512
857
2.6
0.5
21.5
4.9
1.4
2.8
14.2
58
56
6,492
2,348
4
4,327
768
66
64
7,581
2,664
5
5,028
874
2.8
0.4
19.4
4.9
0.9
2.5
14.1
5,410
2,540
1,203
6,881
3,064
1,376
—
—
—
5,287
2,312
1,170
6,865
2,871
1,368
—
—
—
5,203
2,192
1,148
6,868
2,758
1,370
—
—
—
4,827
1,841
1,037
6,660
2,479
1,296
—
—
—
1,284
29
2,162
12,628
1,789
30
89
13,230
—
—
—
10.6
1,261
36
2,148
12,214
1,787
38
93
13,023
—
—
—
10.3
1,205
41
2,043
11,832
1,740
44
87
12,867
—
—
—
10.1
1,078
36
1,678
10,497
1,618
42
75
12,170
—
—
—
9.4
2010
2011
Estimateda
2012
Estimateda
2013
Estimateda
Estimateda
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and
injection drug use
Heterosexual contactd
Perinatal
Othere
Subtotal
Vol. 26
HIV Surveillance Report
Table 12a. Deaths of persons with diagnosed HIV infection, by year of death and selected characteristics, 2010–2013—United States (cont)
2010
2011
a
Female adult or adolescent
Injection drug use
Heterosexual contactd
Perinatal
Othere
Subtotal
Child (<13 yrs at death)
Perinatal
Othere
Subtotal
72
Region of residence
Northeast
Midwest
South
West
Totalf
No.
1,329
1,970
31
1,095
4,425
1,680
2,887
32
30
4,629
6
1
7
Rate
No.
No.
—
—
—
—
3.5
1,327
1,846
45
1,038
4,256
1,669
2,758
48
35
4,510
7
1
8
—
—
0.0
0
0
0
4,596
1,928
8,035
2,501
4,786
2,034
8,426
2,621
8.6
3.0
7.3
3.6
17,060
17,866
5.8
Rate
2013
a
Estimated
Estimated
No.
2012
a
Estimateda
Estimated
No.
No.
—
—
—
—
3.4
1,229
1,879
44
1,075
4,227
1,612
2,889
47
40
4,588
0
0
0
—
—
0.0
3
1
4
4,367
1,860
7,753
2,490
4,610
1,999
8,272
2,653
8.3
3.0
7.1
3.6
16,470
17,534
5.6
Rate
No.
No.
Rate
—
—
—
—
3.4
1,088
1,593
27
847
3,555
1,504
2,544
31
31
4,110
—
—
—
—
3.0
3
1
5
—
—
0.0
1
0
1
1
0
1
—
—
0.0
4,019
1,844
7,710
2,490
4,313
2,024
8,437
2,685
7.7
3.0
7.2
3.6
3,798
1,581
6,461
2,213
4,302
1,888
7,620
2,472
7.7
2.8
6.4
3.3
16,063
17,459
5.6
14,053
16,281
5.1
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. Deaths of persons with diagnosed HIV infection may be due to any cause.
Reported numbers less than 12, as well as estimated numbers (and accompanying rates and trends) based on these numbers, should be interpreted with caution because the numbers have underlying
relative standard errors greater than 30% and are considered unreliable.
a
Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting. Rates are per 100,000 population. Rates
are not calculated by transmission category because of the lack of denominator data.
b
Includes Asian/Pacific Islander legacy cases (see Technical Notes).
c Hispanics/Latinos can be of any race.
d
e
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
f Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Vol. 26
HIV Surveillance Report
Table 12b. Deaths of persons with diagnosed HIV infection, by year of death and selected characteristics, 2010–2013—United States and
6 dependent areas
2010
2011
Estimateda
2012
Estimateda
2013
Estimateda
Estimateda
73
No.
No.
Rate
No.
No.
Rate
No.
No.
Rate
No.
No.
Rate
Age at death (yr)
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
7
3
41
199
433
799
1,249
2,181
3,325
3,268
2,627
1,737
1,749
8
3
43
209
457
840
1,308
2,285
3,481
3,419
2,750
1,818
1,835
0.0
0.0
0.2
1.0
2.1
4.1
6.4
10.8
15.2
15.1
13.7
10.6
4.5
0
1
26
203
427
711
1,097
1,900
3,024
3,251
2,721
1,775
1,886
0
1
28
217
458
760
1,167
2,022
3,221
3,460
2,894
1,889
2,012
0.0
0.0
0.1
1.0
2.1
3.7
5.9
9.5
14.3
15.1
14.1
10.5
4.8
4
2
25
178
428
722
988
1,659
2,705
3,179
2,706
1,910
2,037
5
2
27
195
470
789
1,079
1,804
2,940
3,451
2,936
2,079
2,215
0.0
0.0
0.1
0.9
2.2
3.7
5.5
8.5
13.4
15.1
14.0
11.5
5.1
1
1
11
157
400
594
789
1,334
2,188
2,788
2,445
1,761
2,008
1
1
14
187
480
694
914
1,553
2,522
3,221
2,827
2,038
2,333
0.0
0.0
0.1
0.8
2.2
3.2
4.6
7.3
11.7
14.1
13.2
11.1
5.1
Race/ethnicity
American Indian/Alaska Native
Asianb
Black/African American
Hispanic/Latinoc
Native Hawaiian/Other Pacific Islander
White
Multiple races
75
73
8,263
3,251
7
5,138
811
79
76
8,648
3,391
7
5,408
847
—
—
—
—
—
—
—
58
88
7,935
3,213
11
4,973
744
61
93
8,442
3,409
11
5,324
790
—
—
—
—
—
—
—
54
73
7,691
2,883
7
5,041
794
59
79
8,362
3,110
7
5,514
860
—
—
—
—
—
—
—
58
56
6,497
2,763
6
4,327
770
66
64
7,587
3,155
7
5,028
876
—
—
—
—
—
—
—
5,477
2,742
1,243
6,956
3,286
1,420
—
—
—
5,370
2,509
1,200
6,958
3,094
1,401
—
—
—
5,260
2,356
1,182
6,936
2,948
1,408
—
—
—
4,895
1,960
1,060
6,741
2,626
1,323
—
—
—
1,366
29
2,182
13,039
1,881
30
90
13,664
—
—
—
10.8
1,336
38
2,165
12,618
1,873
40
93
13,459
—
—
—
10.5
1,286
43
2,059
12,186
1,834
46
88
13,260
—
—
—
10.3
1,153
38
1,687
10,793
1,711
44
75
12,519
—
—
—
9.6
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and
injection drug use
Heterosexual contactd
Perinatal
Othere
Subtotal
Vol. 26
HIV Surveillance Report
Table 12b. Deaths of persons with diagnosed HIV infection, by year of death and selected characteristics, 2010–2013—United States and
6 dependent areas (cont)
2010
2011
a
Estimated
Estimated
Female adult or adolescent
Injection drug use
Heterosexual contactd
Perinatal
Othere
Subtotal
Child (<13 yrs at death)
Perinatal
Othere
Subtotal
74
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
Totalf
No.
No.
1,376
2,066
33
1,097
4,572
1,730
2,990
34
30
4,784
6
1
7
2012
Rate
No.
No.
—
—
—
—
3.6
1,376
1,936
48
1,044
4,404
1,723
2,861
51
36
4,671
7
1
8
—
—
0.0
0
0
0
4,596
1,928
8,035
2,501
558
4,786
2,034
8,426
2,621
589
8.6
3.0
7.3
3.6
14.3
17,618
18,456
5.9
a
Rate
2013
Estimated
No.
No.
—
—
—
—
3.5
1,265
1,960
46
1,082
4,353
1,653
2,984
49
41
4,728
0
0
0
—
—
0.0
3
1
4
4,367
1,860
7,753
2,490
552
4,610
1,999
8,272
2,653
597
8.3
3.0
7.1
3.6
14.6
17,022
18,130
5.7
a
Rate
Estimateda
No.
No.
Rate
—
—
—
—
3.5
1,135
1,666
29
853
3,683
1,560
2,638
33
31
4,262
—
—
—
—
3.1
3
1
5
—
—
0.0
1
0
1
1
0
1
—
—
0.0
4,019
1,844
7,710
2,490
480
4,313
2,024
8,437
2,685
533
7.7
3.0
7.2
3.6
13.2
3,798
1,581
6,461
2,213
424
4,302
1,888
7,620
2,472
502
7.7
2.8
6.4
3.3
12.6
16,543
17,992
5.7
14,477
16,783
5.2
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. Deaths of persons with diagnosed HIV infection may be due to any cause.
Reported numbers less than 12, as well as estimated numbers (and accompanying rates and trends) based on these numbers, should be interpreted with caution because the numbers have underlying
relative standard errors greater than 30% and are considered unreliable.
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting. Rates are per 100,000 population. Rates
by race/ethnicity are not provided because U.S. census information for U.S. dependent areas is limited. Rates are not calculated by transmission category because of the lack of denominator data.
b
Includes Asian/Pacific Islander legacy cases (see Technical Notes).
c
Hispanics/Latinos can be of any race.
d Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
e
f
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Vol. 26
HIV Surveillance Report
Table 13a. Deaths of persons with diagnosed HIV infection ever classified as stage 3 (AIDS), by year of death and selected characteristics, 2010–2013 and
cumulative—United States
No.
No.
Rate
No.
No.
Rate
No.
No.
Rate
No.
No.
Rate
Age at death (yr)
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
0
2
27
147
313
614
990
1,786
2,688
2,611
2,056
1,371
1,316
0
2
28
152
324
637
1,025
1,852
2,784
2,697
2,122
1,416
1,360
0.0
0.0
0.1
0.7
1.5
3.2
5.1
8.9
12.3
12.1
10.7
8.3
3.4
0
1
20
149
310
553
888
1,524
2,465
2,614
2,163
1,395
1,401
0
1
21
155
325
581
931
1,598
2,590
2,739
2,261
1,457
1,462
0.0
0.0
0.1
0.7
1.5
2.8
4.7
7.6
11.7
12.1
11.2
8.2
3.5
1
1
16
133
319
551
774
1,338
2,221
2,573
2,180
1,498
1,527
1
1
17
142
341
588
828
1,428
2,373
2,739
2,316
1,594
1,616
0.0
0.0
0.1
0.6
1.6
2.8
4.2
6.8
10.9
12.1
11.1
8.9
3.7
1
0
8
119
290
476
645
1,095
1,790
2,291
1,987
1,413
1,544
1
0
10
134
327
534
719
1,227
1,986
2,551
2,204
1,566
1,703
0.0
0.0
0.0
0.6
1.5
2.5
3.7
5.9
9.3
11.3
10.4
8.6
3.8
4,988
4,998
294
296
1,308
1,318
9,897
9,967
47,146
47,389
102,204 102,708
128,451 129,198
122,261 123,245
95,240
96,371
65,453
66,507
41,007
41,777
24,182
24,673
24,597
25,091
75
Race/ethnicity
American Indian/Alaska Native
Asianc
Black/African American
Hispanic/Latinod
Native Hawaiian/Other Pacific Islander
White
Multiple races
58
58
6,734
2,309
7
4,063
692
60
60
6,959
2,377
7
4,220
715
2.6
0.4
18.3
4.7
1.4
2.1
12.7
48
70
6,435
2,268
9
3,999
654
50
73
6,729
2,362
9
4,211
687
2.2
0.5
17.5
4.5
1.8
2.1
11.8
39
63
6,248
2,079
6
4,024
673
41
67
6,653
2,191
6
4,309
717
1.8
0.4
17.2
4.1
1.2
2.2
11.9
48
52
5,338
2,029
3
3,513
676
51
58
5,987
2,220
3
3,897
746
2.2
0.4
15.3
4.1
0.6
2.0
12.0
1,899
1,919
3,431
3,462
274,025 277,059
102,923 103,819
359
361
271,923 274,206
12,468
12,710
4,481
2,096
1,050
5,512
2,463
1,182
—
—
—
4,451
1,911
1,007
5,508
2,296
1,151
—
—
—
4,350
1,847
990
5,480
2,242
1,154
—
—
—
4,038
1,574
894
5,237
2,001
1,072
—
—
—
292,934 317,564
119,888 132,455
48,032
51,413
1,079
26
1,616
10,348
1,451
27
77
10,712
—
—
—
8.6
1,037
33
1,544
9,983
1,408
35
78
10,475
—
—
—
8.3
1,000
38
1,507
9,732
1,388
40
73
10,377
—
—
—
8.1
897
33
1,254
8,690
1,264
37
55
9,667
—
—
—
7.5
28,571
36,648
407
419
52,356
8,751
542,188 547,251
2010
2011
Estimateda
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and
injection drug use
Heterosexual contacte
Perinatal
Otherf
Subtotal
2012
Estimateda
2013
Estimateda
Estimateda
Cumulativeb
No.
Est. No.a
Vol. 26
HIV Surveillance Report
Table 13a. Deaths of persons with diagnosed HIV infection ever classified as stage 3 (AIDS), by year of death and selected characteristics, 2010–2013 and
cumulative—United States (cont)
2010
2011
a
Estimated
Estimated
Female adult or adolescent
Injection drug use
Heterosexual contacte
Perinatal
Otherf
Subtotal
Child (<13 yrs at death)
Perinatal
Otherf
Subtotal
76
Region of residence
Northeast
Midwest
South
West
Totalg
No.
No.
1,110
1,636
29
798
3,573
1,367
2,266
30
24
3,687
0
0
0
Rate
2012
No.
No.
—
—
—
—
2.8
1,126
1,563
43
768
3,500
1,373
2,199
45
28
3,647
0
0
0
—
—
0.0
0
0
0
3,744
1,536
6,556
2,085
3,847
1,601
6,791
2,160
6.9
2.4
5.9
3.0
13,921
14,399
4.7
a
Rate
2013
a
Estimateda
Estimated
No.
No.
—
—
—
—
2.8
1,029
1,534
44
792
3,399
1,302
2,224
47
32
3,605
0
0
0
—
—
0.0
1
0
1
3,574
1,468
6,344
2,097
3,708
1,553
6,659
2,202
6.7
2.3
5.7
3.0
13,483
14,122
4.5
Rate
Rate
Cumulativeb
No.
Est. No.a
No.
No.
—
—
—
—
2.7
938
1,352
27
651
2,968
1,233
2,005
31
26
3,295
—
—
—
—
2.4
1
0
1
—
—
0.0
1
0
1
1
0
1
—
—
0.0
3,314
1,458
6,266
2,094
3,477
1,567
6,726
2,213
6.2
2.3
5.7
3.0
3,152
1,268
5,355
1,884
3,403
1,456
6,093
2,010
6.1
2.2
5.1
2.7
210,310 211,694
67,858
68,733
257,293 260,531
131,567 132,579
13,132
13,984
4.5
11,659
12,963
4.1
667,028 673,538
50,505
57,596
47,301
59,511
511
527
21,535
3,656
119,852 121,289
4,525
463
4,988
4,534
464
4,998
Note. Deaths of persons with diagnosed HIV infection may be due to any cause.
Reported numbers less than 12, as well as estimated numbers (and accompanying rates and trends) based on these numbers, should be interpreted with caution because the numbers have underlying
relative standard errors greater than 30% and are considered unreliable.
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting. Rates are per 100,000 population. Rates
are not calculated by transmission category because of the lack of denominator data.
b
From the beginning of the epidemic through 2013.
c
Includes Asian/Pacific Islander legacy cases (see Technical Notes).
d Hispanics/Latinos can be of any race.
e
f
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
g Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Vol. 26
HIV Surveillance Report
Table 13b. Deaths of persons with diagnosed HIV infection ever classified as stage 3 (AIDS), by year of death and selected characteristics, 2010–2013 and
cumulative—United States and 6 dependent areas
No.
No.
Rate
No.
No.
Rate
No.
No.
Rate
No.
No.
Rate
Age at death (yr)
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
0
2
29
148
321
639
1,029
1,843
2,791
2,680
2,103
1,411
1,359
0
2
30
153
333
663
1,065
1,911
2,891
2,769
2,171
1,457
1,405
0.0
0.0
0.1
0.7
1.6
3.3
5.2
9.0
12.6
12.2
10.8
8.5
3.4
0
1
21
151
322
565
919
1,578
2,558
2,696
2,218
1,430
1,448
0
1
22
158
338
593
964
1,655
2,689
2,827
2,320
1,495
1,512
0.0
0.0
0.1
0.7
1.6
2.9
4.8
7.8
12.0
12.4
11.3
8.3
3.6
1
1
18
135
326
569
800
1,376
2,292
2,631
2,226
1,528
1,571
1
1
19
144
349
607
856
1,468
2,450
2,802
2,366
1,626
1,664
0.0
0.0
0.1
0.6
1.6
2.9
4.3
6.9
11.1
12.3
11.2
9.0
3.8
1
0
8
122
293
488
662
1,119
1,850
2,350
2,033
1,452
1,586
1
0
10
138
331
547
738
1,254
2,052
2,616
2,254
1,609
1,750
0.0
0.0
0.0
0.6
1.5
2.5
3.7
5.9
9.5
11.4
10.5
8.8
3.9
5,237
5,248
303
305
1,374
1,385
10,393 10,465
49,263 49,516
106,183 106,707
133,373 134,152
126,609 127,634
98,449 99,626
67,524 68,615
42,182 42,976
24,965 25,473
25,603 26,117
77
Race/ethnicity
American Indian/Alaska Native
Asianc
Black/African American
Hispanic/Latinod
Native Hawaiian/Other Pacific Islander
White
Multiple races
58
58
6,738
2,739
7
4,063
692
60
60
6,964
2,825
7
4,220
715
—
—
—
—
—
—
—
48
72
6,441
2,682
10
3,999
655
50
75
6,736
2,802
10
4,211
688
—
—
—
—
—
—
—
39
64
6,255
2,409
6
4,025
676
41
68
6,660
2,548
6
4,310
720
—
—
—
—
—
—
—
48
52
5,341
2,328
5
3,513
677
51
58
5,990
2,550
5
3,897
747
—
—
—
—
—
—
—
1,899
1,919
3,466
3,497
274,298 277,336
126,953 128,095
366
368
272,001 274,285
12,475 12,718
4,535
2,258
1,083
5,569
2,634
1,216
—
—
—
4,519
2,059
1,035
5,582
2,456
1,181
—
—
—
4,390
1,965
1,018
5,525
2,373
1,184
—
—
—
4,095
1,655
914
5,300
2,090
1,094
—
—
—
296,703 321,408
130,221 143,010
49,888 53,298
1,140
26
1,622
10,664
1,516
27
78
11,040
—
—
—
8.7
1,095
35
1,552
10,295
1,472
37
78
10,806
—
—
—
8.5
1,052
40
1,515
9,980
1,446
42
74
10,645
—
—
—
8.2
955
34
1,254
8,907
1,328
38
55
9,906
—
—
—
7.6
31,001 39,151
435
448
52,698
8,877
560,946 566,193
2010
2011
Estimateda
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and
injection drug use
Heterosexual contacte
Perinatal
Otherf
Subtotal
2012
Estimateda
2013
Estimateda
Estimateda
Cumulativeb
No.
Est. No.a
Vol. 26
HIV Surveillance Report
Table 13b. Deaths of persons with diagnosed HIV infection ever classified as stage 3 (AIDS), by year of death and selected characteristics, 2010–2013 and
cumulative—United States and 6 dependent areas (cont)
2010
2011
a
Female adult or adolescent
Injection drug use
Heterosexual contacte
Perinatal
Otherf
Subtotal
Child (<13 yrs at death)
Perinatal
Otherf
Subtotal
78
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
Totalg
No.
1,147
1,715
31
798
3,691
1,406
2,348
32
24
3,810
0
0
0
Rate
No.
No.
—
—
—
—
2.9
1,166
1,629
45
772
3,612
1,417
2,273
48
29
3,766
0
0
0
—
—
0.0
0
0
0
3,744
1,536
6,556
2,085
434
3,847
1,601
6,791
2,160
452
6.9
2.4
5.9
3.0
11.0
14,355
14,851
4.7
Rate
2013
a
Estimated
Estimated
No.
2012
a
Estimateda
Estimated
No.
No.
—
—
—
—
2.8
1,059
1,593
46
795
3,493
1,335
2,290
49
33
3,707
0
0
0
—
—
0.0
1
0
1
3,574
1,468
6,344
2,097
424
3,708
1,553
6,659
2,202
451
6.7
2.3
5.7
3.0
11.0
13,907
14,573
4.6
Rate
Rate
Cumulativeb
No.
Est. No.a
No.
No.
—
—
—
—
2.7
970
1,403
29
654
3,056
1,268
2,065
33
26
3,392
—
—
—
—
2.5
1
0
1
—
—
0.0
1
0
1
1
0
1
—
—
0.0
3,314
1,458
6,266
2,094
342
3,477
1,567
6,726
2,213
369
6.2
2.3
5.7
3.0
9.2
3,152
1,268
5,355
1,884
305
3,403
1,456
6,093
2,010
336
6.1
2.2
5.1
2.7
8.4
210,310 211,694
67,858 68,733
257,293 260,531
131,567 132,579
24,430 24,681
13,474
14,353
4.5
11,964
13,299
4.1
691,458 698,219
52,630 59,774
50,386 62,688
545
562
21,714
3,754
125,275 126,778
4,757
480
5,237
4,767
481
5,248
Note. Deaths of persons with diagnosed HIV infection may be due to any cause.
Reported numbers less than 12, as well as estimated numbers (and accompanying rates and trends) based on these numbers, should be interpreted with caution because the numbers have underlying
relative standard errors greater than 30% and are considered unreliable.
a
Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting. Rates are per 100,000 population. Rates
by race/ethnicity are not provided because U.S. census information for U.S. dependent areas is limited. Rates are not calculated by transmission category because of the lack of denominator data.
b From the beginning of the epidemic through 2013.
c
Includes Asian/Pacific Islander legacy cases (see Technical Notes).
d
Hispanics/Latinos can be of any race.
e Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
f
g
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Vol. 26
HIV Surveillance Report
Table 14a. Deaths of persons with diagnosed HIV infection, by race/ethnicity and selected characteristics, 2013—United States
American Indian/
Alaska Native
Asiana
Estimatedc
Black/African American
Estimatedc
Hispanic/Latinob
Estimatedc
No.
No.
Rate
Native Hawaiian/
Other Pacific Islander
Estimatedc
79
No.
No.
Rate
No.
No.
Rate
No.
<13
0
0
0.0
0
0
0.0
1
1
0.0
0
13–14
0
0
0.0
0
0
0.0
1
1
0.1
15–19
0
0
0.0
0
0
0.0
7
8
0.3
20–24
0
0
0.0
0
0
0.0
107
127
25–29
3
4
2.1
4
5
0.3
227
30–34
5
6
3.8
4
5
0.3
35–39
5
5
3.7
5
6
0.4
40–44
6
6
4.3
4
5
45–49
11
13
8.1
8
50–54
13
16
9.5
55–59
8
9
6.0
60–64
2
2
65
5
No.
White
Estimatedc
Multiple races
Estimatedc
Rate
No.
No.
Rate
No.
0
0.0
0
0
0.0
0
0
0
0.0
0
0
0.0
4
5
0.1
0
0
0.0
3.7
24
29
0.6
0
0
271
9.5
69
81
1.8
0
297
349
12.8
104
118
2.7
395
458
18.5
143
164
4.0
0.3
570
664
25.4
250
286
9
0.7
911
1,053
39.7
368
8
9
0.9
1,149
1,339
49.2
8
10
1.0
1,134
1,321
54.3
1.9
6
7
0.9
805
949
5
2.4
9
10
0.6
888
23
31
—
24
39
—
Injection drug use
6
7
—
1
4
Male-to-male sexual contact
and injection drug use
2
4
—
1
Heterosexual contacte
4
6
—
Perinatal
0
0
—
Otherf
7
0
42
48
No.
Total
Estimatedc
Rate
No.
No.
Rate
0
0.0
0
0
0.0
0
0
0.0
0
0
0.0
0
0
0.0
0
0
0.0
0.0
13
16
0.1
9
10
1.9
0
0.0
62
78
0.6
26
29
1
1
2.3
127
150
1.2
34
0
0
0.0
170
199
1.8
45
7.6
0
0
0.0
389
458
3.6
415
12.5
1
1
3.2
682
792
469
533
18.9
2
3
7.6
900
342
385
17.4
0
0
0.0
780
49.4
283
319
19.5
0
0
0.0
1,039
27.1
292
330
9.8
0
0
1,436
2,168
—
748
1,019
—
1
—
901
1,278
—
451
590
—
1
—
332
445
—
193
234
4
7
—
714
1,108
—
172
0
0
—
27
31
—
6
—
16
0
—
907
23
—
5.2
46
52
0.8
4317
5,053
33.6
Estimatedc
No.d
No.
Rate
Age at death (yr)
1
1
0.0
1
1
0.0
11
14
0.1
153
182
0.8
7.1
391
468
2.2
39
10.8
572
667
3.1
50
16.9
763
882
4.5
79
90
33.0
1,298
1,509
7.2
5.8
123
139
58.0
2,104
2,422
11.4
1038
6.7
167
190
79.9
2,708
3,127
13.8
904
5.9
114
130
63.6
2,386
2,757
13.0
532
610
4.5
87
98
63.4
1,715
1,985
10.9
0.0
672
783
2.2
84
97
31.8
1,950
2,265
5.1
1
—
2,342
3,059
—
253
342
—
4,827
6,660
—
0
0
—
382
473
—
100
127
—
1,841
2,479
—
—
1
1
—
430
514
—
78
98
—
1,037
1,296
—
236
—
0
0
—
139
199
—
45
62
—
1,078
1,618
—
7
—
0
0
—
1
1
—
2
2
—
36
42
—
275
8
—
0
0
—
394
39
—
79
4
—
1,678
75
—
1,845
2,094
10.1
2
3
1.2
3,688
4,285
5.1
557
635
33.3
10,497 12,170
9.4
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Subtotal
Vol. 26
HIV Surveillance Report
Table 14a. Deaths of persons with diagnosed HIV infection, by race/ethnicity and selected characteristics, 2013—United States (cont)
American Indian/
Alaska Native
Asiana
Estimatedc
Black/African American
Estimatedc
Hispanic/Latinob
Estimatedc
No.
No.
Rate
Native Hawaiian/
Other Pacific Islander
Estimatedc
No.
No.
Rate
No.
No.
Rate
No.
No.
3
5
—
0
0
—
570
818
—
188
245
Heterosexual contact
6
12
—
7
11
—
1,029
1,676
—
206
Perinatal
0
0
—
0
0
—
18
21
—
4
Rate
White
Estimatedc
Rate
Multiple races
Estimatedc
No.
No.
No.
—
0
0
—
263
316
—
1
2
—
5
—
0
0
No.
Total
Estimatedc
Estimatedc
No.
No.d
—
1,088
1,504
—
140
—
1,593
2,544
—
3
—
27
31
—
Rate
No.
No.
Rate
342
—
64
94
258
387
—
86
—
2
2
—
3
Rate
Female adult or adolescent
Injection drug use
e
f
Other
7
0
—
3
0
—
557
12
—
105
4
—
1
0
—
116
12
—
58
2
—
847
31
—
16
18
1.8
10
12
0.2
2,174
2,527
15.0
503
570
2.8
2
2
1.0
639
743
0.9
211
239
11.6
3,555
4,110
3.0
Perinatal
0
0
—
0
0
—
1
1
—
0
0
—
0
0
—
0
0
—
0
0
—
1
1
—
Otherf
0
0
—
0
0
—
0
0
—
0
0
—
0
0
—
0
0
—
0
0
—
0
0
—
Subtotal
0
0
0.0
0
0
0.0
1
1
0.0
0
0
0.0
0
0.0
0.0
0
0
0.0
0
0
0.0
1
1
0.0
Northeast
1
1
1.1
11
12
0.4
1,671
1,891
30.1
1,032
1,159
15.3
0
0
0.0
806
929
2.5
277
309
35.8
3,798
4,302
7.7
Midwest
6
7
1.7
6
8
0.4
728
883
12.7
118
148
2.9
0
0
0.0
648
755
1.5
75
88
7.4
1,581
1,888
2.8
South
20
23
3.0
16
19
0.5
3,693
4,360
19.4
687
797
4.0
1
1
1.4
1,757
2,087
3.0
287
332
16.5
6,461
7,620
6.4
West
31
34
3.3
23
25
0.3
400
447
13.2
511
560
2.6
3
4
0.9
1,116
1,257
3.3
129
146
6.8
2,213
2,472
3.3
Totalg
58
66
2.8
56
64
0.4
6,492
7,581
19.4
2,348
2,664
4.9
4
5
0.9
4,327
5,028
2.5
768
874
14.1
14,053 16,281
5.1
Subtotal
Child (<13 yrs at death)
80
Region of residence
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. Deaths of persons with a diagnosis of HIV infection may be due to any cause.
Reported numbers less than 12, as well as estimated numbers (and accompanying rates and trends) based on these numbers, should be interpreted with caution because the numbers have underlying relative standard errors greater than 30% and
are considered unreliable.
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanics/Latinos can be of any race.
c Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting. Rates are per 100,000 population. Rates are not calculated by transmission category
because of the lack of denominator data.
d Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
e
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
f Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
g
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Vol. 26
HIV Surveillance Report
Table 14b. Deaths of persons with diagnosed HIV infection, by race/ethnicity and selected characteristics, 2013—United States and 6 dependent areas
American Indian/
Alaska Native
Black/African
American
Asiana
Hispanic/Latinob
No.
Est. No.c
No.
Est. No.c
<13
0
0
0
0
1
1
0
13–14
0
0
0
0
1
1
15–19
0
0
0
0
7
8
20–24
0
0
0
0
107
25–29
3
4
4
5
30–34
5
6
4
35–39
5
5
5
40–44
6
6
45–49
11
50–54
55–59
Multiple races
81
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
4
5
0
0
0
0
0
0
11
14
127
28
33
0
0
13
16
9
10
157
187
227
271
78
93
0
0
62
78
26
29
400
480
5
297
349
126
144
1
1
127
150
34
39
594
694
6
395
458
168
194
1
1
170
199
45
50
789
914
4
5
571
665
285
328
0
0
389
458
79
90
1,334
1,553
13
8
9
911
1,053
451
514
2
2
682
792
123
139
2,188
2,522
13
16
8
9
1,151
1,342
546
622
2
3
900
1,038
168
191
2,788
3,221
8
9
8
10
1,134
1,321
400
453
0
0
780
904
115
131
2,445
2,827
60–64
2
2
6
7
805
949
329
372
0
0
532
610
87
98
1,761
2,038
65
5
5
9
10
890
1,042
348
396
0
0
672
783
84
97
2,008
2,333
23
31
24
39
1,437
2,169
813
1,097
2
2
2,342
3,059
254
344
4,895
6,741
Injection drug use
6
7
1
4
901
1,278
570
736
0
0
382
473
100
127
1,960
2,626
Male-to-male sexual contact and
injection drug use
2
4
1
1
332
445
216
261
1
1
430
514
78
98
1,060
1,323
Heterosexual contacte
4
6
4
7
714
1,109
245
325
1
1
139
199
46
63
1,153
1,711
Perinatal
0
0
0
0
27
31
8
9
0
0
1
1
2
2
38
44
Otherf
7
0
16
0
908
23
283
8
0
0
394
39
79
4
1,687
75
42
48
46
52
4,319
5,055
2,135
2,437
4
5
3,688
4,285
559
638
10,793
12,519
No.
Est. No.c
No.
Est. No.c
Total
Est. No.c
No.
Est. No.c
White
No.
No.
Est. No.c
Native Hawaiian/
Other Pacific Islander
Est. No.c,d
No.
Age at death (yr)
1
1
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Subtotal
Vol. 26
HIV Surveillance Report
Table 14b. Deaths of persons with diagnosed HIV infection, by race/ethnicity and selected characteristics, 2013—United States and 6 dependent areas (cont)
American Indian/
Alaska Native
Black/African
American
Asiana
Hispanic/Latinob
No.
Est. No.c
No.
Est. No.c
3
5
0
0
570
819
235
Heterosexual contact
6
12
7
11
1,029
1,679
Perinatal
0
0
0
0
18
No.
Est. No.c
White
Multiple races
No.
300
0
0
263
342
64
94
1,135
1,560
279
407
1
2
258
387
86
140
1,666
2,638
21
6
7
0
0
2
2
3
3
29
33
No.
Est. No.c
Total
Est. No.c
No.
Est. No.c
Native Hawaiian/
Other Pacific Islander
No.
Est. No.c
No.
Est. No.c,d
Female adult or adolescent
Injection drug use
e
f
Other
7
0
3
0
560
12
108
4
1
0
116
12
58
2
853
31
16
18
10
12
2,177
2,531
628
718
2
2
639
743
211
239
3,683
4,262
0
0
0
0
1
1
0
0
0
0
0
0
0
0
1
1
Other
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Subtotal
0
0
0
0
1
1
0
0
0
0
0
0
0
0
1
1
Northeast
1
1
11
12
1,671
1,891
1,032
1,159
0
0
806
929
277
309
3,798
4,302
Midwest
6
7
6
8
728
883
118
148
0
0
648
755
75
88
1,581
1,888
South
20
23
16
19
3,693
4,360
687
797
1
1
1,757
2,087
287
332
6,461
7,620
West
31
34
23
25
400
447
511
560
3
4
1,116
1,257
129
146
2,213
2,472
0
0
0
0
5
6
415
491
2
2
0
0
2
2
424
502
58
66
56
64
6,497
7,587
2,763
3,155
6
7
4,327
5,028
770
876
14,477
16,783
Subtotal
Child (<13 yrs at end of year)
Perinatal
f
Region of residence
82
U.S. dependent areas
Totalg
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. Deaths of persons with a diagnosis of HIV infection may be due to any cause.
Reported numbers less than 12, as well as estimated numbers (and accompanying trends) based on these numbers, should be interpreted with caution because the numbers have underlying relative standard errors greater than 30% and are
considered unreliable.
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanics/Latinos can be of any race.
c Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting.
d Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
e
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
f Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
g
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Vol. 26
HIV Surveillance Report
Table 15a. Deaths of persons with diagnosed HIV infection ever classified as stage 3 (AIDS), by race/ethnicity and selected characteristics, 2013—United States
American Indian/
Alaska Native
Asiana
Estimatedc
Black/African American
Estimatedc
Hispanic/Latinob
Estimatedc
No.
No.
Rate
Native Hawaiian/
Other Pacific Islander
Estimatedc
83
No.
No.
Rate
No.
No.
Rate
No.
<13
0
0
0.0
0
0
0.0
1
1
0.0
0
13–14
0
0
0.0
0
0
0.0
0
0
0.0
15–19
0
0
0.0
0
0
0.0
4
4
0.1
20–24
0
0
0.0
0
0
0.0
85
97
25–29
2
2
1.3
3
3
0.2
180
30–34
4
4
2.8
4
5
0.3
35–39
5
5
3.7
4
5
0.4
40–44
6
6
4.3
4
5
45–49
8
8
5.5
9
50–54
9
10
5.9
55–59
7
7
5.1
60–64
2
2
65
5
No.
White
Estimatedc
Multiple races
Estimatedc
Rate
No.
No.
Rate
No.
0
0.0
0
0
0.0
0
0
0
0.0
0
0
0.0
4
5
0.1
0
0
0.0
2.8
19
21
0.4
0
0
206
7.2
52
57
1.3
0
254
289
10.6
94
103
2.4
343
387
15.6
121
132
3.3
0.3
497
562
21.5
215
238
10
0.8
767
855
32.2
324
8
9
0.9
962
1,081
39.7
7
8
0.8
921
1,026
42.2
1.9
4
4
0.5
637
717
5
2.4
9
10
0.6
687
19
23
—
23
36
—
Injection drug use
6
7
—
1
4
Male-to-male sexual contact
and injection drug use
1
2
—
1
Heterosexual contacte
3
4
—
Perinatal
0
0
—
Otherf
5
0
34
36
No.
Total
Estimatedc
Estimatedc
No.d
Rate
No.
No.
Rate
No.
0
0.0
0
0
0.0
1
0
0
0.0
0
0
0.0
0
0
0.0
0
0
0.0
0.0
8
9
0.1
7
8
0
0.0
30
33
0.3
23
26
1
1
2.3
91
100
0.8
28
0
0
0.0
128
141
1.2
44
6.3
0
0
0.0
308
346
2.7
353
10.7
1
1
3.2
570
636
412
455
16.1
1
1
3.2
750
296
322
14.5
0
0
0.0
655
37.4
245
266
16.2
0
0
0.0
761
19.8
247
269
8.0
0
0
1,198
1,679
—
671
869
—
1
—
768
1,023
—
386
478
—
1
—
286
366
—
169
197
4
7
—
593
863
—
146
0
0
—
23
26
—
7
—
15
0
—
665
14
—
4.0
44
49
0.8
3,533
3,971
26.4
Rate
Age at death (yr)
1
0.0
0
0
0.0
8
10
0.0
1.4
119
134
0.6
6.2
290
327
1.5
31
8.6
476
534
2.5
49
16.5
645
719
3.7
65
71
25.9
1,095
1,227
5.9
4.6
111
123
51.1
1,790
1,986
9.3
830
5.3
149
165
69.5
2,291
2,551
11.3
730
4.8
101
111
54.5
1,987
2,204
10.4
447
491
3.6
78
86
55.2
1,413
1,566
8.6
0.0
526
581
1.6
70
78
25.3
1,544
1,703
3.8
1
—
1,904
2,342
—
222
287
—
4,038
5,237
—
0
0
—
323
381
—
90
109
—
1,574
2,001
—
—
0
0
—
366
419
—
71
86
—
894
1,072
—
187
—
0
0
—
109
148
—
42
55
—
897
1,264
—
8
—
0
0
—
1
1
—
2
2
—
33
37
—
215
7
—
0
0
—
292
33
—
62
1
—
1,254
55
—
1,594
1,746
8.4
1
1
0.5
2,995
3,323
4.0
489
541
28.4
8,690
9,667
7.5
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Subtotal
Vol. 26
HIV Surveillance Report
Table 15a. Deaths of persons with diagnosed HIV infection ever classified as stage 3 (AIDS), by race/ethnicity and selected characteristics, 2013—United States (cont)
American Indian/
Alaska Native
Asiana
Estimatedc
Black/African American
Estimatedc
Hispanic/Latinob
Estimatedc
No.
No.
Rate
Native Hawaiian/
Other Pacific Islander
Estimatedc
No.
No.
Rate
No.
No.
Rate
No.
No.
3
5
—
0
0
—
484
661
—
171
214
Heterosexual contact
5
10
—
6
9
—
876
1,325
—
172
Perinatal
0
0
—
0
0
—
18
21
—
4
Rate
White
Estimatedc
Rate
Multiple races
Estimatedc
No.
No.
No.
—
0
0
—
222
252
—
1
2
—
5
—
0
0
—
No.
Total
Estimatedc
Estimatedc
No.d
Rate
No.
No.
Rate
No.
Rate
270
—
58
82
—
938
1,233
—
214
290
—
78
118
—
1,352
2,005
—
2
2
—
3
3
—
27
31
—
Female adult or adolescent
Injection drug use
e
f
Other
6
0
—
2
0
—
426
9
—
88
4
—
1
0
—
80
11
—
48
2
—
651
26
—
14
15
1.6
8
9
0.1
1,804
2,015
11.9
435
474
2.3
2
2
1.0
518
574
0.7
187
205
10.0
2,968
3,295
2.4
Perinatal
0
0
—
0
0
—
1
1
—
0
0
—
0
0
—
0
0
—
0
0
—
1
1
—
Otherf
0
0
—
0
0
—
0
0
—
0
0
—
0
0
—
0
0
—
0
0
—
0
0
—
Subtotal
0
0
0.0
0
0
0.0
1
1
0.0
0
0
0.0
0
0
0.0
0
0
0.0
0
0
0.0
1
1
0.0
Northeast
0
0
0.0
10
11
0.3
1,373
1,478
23.5
878
945
12.5
0
0
0.0
650
712
1.9
241
258
29.9
3,152
3,403
6.1
Midwest
3
3
0.8
5
6
0.3
579
677
9.7
99
122
2.4
0
0
0.0
520
576
1.1
62
71
6.0
1,268
1,456
2.2
South
18
20
2.6
14
17
0.5
3,047
3,472
15.4
591
665
3.4
1
1
1.4
1,427
1,628
2.3
257
291
14.5
5,355
6,093
5.1
West
27
28
2.7
23
24
0.3
339
360
10.6
461
489
2.2
2
2
0.5
916
980
2.6
116
126
5.9
1,884
2,010
2.7
Totalg
48
51
2.2
52
58
0.4
5,338
5,987
15.3
2,029
2,220
4.1
3
3
0.6
3,513
3,897
2.0
676
746
12.0
11,659 12,963
4.1
Subtotal
Child (<13 yrs at death)
84
Region of residence
Note. Deaths of persons with a diagnosis of HIV infection may be due to any cause.
Reported numbers less than 12, as well as estimated numbers (and accompanying rates and trends) based on these numbers, should be interpreted with caution because the numbers have underlying relative standard errors greater than 30% and
are considered unreliable.
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanics/Latinos can be of any race.
c Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting. Rates are per 100,000 population. Rates are not calculated by transmission category
because of the lack of denominator data.
d Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
e
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
f Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
g
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Vol. 26
HIV Surveillance Report
Table 15b. Deaths of persons with diagnosed HIV infection ever classified as stage 3 (AIDS), by race/ethnicity and selected characteristics, 2013—United States and 6 dependent areas
American Indian/
Alaska Native
Black/
African American
Asiana
No.
Est. No.c
No.
Est. No.c
<13
0
0
0
0
1
1
0
13–14
0
0
0
0
0
0
15–19
0
0
0
0
4
4
20–24
0
0
0
0
85
25–29
2
2
3
3
30–34
4
4
4
35–39
5
5
4
40–44
6
6
45–49
8
50–54
55–59
White
Multiple races
85
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
4
5
0
0
0
0
0
0
8
10
97
22
24
0
0
8
9
7
8
122
138
180
206
55
60
0
0
30
33
23
26
293
331
5
254
289
106
116
1
1
91
100
28
31
488
547
5
343
387
137
150
1
1
128
141
44
49
662
738
4
5
498
563
238
263
0
0
308
346
65
71
1,119
1,254
8
9
10
767
855
383
419
2
2
570
636
111
123
1,850
2,052
9
10
8
9
963
1,082
470
518
1
1
750
830
149
165
2,350
2,616
7
7
7
8
921
1,026
341
371
0
0
655
730
102
112
2,033
2,254
60–64
2
2
4
4
637
717
284
308
0
0
447
491
78
86
1,452
1,609
65
5
5
9
10
688
762
288
314
0
0
526
581
70
78
1,586
1,750
19
23
23
36
1,199
1,680
725
928
2
2
1,904
2,342
223
288
4,095
5,300
Injection drug use
6
7
1
4
768
1,023
467
567
0
0
323
381
90
109
1,655
2,090
Male-to-male sexual contact and
injection drug use
1
2
1
1
286
366
189
219
0
0
366
419
71
86
914
1,094
Heterosexual contacte
3
4
4
7
593
863
203
250
1
1
109
148
42
55
955
1,328
Perinatal
0
0
0
0
23
26
8
9
0
0
1
1
2
2
34
38
Otherf
5
0
15
0
665
14
215
7
0
0
292
33
62
1
1,254
55
34
36
44
49
3,534
3,972
1,807
1,981
3
3
2,995
3,323
490
542
8,907
9,906
No.
Est. No.c
No.
Est. No.c
Total
Est. No.c
No.
Est. No.c
Native Hawaiian/
Other Pacific Islander
No.
No.
Est. No.c
Hispanic/Latinob
Est. No.c,d
No.
Age at death (yr)
1
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Subtotal
Vol. 26
HIV Surveillance Report
Table 15b. Deaths of persons with diagnosed HIV infection ever classified as stage 3 (AIDS), by race/ethnicity and selected characteristics, 2013—United States and 6 dependent areas (cont)
American Indian/
Alaska Native
Black/
African American
Asiana
No.
Est. No.c
No.
Est. No.c
3
5
0
0
484
661
203
Heterosexual contact
5
10
6
9
876
1,327
Perinatal
0
0
0
0
18
21
No.
Est. No.c
Hispanic/Latinob
White
No.
Est. No.c
249
0
0
222
223
309
1
2
6
7
0
0
No.
Est. No.c
Native Hawaiian/
Other Pacific Islander
Multiple races
Total
No.
Est. No.c
270
58
82
970
1,268
214
290
78
118
1,403
2,065
2
2
3
3
29
33
No.
Est. No.c
Est. No.c,d
No.
Female adult or adolescent
Injection drug use
e
f
Other
6
0
2
0
428
9
89
4
1
0
80
11
48
2
654
26
14
15
8
9
1,806
2,018
521
569
2
2
518
574
187
205
3,056
3,392
0
0
0
0
1
1
0
0
0
0
0
0
0
0
1
1
Other
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Subtotal
0
0
0
0
1
1
0
0
0
0
0
0
0
0
1
1
Northeast
0
0
10
11
1,373
1,478
878
945
0
0
650
712
241
258
3,152
3,403
Midwest
3
3
5
6
579
677
99
122
0
0
520
576
62
71
1,268
1,456
South
18
20
14
17
3,047
3,472
591
665
1
1
1,427
1,628
257
291
5,355
6,093
West
27
28
23
24
339
360
461
489
2
2
916
980
116
126
1,884
2,010
0
0
0
0
3
4
299
330
2
2
0
0
1
1
305
336
48
51
52
58
5,341
5,990
2,328
2,550
5
5
3,513
3,897
677
747
11,964
13,299
Subtotal
Child (<13 yrs at end of year)
Perinatal
f
Region of residence
86
U.S. dependent areas
Totalg
Note. Deaths of persons with a diagnosis of HIV infection may be due to any cause.
Reported numbers less than 12, as well as estimated numbers (and accompanying trends) based on these numbers, should be interpreted with caution because the numbers have underlying relative standard errors greater than 30% and are
considered unreliable.
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanics/Latinos can be of any race.
c Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting.
d Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
e
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
f Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
g
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Vol. 26
Table 16a. Survival for more than 12, 24, and 36 months after a diagnosis of HIV infection during
2005–2010, by selected characteristics—United States
Proportion survived
(in months)
No. of persons
>12
>24
>36
1,526
264
11,725
36,203
38,495
35,958
39,229
40,942
33,585
22,257
12,800
6,134
5,041
0.98
0.99
0.99
0.99
0.98
0.97
0.96
0.94
0.92
0.90
0.87
0.83
0.74
0.98
0.99
0.99
0.98
0.97
0.96
0.95
0.93
0.90
0.87
0.83
0.79
0.69
0.98
0.99
0.99
0.98
0.97
0.95
0.94
0.92
0.89
0.85
0.81
0.76
0.64
Race/ethnicity
American Indian/Alaska Native
Asian
Black/African American
Hispanic/Latinoa
Native Hawaiian/Other Pacific Islander
White
Multiple races
982
3,949
131,958
57,303
356
79,444
10,167
0.92
0.96
0.94
0.95
0.97
0.95
0.95
0.90
0.95
0.93
0.94
0.96
0.93
0.93
0.88
0.94
0.91
0.93
0.95
0.92
0.92
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and injection drug use
Heterosexual contactb
Otherc
Subtotal
129,329
12,499
9,442
20,436
42,600
214,306
0.97
0.90
0.96
0.94
0.89
0.95
0.96
0.87
0.95
0.92
0.87
0.93
0.95
0.85
0.94
0.90
0.85
0.92
Female adult or adolescent
Injection drug use
Heterosexual contactb
Otherc
Subtotal
7,424
34,765
26,138
68,327
0.94
0.96
0.93
0.95
0.91
0.95
0.91
0.93
0.88
0.94
0.89
0.92
Child (<13 yrs at diagnosis)
Perinatal
Otherd
Subtotal
1,249
277
1,526
0.98
0.99
0.98
0.98
0.99
0.98
0.98
0.99
0.98
57,962
34,829
141,089
50,279
0.95
0.96
0.94
0.95
0.93
0.94
0.93
0.94
0.92
0.93
0.91
0.93
48,353
48,591
49,735
48,218
45,651
43,611
0.94
0.94
0.95
0.95
0.95
0.96
0.92
0.92
0.93
0.94
0.94
0.95
0.90
0.91
0.92
0.92
0.93
0.94
284,159
0.95
0.93
0.92
Age at diagnosis (yr)
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
Region of residence
Northeast
Midwest
South
West
Year of diagnosis
2005
2006
2007
2008
2009
2010
Total
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. Data exclude
persons whose month of diagnosis or month of death is unknown.
See Technical Notes for method for calculating proportion of persons surviving.
a
Hispanics/Latinos can be of any race.
b
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
c
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
d
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
HIV Surveillance Report
87
Vol. 26
Table 16b. Survival for more than 12, 24, and 36 months after a diagnosis of HIV infection during
2005–2010, by selected characteristics—United States and 6 dependent areas
Proportion survived
(in months)
No. of persons
>12
>24
>36
1,551
273
11,871
36,695
39,220
36,753
40,081
41,843
34,354
22,811
13,135
6,333
5,269
0.98
0.99
0.99
0.99
0.98
0.97
0.96
0.94
0.92
0.89
0.86
0.83
0.74
0.98
0.99
0.99
0.98
0.97
0.96
0.95
0.93
0.90
0.86
0.83
0.79
0.69
0.98
0.99
0.99
0.98
0.97
0.95
0.93
0.91
0.88
0.84
0.80
0.75
0.64
Race/ethnicity
American Indian/Alaska Native
Asian
Black/African American
Hispanic/Latinoa
Native Hawaiian/Other Pacific Islander
White
Multiple races
982
3,951
132,080
63,178
369
79,456
10,173
0.92
0.96
0.94
0.94
0.96
0.95
0.95
0.90
0.95
0.93
0.93
0.95
0.93
0.93
0.88
0.94
0.91
0.92
0.95
0.92
0.92
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and injection drug use
Heterosexual contactb
Otherc
Subtotal
130,766
13,808
9,653
21,439
42,894
218,560
0.97
0.89
0.96
0.94
0.89
0.94
0.96
0.86
0.95
0.92
0.86
0.93
0.95
0.84
0.93
0.90
0.85
0.92
Female adult or adolescent
Injection drug use
Heterosexual contactb
Otherc
Subtotal
7,716
36,073
26,289
70,078
0.93
0.96
0.93
0.95
0.91
0.95
0.91
0.93
0.88
0.94
0.89
0.91
Child (<13 yrs at diagnosis)
Perinatal
Otherd
Subtotal
1,269
282
1,551
0.98
0.99
0.98
0.98
0.99
0.98
0.98
0.99
0.98
57,962
34,829
141,089
50,279
6,030
0.95
0.96
0.94
0.95
0.87
0.93
0.94
0.93
0.94
0.85
0.92
0.93
0.91
0.93
0.83
49,610
49,684
50,730
49,194
46,532
44,439
0.94
0.94
0.94
0.95
0.95
0.96
0.92
0.92
0.93
0.93
0.94
0.94
0.90
0.91
0.92
0.92
0.93
0.93
290,189
0.95
0.93
0.92
Age at diagnosis (yr)
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
Year of diagnosis
2005
2006
2007
2008
2009
2010
Total
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. Data exclude
persons whose month of diagnosis or month of death is unknown.
See Technical Notes for method for calculating proportion of persons surviving.
a
Hispanics/Latinos can be of any race.
b Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
c
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
d
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
HIV Surveillance Report
88
Vol. 26
Table 17a. Survival for more than 12, 24, and 36 months after a stage 3 (AIDS) classification during
2005–2010, by selected characteristics—United States
Proportion survived
(in months)
No. of persons
>12
>24
>36
205
374
2,542
10,600
18,343
23,035
30,113
34,622
29,901
20,033
11,245
5,495
4,468
0.93
0.99
0.98
0.96
0.95
0.94
0.92
0.91
0.88
0.85
0.81
0.77
0.68
0.92
0.98
0.97
0.94
0.93
0.92
0.90
0.88
0.85
0.81
0.77
0.71
0.62
0.92
0.97
0.95
0.93
0.91
0.90
0.88
0.86
0.82
0.78
0.73
0.67
0.57
670
2,210
89,689
39,261
210
50,523
8,413
0.86
0.92
0.89
0.91
0.94
0.90
0.91
0.83
0.91
0.85
0.89
0.92
0.87
0.88
0.79
0.90
0.83
0.87
0.91
0.85
0.86
76,177
13,350
9,539
16,004
25,425
140,495
0.93
0.85
0.92
0.89
0.82
0.90
0.90
0.81
0.88
0.86
0.79
0.87
0.89
0.77
0.86
0.83
0.77
0.85
Female adult or adolescent
Injection drug use
Heterosexual contactc
Otherd
Subtotal
8,610
26,479
15,187
50,276
0.88
0.92
0.86
0.89
0.83
0.89
0.83
0.86
0.78
0.86
0.81
0.83
Child (<13 yrs at diagnosis)
Perinatal
Othere
Subtotal
186
19
205
0.93
0.89
0.93
0.92
0.89
0.92
0.92
0.89
0.92
Region of residence
Northeast
Midwest
South
West
44,309
22,324
91,061
33,282
0.91
0.90
0.88
0.91
0.88
0.88
0.85
0.89
0.86
0.85
0.82
0.87
Year of diagnosis
2005
2006
2007
2008
2009
2010
35,280
33,495
32,427
31,698
30,479
27,597
0.89
0.89
0.89
0.90
0.90
0.91
0.85
0.85
0.86
0.87
0.88
0.88
0.83
0.83
0.84
0.85
0.86
0.86
190,976
0.90
0.87
0.84
Age at diagnosis (yr)
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
Race/ethnicity
American Indian/Alaska Native
Asiana
Black/African American
Hispanic/Latinob
Native Hawaiian/Other Pacific Islander
White
Multiple races
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and injection drug use
Heterosexual contactc
Otherd
Subtotal
Total
Note. Data exclude persons whose month of diagnosis or month of death is unknown.
See Technical Notes for method for calculating proportion of persons surviving.
a
Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b
Hispanics/Latinos can be of any race.
c Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
d
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
e
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
HIV Surveillance Report
89
Vol. 26
Table 17b. Survival for more than 12, 24, and 36 months after a stage 3 (AIDS) classification during
2005–2010, by selected characteristics—United States and 6 dependent areas
Proportion survived
(in months)
No. of persons
>12
>24
>36
Age at diagnosis (yr)
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
210
381
2,591
10,731
18,662
23,541
30,757
35,442
30,630
20,563
11,540
5,665
4,649
0.92
0.99
0.98
0.96
0.94
0.93
0.92
0.90
0.88
0.84
0.81
0.76
0.68
0.91
0.98
0.97
0.94
0.93
0.91
0.89
0.88
0.84
0.80
0.76
0.71
0.61
0.91
0.97
0.95
0.93
0.91
0.90
0.88
0.85
0.82
0.77
0.73
0.67
0.57
Race/ethnicity
American Indian/Alaska Native
Asiana
Black/African American
Hispanic/Latinob
Native Hawaiian/Other Pacific Islander
White
Multiple races
670
2,211
89,771
43,545
220
50,531
8,414
0.86
0.92
0.89
0.89
0.94
0.90
0.91
0.83
0.91
0.85
0.87
0.91
0.87
0.88
0.79
0.90
0.83
0.85
0.90
0.85
0.86
77,003
14,606
9,755
16,676
25,518
143,558
0.92
0.84
0.91
0.89
0.82
0.89
0.90
0.79
0.88
0.85
0.79
0.86
0.89
0.75
0.86
0.83
0.77
0.84
Female adult or adolescent
Injection drug use
Heterosexual contactc
Otherd
Subtotal
8,925
27,433
15,236
51,594
0.88
0.91
0.86
0.89
0.82
0.88
0.83
0.86
0.78
0.86
0.81
0.83
Child (<13 yrs at diagnosis)
Perinatal
Othere
Subtotal
191
19
210
0.92
0.89
0.92
0.92
0.89
0.91
0.91
0.89
0.91
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
44,309
22,324
91,061
33,282
4,386
0.91
0.90
0.88
0.91
0.76
0.88
0.88
0.85
0.89
0.72
0.86
0.85
0.82
0.87
0.69
Year of diagnosis
2005
2006
2007
2008
2009
2010
36,216
34,300
33,163
32,417
31,127
28,139
0.88
0.88
0.89
0.89
0.90
0.90
0.85
0.85
0.86
0.87
0.87
0.88
0.82
0.83
0.84
0.84
0.85
0.86
195,362
0.89
0.86
0.84
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and injection drug use
Heterosexual contactc
Otherd
Subtotal
Total
Note. Data exclude persons whose month of diagnosis or month of death is unknown.
See Technical Notes for method for calculating proportion of persons surviving.
a
Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanics/Latinos can be of any race.
c
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
d
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
e Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
HIV Surveillance Report
90
Vol. 26
HIV Surveillance Report
Table 18a. Persons living with diagnosed HIV infection, by year and selected characteristics, 2010–2013—United States
2010
2011
Estimated
a
2012
Estimated
a
2013
a
Estimateda
Estimated
91
No.
No.
Rate
No.
No.
Rate
No.
No.
Rate
No.
No.
Rate
Age at end of year (yr)
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
2,944
1,171
7,223
28,998
49,217
67,908
89,171
136,072
168,318
135,093
86,897
46,254
34,243
2,971
1,177
7,293
29,400
49,774
68,482
89,707
136,593
168,608
135,105
86,743
46,106
34,017
5.6
14.2
33.2
135.5
235.4
341.2
446.7
653.4
744.8
604.4
438.2
271.4
84.0
2,671
1,036
6,751
30,612
51,438
69,832
85,525
129,908
168,721
144,048
96,115
52,913
39,502
2,701
1,042
6,842
31,167
52,172
70,558
86,152
130,501
169,061
144,034
95,882
52,679
39,159
5.1
12.6
31.6
140.6
245.0
343.7
439.2
619.8
762.2
637.9
473.0
295.6
94.7
2,526
872
6,231
31,852
53,785
71,538
84,038
123,946
165,109
153,033
105,582
59,605
46,089
2,563
878
6,349
32,622
54,780
72,473
84,798
124,641
165,505
152,984
105,251
59,243
45,568
4.9
10.6
29.7
144.3
256.0
346.3
434.4
591.9
762.1
676.9
506.3
332.3
105.6
2,370
751
5,637
31,945
57,276
72,783
84,253
117,410
159,884
162,207
114,839
66,899
53,848
2,415
759
5,778
32,980
58,652
73,984
85,193
118,185
160,327
162,034
114,306
66,334
52,994
4.6
9.1
27.3
144.3
271.5
347.4
433.6
565.7
754.3
717.2
538.9
365.8
118.5
Race/ethnicity
American Indian/Alaska Native
Asianb
Black/African American
Hispanic/Latinoc
Native Hawaiian/Other Pacific Islander
White
Multiple races
2,514
9,183
362,984
169,564
712
277,765
30,787
2,514
9,255
364,116
170,378
717
278,081
30,915
110.8
62.6
957.9
335.7
143.5
140.9
547.3
2,615
9,871
374,401
175,810
758
284,169
31,448
2,615
9,965
375,745
176,782
765
284,497
31,582
114.3
65.3
978.7
340.3
149.8
144.1
541.8
2,748
10,608
385,351
182,346
809
290,389
31,955
2,750
10,735
386,974
183,560
818
290,736
32,084
119.0
68.2
997.9
345.8
156.9
147.1
533.6
2,868
11,361
396,852
188,827
859
296,976
32,359
2,870
11,530
398,645
190,282
869
297,289
32,456
123.2
70.9
1,018.1
350.8
162.8
150.3
523.5
377,287
67,465
45,693
431,706
82,781
50,933
—
—
—
393,828
66,233
45,623
451,841
81,729
50,958
—
—
—
410,383
64,957
45,511
472,561
80,613
50,929
—
—
—
427,150
63,990
45,398
493,543
79,709
50,849
—
—
—
54,122
3,922
89,985
638,474
67,751
3,929
3,138
640,239
—
—
—
512.0
55,600
4,100
94,090
659,474
69,847
4,106
3,104
661,585
—
—
—
524.0
56,895
4,232
98,539
680,517
71,724
4,237
3,086
683,152
—
—
—
535.7
58,215
4,335
103,032
702,120
73,652
4,336
3,075
705,165
—
—
—
547.4
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and
injection drug use
Heterosexual contactd
Perinatal
Othere
Subtotal
Vol. 26
HIV Surveillance Report
Table 18a. Persons living with diagnosed HIV infection, by year and selected characteristics, 2010–2013—United States (cont)
2010
2011
Estimated
a
2012
Estimated
a
2013
a
Estimateda
Estimated
No.
No.
Rate
No.
No.
Rate
No.
No.
Rate
No.
No.
Rate
39,701
110,583
4,275
57,532
212,091
53,226
153,479
4,282
1,778
212,765
—
—
—
—
162.0
39,046
113,044
4,473
60,364
216,927
52,841
158,553
4,479
1,791
217,665
—
—
—
—
164.2
38,434
115,070
4,626
63,033
221,163
52,408
163,103
4,631
1,800
221,941
—
—
—
—
166.0
37,905
117,259
4,792
65,656
225,612
51,976
167,772
4,795
1,817
226,361
—
—
—
—
167.7
2,602
342
2,944
2,624
347
2,971
—
—
5.6
2,323
348
2,671
2,347
354
2,701
—
—
5.1
2,144
382
2,526
2,173
391
2,563
—
—
4.9
1,965
405
2,370
1,999
416
2,415
—
—
4.6
Region of residence
Northeast
Midwest
South
West
224,220
100,550
365,470
163,269
224,961
100,658
366,476
163,879
406.2
150.3
319.0
227.2
227,653
104,114
379,033
168,272
228,438
104,239
380,283
168,990
410.6
155.2
327.6
232.0
231,280
107,777
391,792
173,357
232,164
107,933
393,326
174,234
415.8
160.3
335.2
236.7
234,718
111,572
405,462
178,350
235,612
111,699
407,214
179,415
420.5
165.3
343.6
241.2
Totalf
853,509
855,974
276.7
879,072
881,951
282.9
904,206
907,657
289.0
930,102
933,941
295.1
Female adult or adolescent
Injection drug use
Heterosexual contactd
Perinatal
Othere
Subtotal
Child (<13 yrs at end of year)
Perinatal
Othere
Subtotal
92
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
a
Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting. Rates are per 100,000 population. Rates
are not calculated by transmission category because of the lack of denominator data.
b
Includes Asian/Pacific Islander legacy cases (see Technical Notes).
c Hispanics/Latinos can be of any race.
d
e
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
f Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Vol. 26
HIV Surveillance Report
Table 18b. Persons living with diagnosed HIV infection, by year and selected characteristics, 2010–2013—United States and 6 dependent areas
2010
2011
Estimated
a
2012
a
Estimated
2013
Estimated
a
Estimateda
93
No.
No.
Rate
No.
No.
Rate
No.
No.
Rate
No.
No.
Rate
Age at end of year (yr)
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
2,991
1,189
7,389
29,431
50,030
69,381
91,150
139,017
171,952
138,036
88,779
47,355
35,295
3,018
1,195
7,460
29,840
50,600
69,973
91,703
139,554
172,254
138,051
88,626
47,208
35,068
5.6
14.2
33.5
135.7
236.3
344.0
450.7
659.0
751.7
610.3
442.2
274.1
85.4
2,713
1,051
6,894
31,049
52,244
71,265
87,420
132,658
172,326
147,132
98,209
54,132
40,680
2,744
1,058
6,987
31,614
52,994
72,013
88,065
133,269
172,676
147,120
97,973
53,896
40,333
5.1
12.6
31.8
140.7
245.9
346.3
443.0
625.0
769.0
644.0
477.6
298.5
96.1
2,554
894
6,350
32,323
54,577
72,914
85,854
126,529
168,637
156,326
107,842
60,954
47,426
2,592
901
6,471
33,108
55,593
73,873
86,632
127,245
169,041
156,278
107,504
60,587
46,896
4.8
10.7
29.8
144.6
256.7
348.6
438.1
596.8
768.8
683.6
511.0
335.5
107.1
2,388
776
5,730
32,432
58,045
74,121
86,030
119,796
163,294
165,666
117,357
68,332
55,364
2,434
784
5,874
33,486
59,444
75,352
86,990
120,590
163,741
165,490
116,813
67,757
54,492
4.6
9.2
27.3
144.7
272.0
349.6
437.1
570.1
760.9
724.1
544.4
369.0
120.1
Race/ethnicity
American Indian/Alaska Native
Asianb
Black/African American
Hispanic/Latinoc
Native Hawaiian/Other Pacific Islander
White
Multiple races
2,515
9,237
363,335
187,545
728
277,831
30,804
2,515
9,309
364,470
188,446
733
278,147
30,932
—
—
—
—
—
—
—
2,616
9,923
374,761
194,000
774
284,235
31,464
2,616
10,017
376,108
195,057
781
284,563
31,598
—
—
—
—
—
—
—
2,749
10,659
385,706
200,817
826
290,454
31,969
2,751
10,786
387,332
202,118
835
290,801
32,097
—
—
—
—
—
—
—
2,869
11,412
397,215
207,546
874
297,044
32,371
2,871
11,581
399,011
209,073
885
297,357
32,467
—
—
—
—
—
—
—
380,876
72,357
46,681
435,436
87,865
51,940
—
—
—
397,591
71,026
46,597
455,769
86,711
51,951
—
—
—
414,377
69,669
46,469
476,742
85,505
51,907
—
—
—
431,350
68,656
46,348
497,957
84,547
51,816
—
—
—
56,555
4,070
90,435
650,974
70,291
4,077
3,188
652,797
—
—
—
515.4
58,094
4,249
94,572
672,129
72,456
4,255
3,154
674,297
—
—
—
527.3
59,443
4,383
99,038
693,379
74,391
4,388
3,139
696,072
—
—
—
539.0
60,804
4,491
103,555
715,204
76,360
4,492
3,128
718,300
—
—
—
550.8
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and
injection drug use
Heterosexual contactd
Perinatal
Othere
Subtotal
Vol. 26
HIV Surveillance Report
Table 18b. Persons living with diagnosed HIV infection, by year and selected characteristics, 2010–2013—United States and 6 dependent areas (cont)
2010
2011
Estimateda
2012
Estimateda
2013
Estimateda
Estimateda
No.
No.
Rate
No.
No.
Rate
No.
No.
Rate
No.
No.
Rate
41,120
114,685
4,402
57,823
218,030
54,701
157,812
4,409
1,814
218,736
—
—
—
—
164.3
40,448
117,221
4,599
60,663
222,931
54,298
162,969
4,605
1,828
223,700
—
—
—
—
166.5
39,821
119,322
4,756
63,348
227,247
53,849
167,611
4,760
1,837
228,057
—
—
—
—
168.3
39,271
121,548
4,922
65,998
231,739
53,393
172,336
4,925
1,857
232,511
—
—
—
—
170.1
2,642
349
2,991
2,664
354
3,018
—
—
5.6
2,360
353
2,713
2,385
359
2,744
—
—
5.1
2,171
383
2,554
2,200
392
2,592
—
—
4.8
1,983
405
2,388
2,018
416
2,434
—
—
4.6
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
224,220
100,550
365,470
163,269
18,486
224,961
100,658
366,476
163,879
18,577
406.2
150.3
319.0
227.2
451.2
227,653
104,114
379,033
168,272
18,701
228,438
104,239
380,283
168,990
18,790
410.6
155.2
327.6
232.0
460.5
231,280
107,777
391,792
173,357
18,974
232,164
107,933
393,326
174,234
19,064
415.8
160.3
335.2
236.7
472.5
234,718
111,572
405,462
178,350
19,229
235,612
111,699
407,214
179,415
19,304
420.5
165.3
343.6
241.2
484.1
Totalf
871,995
874,551
279.0
897,773
900,741
285.2
923,180
926,721
291.3
949,331
953,245
297.4
Female adult or adolescent
Injection drug use
Heterosexual contactd
Perinatal
Othere
Subtotal
Child (<13 yrs at end of year)
Perinatal
Othere
Subtotal
94
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
a
Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting. Rates are per 100,000 population. Rates
by race/ethnicity are not provided because U.S. census information for U.S. dependent areas is limited. Rates are not calculated by transmission category because of the lack of denominator data.
b Includes Asian/Pacific Islander legacy cases (see Technical Notes).
c
Hispanics/Latinos can be of any race.
d
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
e Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
f
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Vol. 26
HIV Surveillance Report
Table 19a. Persons living with diagnosed HIV infection ever classified as stage 3 (AIDS), by year and selected characteristics, 2010–2013—United States
2010
2011
Estimateda
2012
Estimateda
2013
Estimateda
Estimateda
95
No.
No.
Rate
No.
No.
Rate
No.
No.
Rate
No.
No.
Rate
Age at end of year (yr)
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
459
324
2,516
7,475
15,752
27,638
44,636
77,472
104,424
87,144
57,449
30,877
23,087
462
326
2,534
7,568
15,932
27,871
44,892
77,729
104,535
87,102
57,341
30,781
22,950
0.9
3.9
11.5
34.9
75.3
138.9
223.6
371.8
461.8
389.7
289.7
181.2
56.7
374
254
2,261
7,974
16,100
27,925
41,978
72,872
103,793
92,674
63,445
35,150
26,613
377
256
2,284
8,112
16,347
28,237
42,298
73,193
103,967
92,637
63,299
35,019
26,420
0.7
3.1
10.5
36.6
76.8
137.6
215.6
347.6
468.7
410.3
312.3
196.5
63.9
314
193
1,953
8,208
16,439
28,186
40,408
68,566
100,646
97,936
69,556
39,536
30,962
317
194
1,980
8,387
16,768
28,592
40,806
68,961
100,862
97,898
69,363
39,338
30,684
0.6
2.4
9.3
37.1
78.3
136.6
209.1
327.5
464.4
433.2
333.7
220.7
71.1
269
152
1,696
8,218
17,296
28,158
39,781
63,972
96,359
103,289
75,413
44,434
36,075
272
154
1,729
8,443
17,733
28,664
40,278
64,418
96,627
103,194
75,120
44,136
35,633
0.5
1.8
8.2
37.0
82.1
134.6
205.0
308.3
454.6
456.8
354.2
243.4
79.7
Race/ethnicity
American Indian/Alaska Native
Asianb
Black/African American
Hispanic/Latinoc
Native Hawaiian/Other Pacific Islander
White
Multiple races
1,356
5,046
198,670
102,059
399
153,116
18,607
1,355
5,077
199,009
102,485
402
152,986
18,710
59.7
34.4
523.5
201.9
80.5
77.5
331.3
1,411
5,338
204,598
105,028
421
155,600
19,017
1,410
5,378
205,096
105,537
425
155,468
19,132
61.6
35.3
534.2
203.1
83.2
78.7
328.2
1,466
5,629
210,380
107,964
441
157,687
19,336
1,466
5,681
211,018
108,568
446
157,514
19,459
63.5
36.1
544.2
204.5
85.5
79.7
323.6
1,509
5,935
216,590
110,803
465
160,179
19,631
1,508
6,001
217,250
111,480
470
159,945
19,747
64.7
36.9
554.8
205.5
88.1
80.9
318.5
208,125
46,705
30,407
232,456
55,288
33,058
—
—
—
214,912
46,034
30,418
240,811
54,766
33,150
—
—
—
221,388
45,303
30,357
248,996
54,172
33,162
—
—
—
228,131
44,686
30,237
257,544
53,649
33,095
—
—
—
33,462
2,198
44,842
365,739
41,047
2,205
2,132
366,187
—
—
—
292.8
34,537
2,281
46,840
375,022
42,536
2,289
2,106
375,658
—
—
—
297.5
35,483
2,327
48,977
383,835
43,875
2,336
2,092
384,634
—
—
—
301.6
36,477
2,386
51,354
393,271
45,341
2,395
2,100
394,124
—
—
—
306.0
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and
injection drug use
Heterosexual contactd
Perinatal
Othere
Subtotal
Vol. 26
HIV Surveillance Report
Table 19a. Persons living with diagnosed HIV infection ever classified as stage 3 (AIDS), by year and selected characteristics, 2010–2013—United States (cont)
2010
2011
Estimateda
No.
No.
25,494
60,000
2,349
25,212
113,055
32,217
77,675
2,357
1,128
113,376
442
17
459
Region of residence
Northeast
Midwest
South
West
Totalf
Female adult or adolescent
Injection drug use
Heterosexual contactd
Perinatal
Othere
Subtotal
Child (<13 yrs at end of year)
Perinatal
Othere
Subtotal
96
a
Rate
2012
Estimateda
2013
Estimateda
Estimateda
No.
No.
Rate
No.
No.
Rate
No.
No.
Rate
—
—
—
—
86.3
25,232
61,753
2,455
26,577
116,017
32,145
80,670
2,464
1,133
116,412
—
—
—
—
87.8
24,984
63,332
2,528
27,910
118,754
32,048
83,485
2,537
1,129
119,200
—
—
—
—
89.1
24,717
64,879
2,638
29,338
121,572
31,905
86,319
2,651
1,130
122,005
—
—
—
—
90.4
445
17
462
—
—
0.9
355
19
374
358
19
377
—
—
0.7
297
17
314
300
17
317
—
—
0.6
254
15
269
257
15
272
—
—
0.5
133,906
52,276
195,618
97,453
134,509
52,242
195,588
97,685
242.9
78.0
170.3
135.4
135,485
54,056
202,223
99,649
136,157
54,031
202,331
99,928
244.7
80.5
174.3
137.2
136,936
55,704
208,565
101,698
137,671
55,679
208,760
102,040
246.6
82.7
177.9
138.6
138,144
57,388
215,877
103,703
138,904
57,311
216,042
104,144
247.9
84.8
182.3
140.0
479,253
480,024
155.2
491,413
492,447
158.0
502,903
504,150
160.5
515,112
516,401
163.2
Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting. Rates are per 100,000 population. Rates
are not calculated by transmission category because of the lack of denominator data.
b
Includes Asian/Pacific Islander legacy cases (see Technical Notes).
c Hispanics/Latinos can be of any race.
d
e
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
f Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Vol. 26
HIV Surveillance Report
Table 19b. Persons living with diagnosed HIV infection ever classified as stage 3 (AIDS), by year and selected characteristics, 2010–2013—United States and
6 dependent areas
No.
No.
Rate
No.
No.
Rate
No.
No.
Rate
No.
No.
Rate
Age at end of year (yr)
<13
13–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
60–64
65
467
331
2,574
7,625
15,979
28,120
45,568
79,133
106,791
89,148
58,772
31,670
23,815
470
333
2,592
7,719
16,161
28,358
45,830
79,393
106,901
89,101
58,659
31,571
23,673
0.9
4.0
11.6
35.1
75.5
139.4
225.2
374.9
466.5
393.9
292.7
183.3
57.7
381
258
2,317
8,109
16,333
28,378
42,830
74,371
106,134
94,759
64,908
36,020
27,434
384
260
2,341
8,248
16,582
28,695
43,157
74,696
106,305
94,716
64,753
35,883
27,234
0.7
3.1
10.7
36.7
76.9
138.0
217.1
350.3
473.4
414.6
315.6
198.7
64.9
320
197
1,998
8,335
16,660
28,611
41,210
69,909
102,897
100,146
71,147
40,489
31,908
323
199
2,025
8,516
16,992
29,023
41,616
70,310
103,109
100,100
70,944
40,283
31,620
0.6
2.4
9.3
37.2
78.5
137.0
210.4
329.8
468.9
437.8
337.2
223.1
72.2
272
158
1,733
8,347
17,521
28,563
40,523
65,206
98,466
105,631
77,161
45,444
37,147
275
161
1,767
8,574
17,961
29,077
41,029
65,659
98,732
105,528
76,856
45,135
36,691
0.5
1.9
8.2
37.1
82.2
134.9
206.2
310.4
458.8
461.8
358.2
245.8
80.9
97
Race/ethnicity
American Indian/Alaska Native
Asianb
Black/African American
Hispanic/Latinoc
Native Hawaiian/Other Pacific Islander
White
Multiple races
1,357
5,070
198,860
112,528
409
153,153
18,616
1,356
5,101
199,200
112,949
412
153,023
18,720
—
—
—
—
—
—
—
1,412
5,361
204,788
115,577
431
155,637
19,026
1,411
5,401
205,287
116,075
435
155,505
19,141
—
—
—
—
—
—
—
1,467
5,651
210,573
118,616
452
157,726
19,342
1,467
5,702
211,211
119,203
457
157,553
19,465
—
—
—
—
—
—
—
1,510
5,957
216,784
121,592
474
160,219
19,636
1,509
6,023
217,444
122,252
479
159,986
19,752
—
—
—
—
—
—
—
210,161
49,766
31,102
234,520
58,383
33,754
—
—
—
216,997
49,047
31,104
242,926
57,808
33,835
—
—
—
223,553
48,290
31,032
251,193
57,182
33,835
—
—
—
230,368
47,666
30,903
259,819
56,652
33,758
—
—
—
34,886
2,294
44,968
373,177
42,499
2,301
2,161
373,618
—
—
—
295.0
36,008
2,378
46,967
382,501
44,034
2,386
2,136
383,125
—
—
—
299.6
36,975
2,424
49,105
391,379
45,395
2,433
2,122
392,161
—
—
—
303.7
38,005
2,485
51,491
400,918
46,899
2,494
2,132
401,755
—
—
—
308.1
2010
2011
Estimated
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Injection drug use
Male-to-male sexual contact and
injection drug use
Heterosexual contactd
Perinatal
Othere
Subtotal
a
2012
a
Estimated
2013
Estimated
a
Estimateda
Vol. 26
HIV Surveillance Report
Table 19b. Persons living with diagnosed HIV infection ever classified as stage 3 (AIDS), by year and selected characteristics, 2010–2013—United States and
6 dependent areas (cont)
2010
2011
Estimateda
2012
Estimateda
No.
No.
Rate
No.
No.
Rate
No.
No.
26,403
62,222
2,435
25,289
116,349
33,138
79,953
2,442
1,140
116,673
—
—
—
—
87.6
26,128
64,025
2,543
26,654
119,350
33,052
82,998
2,551
1,145
119,746
—
—
—
—
89.1
25,873
65,650
2,615
27,990
122,128
32,947
85,862
2,624
1,141
122,574
448
19
467
451
19
470
—
—
0.9
360
21
381
363
21
384
—
—
0.7
302
18
320
Region of residence
Northeast
Midwest
South
West
U.S. dependent areas
133,906
52,276
195,618
97,453
10,740
134,509
52,242
195,588
97,685
10,736
242.9
78.0
170.3
135.4
260.8
135,485
54,056
202,223
99,649
10,819
136,157
54,031
202,331
99,928
10,808
244.7
80.5
174.3
137.2
264.9
Totalf
489,993
490,760
156.6
502,232
503,254
159.4
Female adult or adolescent
Injection drug use
Heterosexual contactd
Perinatal
Othere
Subtotal
Child (<13 yrs at end of year)
Perinatal
Othere
Subtotal
2013
Estimateda
Rate
Estimateda
98
No.
No.
Rate
—
—
—
—
90.5
25,600
67,236
2,723
29,423
124,982
32,797
88,737
2,736
1,145
125,415
—
—
—
—
91.7
305
18
323
—
—
0.6
257
15
272
260
15
275
—
—
0.5
136,936
55,704
208,565
101,698
10,924
137,671
55,679
208,760
102,040
10,907
246.6
82.7
177.9
138.6
270.3
138,144
57,388
215,877
103,703
11,060
138,904
57,311
216,042
104,144
11,043
247.9
84.8
182.3
140.0
276.9
513,827
515,057
161.9
526,172
527,445
164.6
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting. Rates are per 100,000 population. Rates
by race/ethnicity are not provided because U.S. census information for U.S. dependent areas is limited. Rates are not calculated by transmission category because of the lack of denominator data.
b
Includes Asian/Pacific Islander legacy cases (see Technical Notes).
c
Hispanics/Latinos can be of any race.
d Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
e
f
Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Vol. 26
HIV Surveillance Report
Table 20a. Persons living with diagnosed HIV infection, by race/ethnicity and selected characteristics, year-end 2013—United States
American Indian/
Alaska Native
Asiana
Estimatedc
No.
No.
Rate
Black/African American
Estimatedc
No.
No.
Rate
Native Hawaiian/
Other Pacific Islander
Hispanic/Latinob
Estimatedc
Estimatedc
No.
No.
Rate
1,547
1,578
21.8
475
No.
No.
White
Estimatedc
Rate
No.
No.
Rate
2.6
3
3
2.9
Multiple races
Estimatedc
No.
No.
Rate
Total
Estimatedc
No.
No.
Estimatedc
Rate
No.
No.d
Rate
Age at end of year (yr)
99
<13
8
8
1.8
66
68
2.7
13–14
0
0
0.0
11
11
3.0
470
15–19
9
9
5.0
50
51
5.2
3,638
20–24
106
109
54.1
324
337
25–29
177
179
104.5
773
30–34
299
302
190.4
35–39
301
302
211.4
40–44
441
443
45–49
503
50–54
55–59
331
336
281
287
1.1
134
137
6.1
2,370
2,415
4.6
40.1
159
160
8.5
0
0
0.0
84
85
1.9
27
27
9.5
751
759
9.1
3,734 121.8
1,107
1,132
24.6
2
2
5.4
589
602
5.2
242
248
38.5
5,637
5,778
27.3
27.7
19,474 20,110 588.5
5,956
6,147 131.4
30
31
64.3
4,732
4,883
38.3
1,323
1,363
250.0
31,945 32,980 144.3
799
59.0
30,615 31,329 1,096.4
12,364 12,686 289.1
66
68
138.6
11,014 11,275
91.1
2,267
2,316
560.3
57,276 58,652 271.5
1,125
1,153
82.5
33,712 34,222 1,251.8
17,725 18,066 412.5
103
105
228.4
16,979 17,252 141.2
2,840
2,884
793.9
72,783 73,984 347.4
1,553
1,584 117.9
36,864 37,234 1,499.6
21,333 21,619 531.3
108
109
280.4
20,965 21,187 188.0
3,129
3,157 1,063.4
84,253 85,193 433.6
299.5
2,116
2,148 160.0
48,098 48,386 1,850.2
27,277 27,521 729.1
132
134
369.4
35,233 35,422 278.8
4,113
4,132 1,512.6 117,410 118,185 565.7
502
326.1
1,863
1,883 162.5
62,760 62,920 2,370.2
33,733 33,900 1,023.2
130
131
384.8
55,171 55,261 403.4
5,724
5,730 2,388.1 159,884 160,327 754.3
469
466
285.0
1,345
1,355 126.4
63,180 63,131 2,321.5
29,647 29,676 1,053.1
106
106
319.2
62,034 61,891 398.1
5,426
5,409 2,277.0 162,207 162,034 717.2
284
281
192.6
985
989 101.7
47,934 47,678 1,958.9
19,358 19,327 873.8
95
96
347.2
42,529 42,310 278.1
3,654
3,625 1,778.2 114,839 114,306 538.9
60–64
160
159
137.6
605
607
74.1
27,825 27,530 1,434.5
10,562 10,505 642.7
53
53
246.1
25,600 25,406 188.6
2,094
2,073 1,334.2
66,899 66,334 365.8
65
111
109
50.0
545
544
31.3
20,735 20,317 529.0
31
31
79.6
21,765 21,430
60.8
1,386
1,354
53,848 52,994 118.5
1,228
1,387
—
6,324
7,764
— 191,955 210,299
—
Injection drug use
198
223
—
262
Male-to-male sexual contact
and injection drug use
273
305
—
Heterosexual contacte
147
168
4
4
247
2,097
9,275
9,207 274.5
441.8
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Perinatal
Otherf
Subtotal
— 122,737 152,303
—
89,409 104,529
—
543
608
397
—
30,731 40,570
—
17,192 21,409
—
23
25
—
13,407 14,610
—
2,177
290
347
—
13,209 16,000
—
9,919
—
34
37
—
20,304 21,426
—
—
645
813
—
35,540 47,257
—
11,802 13,953
—
36
41
—
8,270
9,382
—
24
24
—
2,554
2,554
—
1,035
1,035
—
1
1
—
543
543
12
—
1,730
70
—
53,555
880
—
21,883
437
—
69
3
—
23,035
1,565
2,099
228.4
9,275
9,416 145.5 258,326 259,563 1,727.4 150,018 151,282 728.6
706
715
8,697
— 427,150 493,543
—
2,475
—
63,990 79,709
—
2,591
2,816
—
45,398 50,849
—
—
1,775
2,038
—
58,215 73,652
—
—
174
174
—
4,335
4,336
—
—
2,513
109
— 103,032
3,075
—
329.8 257,514 257,826 308.7
14,954 16,652
24,184 24,263 1,272.6 702,120 705,165 547.4
Vol. 26
HIV Surveillance Report
Table 20a. Persons living with diagnosed HIV infection, by race/ethnicity and selected characteristics, year-end 2013—United States (cont)
American Indian/
Alaska Native
Asiana
Estimatedc
No.
No.
Rate
Black/African American
Estimatedc
No.
No.
Rate
Estimatedc
No.
No.
Native Hawaiian/
Other Pacific Islander
Hispanic/Latinob
Estimatedc
Rate
No.
No.
6,834
9,257
20,598 28,065
White
Estimatedc
Rate
Multiple races
Estimatedc
No.
No.
Rate
No.
No.
—
21
26
—
10,193 12,478
—
84
121
—
19,506 25,595
2
2
—
Rate
Total
Estimatedc
Estimatedc
Rate
No.
No.d
No.
No.
Rate
—
1,885
2,372
—
37,905 51,976
—
—
4,076
5,423
— 117,259 167,772
—
—
194
194
—
4,792
4,795
—
—
65,656
1,817
—
Female adult or adolescent
Injection drug use
e
Heterosexual contact
Perinatal
f
181
238
—
89
170
—
18,702 27,435
—
372
504
—
1,146
1,788
—
71,477 106,276
—
7
7
—
18
18
—
2,938
2,941
—
—
43,862
853
—
1,058
1,058
—
9,988
283
—
43
2
—
38,478 38,664 190.0
150
151
70.9
575
575
8,907
528
—
1,886
67
39,181 39,177
44.9
8,041
8,056
Other
203
14
—
767
70
Subtotal
763
763
79.5
2,020
2,047
Perinatal
7
7
—
44
45
—
1,275
1,298
—
308
312
—
3
3
—
208
212
—
120
122
—
1,965
1,999
—
Otherf
1
1
—
22
23
—
272
280
—
23
23
—
0
0
—
73
75
—
14
14
—
405
416
—
Subtotal
8
8
1.8
66
68
2.7
1,547
1,578
21.8
331
336
2.6
3
3
2.9
281
287
1.1
134
137
6.1
2,370
2,415
4.6
Northeast
165
166
131.8
2,583
2,623
76.1
95,442 95,740 1,524.1
66,955 67,265 887.5
58
59
290.8
57,917 58,130 154.1
Midwest
361
361
90.2
989
1,000
51.0
48,987 49,007 702.7
11,694 11,777 235.4
38
38
132.3
45,297 45,299
South
708
705
91.5
2,118
2,152
58.3 224,317 225,606 1,001.8
56,968 57,389 289.3
130
132
163.5 108,706 108,666 156.1
West
1,634
1,639
158.4
5,671
5,755
80.4
53,210 53,851 246.8
633
640
158.5
Totalg
2,868
2,870
123.2
70.9 396,852 398,645 1,018.1 188,827 190,282 350.8
859
869
162.8 296,976 297,289 150.3
28.0 136,979 137,504 813.8
391.4 225,612 226,361 167.7
Child (<13 yrs at end of year)
100
Region of residence
11,361 11,530
28,106 28,292 836.9
87.1
85,056 85,194 221.6
11,598 11,630 1,348.7 234,718 235,612 420.5
4,206
4,217
355.8 111,572 111,699 165.3
12,515 12,565
624.4 405,462 407,214 343.6
4,040
4,045
189.0 178,350 179,415 241.2
32,359 32,456
523.5 930,102 933,941 295.1
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
Reported numbers less than 12, as well as estimated numbers (and accompanying rates and trends) based on these numbers, should be interpreted with caution because the numbers have underlying relative standard errors greater than 30% and
are considered unreliable.
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanics/Latinos can be of any race.
c Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting. Rates are per 100,000 population. Rates are not calculated by transmission category
because of the lack of denominator data.
d Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
e
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
f Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
g
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Vol. 26
HIV Surveillance Report
Table 20b. Persons living with diagnosed HIV infection, by race/ethnicity and selected characteristics, year-end 2013—United States and 6 dependent areas
American Indian/
Alaska Native
No.
Est. No.c
Black/
African American
Asiana
No.
Est. No.c
No.
Est. No.c
Hispanic/Latinob
No.
Native Hawaiian/
Other Pacific Islander
Est. No.c
No.
Est. No.c
352
3
3
White
No.
Multiple races
Est. No.c
No.
Est. No.c
Total
No.
Est. No.c,d
Age at end of year (yr)
101
<13
8
8
66
68
1,548
1,579
347
281
287
135
138
2,388
2,434
13–14
0
0
11
11
471
476
183
185
0
0
84
85
27
27
776
784
15–19
9
9
50
51
3,641
3,737
1,196
1,223
2
2
589
602
243
249
5,730
5,874
20–24
106
109
324
337
19,479
20,115
6,438
6,649
30
31
4,732
4,883
1,323
1,363
32,432
33,486
25–29
177
179
774
800
30,627
31,342
13,119
13,464
67
69
11,014
11,275
2,267
2,316
58,045
59,444
30–34
299
302
1,129
1,157
33,746
34,257
19,016
19,386
105
107
16,984
17,257
2,842
2,886
74,121
75,352
35–39
301
302
1,560
1,591
36,893
37,264
23,072
23,377
110
111
20,965
21,187
3,129
3,157
86,030
86,990
40–44
441
443
2,126
2,157
48,151
48,440
29,587
29,849
135
137
35,241
35,430
4,115
4,134
119,796
120,590
45–49
503
502
1,874
1,894
62,826
62,987
37,045
37,215
133
134
55,187
55,277
5,726
5,732
163,294
163,741
50–54
470
467
1,352
1,362
63,231
63,182
33,030
33,056
108
108
62,047
61,904
5,428
5,411
165,666
165,490
55–59
284
281
989
993
47,976
47,720
21,820
21,778
95
96
42,538
42,319
3,655
3,626
117,357
116,813
60–64
160
159
608
610
27,850
27,555
11,955
11,888
55
55
25,609
25,415
2,095
2,074
68,332
67,757
65
111
109
549
548
20,776
20,358
10,738
10,653
31
31
21,773
21,438
1,386
1,354
55,364
54,492
1,228
1,387
6,345
7,790
122,804
152,383
93,474
108,786
550
615
191,989
210,337
14,960
16,658
431,350
497,957
Injection drug use
198
223
263
405
30,749
40,615
21,835
26,188
23
26
13,411
14,616
2,177
2,475
68,656
84,547
Male-to-male sexual contact and
injection drug use
273
305
291
349
13,214
16,006
9,635
10,871
34
37
20,310
21,432
2,591
2,816
46,348
51,816
Heterosexual contacte
148
169
647
817
35,585
47,331
14,341
16,580
37
42
8,271
9,383
1,775
2,037
60,804
76,360
4
4
24
24
2,558
2,558
1,186
1,186
1
1
543
543
175
175
4,491
4,492
247
12
1,745
70
53,624
880
22,316
489
70
3
23,040
1,565
2,513
109
103,555
3,128
2,098
2,100
9,315
9,456
258,534
259,773
162,787
164,101
715
724
257,564
257,876
24,191
24,270
715,204
718,300
Transmission category
Male adult or adolescent
Male-to-male sexual contact
Perinatal
Otherf
Subtotal
Vol. 26
HIV Surveillance Report
Table 20b. Persons living with diagnosed HIV infection, by race/ethnicity and selected characteristics, year-end 2013—United States and 6 dependent areas (cont)
American Indian/
Alaska Native
No.
Est. No.c
Black/
African American
Asiana
No.
Est. No.c
No.
Est. No.c
Hispanic/Latinob
No.
Est. No.c
Native Hawaiian/
Other Pacific Islander
No.
Est. No.c
White
Multiple races
No.
Est. No.c
Total
No.
Est. No.c
No.
Est. No.c,d
Female adult or adolescent
Injection drug use
e
Heterosexual contact
Perinatal
f
181
238
89
173
18,711
27,454
8,188
10,647
21
27
10,196
12,483
1,885
2,372
39,271
53,393
372
504
1,149
1,796
71,553
106,403
24,792
32,473
87
127
19,516
25,608
4,079
5,426
121,548
172,336
7
7
18
18
2,943
2,946
1,183
1,183
2
2
575
575
194
194
4,922
4,925
Other
203
14
775
71
43,926
856
10,249
318
46
2
8,912
528
1,887
68
65,998
1,857
Subtotal
763
763
2,031
2,058
137,133
137,659
44,412
44,620
156
158
39,199
39,195
8,045
8,060
231,739
232,511
7
7
44
45
1,276
1,299
324
329
3
3
208
212
121
123
1,983
2,018
Other
1
1
22
23
272
280
23
23
0
0
73
75
14
14
405
416
Subtotal
8
8
66
68
1,548
1,579
347
352
3
3
281
287
135
138
2,388
2,434
Northeast
165
166
2,583
2,623
95,442
95,740
66,955
67,265
58
59
57,917
58,130
11,598
11,630
234,718
235,612
Midwest
361
361
989
1,000
48,987
49,007
11,694
11,777
38
38
45,297
45,299
4,206
4,217
111,572
111,699
South
708
705
2,118
2,152
224,317
225,606
56,968
57,389
130
132
108,706
108,666
12,515
12,565
405,462
407,214
West
1,634
1,639
5,671
5,755
28,106
28,292
53,210
53,851
633
640
85,056
85,194
4,040
4,045
178,350
179,415
1
1
51
51
363
366
18,719
18,791
15
15
68
68
12
11
19,229
19,304
2,869
2,871
11,412
11,581
397,215
399,011
207,546
209,073
874
885
297,044
297,357
32,371
32,467
949,331
953,245
Child (<13 yrs at end of year)
Perinatal
f
Region of residence
102
U.S. dependent areas
Totalg
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
Reported numbers less than 12, as well as estimated numbers (and accompanying trends) based on these numbers, should be interpreted with caution because the numbers have underlying relative standard errors greater than 30% and are
considered unreliable.
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanics/Latinos can be of any race.
c Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting.
d Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
e
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
f Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
g
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Vol. 26
HIV Surveillance Report
Table 21a. Persons living with diagnosed HIV infection ever classified as stage 3 (AIDS), by race/ethnicity and selected characteristics, year-end 2013—United States
American Indian/
Alaska Native
Estimated
No.
No.
Asian
c
Rate
a
Black/African American
c
Estimated
No.
No.
Rate
Estimated
No.
No.
Hispanic/Latino
c
Estimated
Rate
No.
No.
Native Hawaiian/
Other Pacific Islander
b
c
White
c
Estimated
Rate
No.
No.
Rate
Multiple races
c
Estimated
No.
No.
Rate
Total
Estimated
No.
No.
c
c
Estimated
Rate
No.
No.
d
Rate
Age at end of year (yr)
103
<13
2
2
0.4
4
4
0.2
174
176
2.4
38
38
0.3
2
2
1.9
32
32
0.1
17
17
0.8
269
272
0.5
13–14
0
0
0.0
2
2
0.5
101
103
8.7
29
29
1.5
0
0
0.0
15
15
0.3
5
5
1.8
152
154
1.8
15–19
2
2
1.1
12
12
1.3
1,128
1,151
37.6
333
339
7.4
1
1
2.5
141
143
1.2
79
81
12.6
1,696
1,729
8.2
20–24
22
22
11.1
48
50
4.1
5,315
5,459
159.8
1,578
1,620
34.6
7
7
14.8
838
861
6.8
410
423
77.6
8,218
8,443
37.0
25–29
50
51
29.5
199
205
15.2
9,721
9,963
348.7
3,974
4,074
92.9
17
18
35.9
2,540
2,603
21.0
795
818
198.0 17,296 17,733
82.1
30–34
111
112
70.6
391
401
28.7
13,691 13,923
509.3
7,519
7,663 175.0
42
43
93.0
5,182
5,276
43.2
1,222
1,246
343.1 28,158 28,664 134.6
35–39
132
132
92.6
655
667
49.7
18,035 18,241
734.7 10,817 10,965 269.5
52
53
134.9
8,391
8,495
75.4
1,699
1,725
581.0 39,781 40,278 205.0
40–44
246
247
167.2
1,130
1,146
85.3
26,694 26,857 1,027.0 15,953 16,094 426.4
71
72
198.9
17,322 17,419 137.1
2,556
2,582
945.2 63,972 64,418 308.3
45–49
290
289
188.0
1,115
1,126
97.2
38,218 38,326 1,443.8 21,892 22,004 664.2
88
89
261.3
30,918 30,934 225.8
3,838
3,858 1,607.8 96,359 96,627 454.6
50–54
293
292
178.7
862
867
80.8
40,038 40,017 1,471.5 20,514 20,550 729.3
76
77
230.5
37,636 37,516 241.3
3,870
3,875 1,631.3 103,289 103,194 456.8
55–59
184
183
125.1
684
687
70.6
31,440 31,329 1,287.2 13,694 13,688 618.9
57
57
208.5
26,730 26,559 174.6
2,624
2,618 1,284.2 75,413 75,120 354.2
60–64
99
98
85.3
439
441
53.8
18,271 18,126
944.5
7,669
7,652 468.1
30
30
139.1
16,403 16,272 120.8
65
78
77
35.3
394
393
22.6
13,764 13,578
353.5
6,793
6,762 201.6
22
22
56.5
Male-to-male sexual contact
632
694
—
3,171
3,899
—
63,264 75,577
— 49,031 57,000
—
300
328
Injection drug use
119
130
—
160
249
—
21,533 26,925
— 12,394 15,036
—
14
Male-to-male sexual contact
and injection drug use
e
Heterosexual contact
183
198
—
188
222
—
9,311 10,716
—
6,003
6,737
—
21
87
21,793 28,345
—
7,998
9,414
—
—
559
562
—
— 12,517
304
1,523
1,517
14,031 13,820
39.2
993
981
975.9 44,434 44,136 243.4
320.0 36,075 35,633
79.7
— 103,301 110,662
—
8,432
9,384
— 228,131 257,544
—
15
—
9,434
—
1,646
1,859
— 44,686 53,649
—
23
—
12,694 13,213
—
1,837
1,985
— 30,237 33,095
—
22
25
—
4,951
5,541
—
1,183
1,363
— 36,477 45,341
—
1
1
—
272
273
—
107
108
—
—
31
2
—
10,438
1,140
—
1,489
75
955.1 88,502 89,053 428.9
389
394
Transmission category
Male adult or adolescent
99
—
443
555
—
Perinatal
f
Other
2
2
—
10
10
—
1,435
1,439
112
10
—
962
54
—
25,805
515
Subtotal
1,135
1,135
123.5
4,934
4,989
77.1
143,141 143,517
8,820
181.6 140,476 140,262 168.0
14,694 14,775
2,386
2,395
—
— 51,354
2,100
—
774.9 393,271 394,124 306.0
Vol. 26
HIV Surveillance Report
Table 21a. Persons living with diagnosed HIV infection ever classified as stage 3 (AIDS), by race/ethnicity and selected characteristics, year-end 2013—United States (cont)
American Indian/
Alaska Native
Estimated
No.
No.
Asiana
c
Rate
Black/African American
c
Estimated
No.
No.
Estimated
Rate
No.
No.
c
Estimated
Rate
Native Hawaiian/
Other Pacific Islander
Hispanic/Latinob
No.
No.
4,714
c
White
c
Estimated
Rate
No.
No.
Rate
Multiple races
c
Estimated
No.
No.
Rate
Estimated
No.
No.
Total
c
c
Estimated
Rate
No.
No.
d
Rate
Female adult or adolescent
Injection drug use
Heterosexual contacte
91
115
—
51
91
—
12,592 17,095
—
6,041
—
13
15
—
5,910
6,893
—
1,346
1,655
— 24,717 31,905
—
190
39,487 54,293
9,998 12,140
— 64,879 86,319
—
—
244
—
609
865
—
— 12,124 15,573
—
43
57
—
—
2,428
3,147
Perinatal
Otherf
4
4
—
6
6
—
1,656
1,664
—
577
580
—
2
2
—
279
280
—
114
115
87
9
—
331
46
—
19,540
504
—
4,848
193
—
16
1
—
3,484
339
—
1,032
38
Subtotal
372
372
38.8
997
1,008
13.8
435.3 22,263 22,389 110.0
74
75
34.9
19,671 19,651
22.5
4,920
4,955
Perinatal
Otherf
1
1
—
4
4
—
163
165
—
38
38
—
2
2
—
29
29
—
17
17
—
254
257
—
1
1
—
0
0
—
11
11
—
0
0
—
0
0
—
3
3
—
0
0
—
15
15
—
Subtotal
2
2
0.4
4
4
0.2
174
176
2.4
38
38
0.3
2
2
1.9
32
32
0.1
17
17
0.8
269
272
0.5
Northeast
85
85
67.9
1,326
1,342
38.9
56,575 56,901
905.8 40,903 41,196 543.5
24
24
119.9
31,804 31,852
84.5
7,427
7,504
870.3 138,144 138,904 247.9
Midwest
169
169
42.2
472
474
24.2
25,116 25,046
359.1
6,532 130.5
17
17
59.4
22,751 22,731
43.7
2,339
2,341
197.5 57,388 57,311
South
326
322
41.9
961
970
26.3
118,494 118,824
527.6 31,391 31,489 158.7
51
51
63.6
57,256 56,960
81.8
7,398
7,426
369.0 215,877 216,042 182.3
West
929
932
90.1
3,176
3,215
44.9
16,405 16,479
487.5 31,985 32,263 147.9
373
378
93.5
48,368 48,403 125.9
2,467
2,476
115.7 103,703 104,144 140.0
1,509
1,508
64.7
5,935
6,001
36.9
216,590 217,250
554.8 110,803 111,480 205.5
465
470
88.1 160,179 159,945
19,631 19,747
318.5 515,112 516,401 163.2
73,275 73,557
2,638
2,651
—
— 29,338
1,130
—
240.7 121,572 122,005
90.4
Child (<13 yrs at end of year)
104
Region of residence
Totalg
6,524
80.9
84.8
Note. Reported numbers less than 12, as well as estimated numbers (and accompanying rates and trends) based on these numbers, should be interpreted with caution because the numbers have underlying relative standard errors greater than
30% and are considered unreliable.
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanics/Latinos can be of any race.
c Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting. Rates are per 100,000 population. Rates are not calculated by transmission category
because of the lack of denominator data.
d Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
e
Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
f Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
g
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Vol. 26
HIV Surveillance Report
Table 21b. Persons living with diagnosed HIV infection ever classified as stage 3 (AIDS), by race/ethnicity and selected characteristics, year-end 2013—United States and 6 dependent areas
American Indian/
Alaska Native
No.
Est. No.
Asian
c
No.
Black/
African American
a
Est. No.
c
No.
Est. No.
Hispanic/Latino
c
No.
b
Native Hawaiian/
Other Pacific Islander
c
Est. No.
No.
41
2
2
Est. No.
c
White
No.
Multiple races
Est. No.
c
No.
Total
Est. No.
c
No.
Est. No.
c,d
Age at end of year
105
<13
2
2
4
4
174
176
41
32
32
17
17
272
275
13–14
0
0
2
2
101
103
35
35
0
0
15
15
5
5
158
161
15–19
2
2
12
12
1,131
1,154
367
374
1
1
141
143
79
81
1,733
1,767
20–24
22
22
48
50
5,316
5,460
1,706
1,751
7
7
838
861
410
423
8,347
8,574
25–29
50
51
199
205
9,723
9,965
4,197
4,301
17
18
2,540
2,603
795
818
17,521
17,961
30–34
111
112
392
402
13,701
13,933
7,912
8,064
43
44
5,182
5,276
1,222
1,246
28,563
29,077
35–39
132
132
657
669
18,046
18,252
11,544
11,701
53
54
8,391
8,495
1,700
1,726
40,523
41,029
40–44
246
247
1,132
1,148
26,722
26,886
17,152
17,301
73
74
17,325
17,422
2,556
2,582
65,206
65,659
45–49
290
289
1,125
1,136
38,261
38,370
23,932
24,042
91
92
30,928
30,945
3,839
3,859
98,466
98,732
50–54
294
293
864
869
40,068
40,046
22,813
22,842
77
78
37,642
37,522
3,873
3,878
105,631
105,528
55–59
184
183
685
688
31,464
31,353
15,409
15,391
57
57
26,738
26,567
2,624
2,618
77,161
76,856
60–64
99
98
441
443
18,291
18,147
8,651
8,623
31
31
16,408
16,277
1,523
1,516
45,444
45,135
65
78
77
396
395
13,786
13,600
7,833
7,787
22
22
14,039
13,828
993
981
37,147
36,691
Male-to-male sexual contact
632
694
3,182
3,912
63,306
75,624
51,186
59,184
304
332
103,323
110,686
8,435
9,387
230,368
259,819
Injection drug use
119
130
161
252
21,546
26,948
15,358
18,011
14
15
8,822
9,437
1,646
1,859
47,666
56,652
Male-to-male sexual contact and
injection drug use
Heterosexual contacte
183
198
189
223
9,313
10,718
6,662
7,392
21
23
12,698
13,217
1,837
1,985
30,903
33,758
88
100
444
556
21,826
28,391
9,491
10,923
22
25
4,951
5,541
1,183
1,363
38,005
46,899
2
2
10
10
1,437
1,441
656
659
1
1
272
273
107
108
2,485
2,494
Transmission category
Male adult or adolescent
Perinatal
f
Other
112
10
967
54
25,833
515
12,617
335
32
2
10,441
1,140
1,489
75
51,491
2,132
Subtotal
1,136
1,136
4,953
5,008
143,261
143,637
95,970
96,504
394
399
140,507
140,294
14,697
14,777
400,918
401,755
Vol. 26
HIV Surveillance Report
Table 21b. Persons living with diagnosed HIV infection ever classified as stage 3 (AIDS), by race/ethnicity and selected characteristics, year-end 2013—United States and 6 dependent areas (cont)
American Indian/
Alaska Native
No.
c
Est. No.
Asian
No.
Black/
African American
a
Est. No.
c
No.
Est. No.
b
Hispanic/Latino
c
No.
Native Hawaiian/
Other Pacific Islander
c
Est. No.
No.
c
Est. No.
White
Multiple races
c
Est. No.
No.
No.
Total
Est. No.
c
No.
Est. No.
c,d
Female adult or adolescent
Injection drug use
Heterosexual contacte
91
115
51
91
12,596
17,103
5,590
6,920
13
15
5,912
6,896
1,347
1,656
25,600
32,797
190
244
611
868
39,528
54,354
14,430
17,918
45
60
10,003
12,145
2,429
3,148
67,236
88,737
4
4
6
6
1,660
1,668
658
661
2
2
279
280
114
115
2,723
2,736
Perinatal
Otherf
87
9
332
46
19,565
505
4,903
207
18
1
3,486
339
1,032
38
29,423
1,145
Subtotal
372
372
1,000
1,011
73,349
73,631
25,581
25,706
78
79
19,680
19,660
4,922
4,957
124,982
125,415
Perinatal
Otherf
1
1
4
4
163
165
41
41
2
2
29
29
17
17
257
260
1
1
0
0
11
11
0
0
0
0
3
3
0
0
15
15
Subtotal
2
2
4
4
174
176
41
41
2
2
32
32
17
17
272
275
Northeast
85
85
1,326
1,342
56,575
56,901
40,903
41,196
24
24
31,804
31,852
7,427
7,504
138,144
138,904
Midwest
169
169
472
474
25,116
25,046
6,524
6,532
17
17
22,751
22,731
2,339
2,341
57,388
57,311
South
326
322
961
970
118,494
118,824
31,391
31,489
51
51
57,256
56,960
7,398
7,426
215,877
216,042
West
929
932
3,176
3,215
16,405
16,479
31,985
32,263
373
378
48,368
48,403
2,467
2,476
103,703
104,144
1
1
22
22
194
194
10,789
10,772
9
9
40
40
5
5
11,060
11,043
1,510
1,509
5,957
6,023
216,784
217,444
121,592
122,252
474
479
160,219
159,986
19,636
19,752
526,172
527,445
Child (<13 yrs at end of year)
Region of residence
106
U.S. dependent areas
Totalg
Note. Reported numbers less than 12, as well as estimated numbers (and accompanying trends) based on these numbers, should be interpreted with caution because the numbers have underlying relative standard errors greater than 30% and are
considered unreliable.
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanics/Latinos can be of any race.
c Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category, but not for incomplete reporting.
d Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
e Heterosexual contact with a person known to have, or to be at high risk for, HIV infection.
f Includes hemophilia, blood transfusion, and risk factor not reported or not identified.
g
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Vol. 26
Table 22. Diagnoses of HIV infection, by area of residence, 2014—United States and 6 dependent areas
Adults and adolescents
Children
Estimateda
Area of residence
Total
Estimateda
Estimateda
No.
No.
Rate
No.
No.
Rate
No.
No.
Rate
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Subtotal
U.S. dependent areas
American Samoa
Guam
Northern Mariana Islands
Puerto Rico
Republic of Palau
U.S. Virgin Islands
Subtotal
633
39
755
309
4,874
379
287
119
327
5,037
1,686
104
25
1,510
463
98
130
344
1,332
57
1,121
543
791
300
488
473
15
88
435
38
1,316
133
3,529
1,338
23
948
303
231
1,238
96
792
27
761
4,377
114
18
927
431
88
217
11
39,718
699
41
798
340
5,533
401
305
132
381
5,332
2,247
110
27
1,728
490
104
138
365
1,408
60
1,388
735
837
318
519
500
16
93
463
41
1,536
141
3,817
1,416
24
1,005
334
244
1,322
101
841
28
808
4,817
120
19
983
455
96
230
12
43,899
17.2
6.8
14.3
13.8
17.2
9.0
10.0
16.8
66.9
31.3
27.0
9.2
2.0
16.1
9.0
4.0
5.8
9.9
36.6
5.2
27.7
12.8
10.0
7.0
21.0
9.9
1.9
6.1
19.6
3.6
20.4
8.2
22.8
17.0
4.0
10.3
10.5
7.3
12.2
11.2
20.7
4.1
14.7
22.1
5.3
3.5
14.1
7.7
6.1
4.8
2.4
16.5
1
1
3
2
16
2
0
0
0
14
4
0
1
8
2
2
2
7
3
1
2
2
5
2
0
6
0
0
2
0
2
1
7
10
0
3
6
0
3
0
5
0
9
15
0
0
5
3
0
1
1
159
1
1
3
2
18
2
0
0
0
15
6
0
1
9
2
2
2
7
3
1
3
3
5
2
0
6
0
0
2
0
2
1
7
11
0
3
6
0
3
0
5
0
9
16
0
0
5
3
0
1
1
174
0.1
0.9
0.3
0.4
0.3
0.2
0.0
0.0
0.0
0.5
0.3
0.0
0.4
0.4
0.2
0.5
0.4
1.0
0.4
0.6
0.3
0.3
0.3
0.2
0.0
0.6
0.0
0.0
0.4
0.0
0.2
0.3
0.2
0.6
0.0
0.2
0.9
0.0
0.2
0.0
0.7
0.0
0.9
0.3
0.0
0.0
0.4
0.3
0.0
0.1
1.0
0.3
634
40
758
311
4,890
381
287
119
327
5,051
1,690
104
26
1,518
465
100
132
351
1,335
58
1,123
545
796
302
488
479
15
88
437
38
1,318
134
3,536
1,348
23
951
309
231
1,241
96
797
27
770
4,392
114
18
932
434
88
218
12
39,877
700
42
801
343
5,551
403
305
132
381
5,347
2,253
110
28
1,737
492
107
140
372
1,411
61
1,391
738
842
320
519
506
16
93
465
41
1,538
142
3,825
1,426
24
1,008
340
244
1,325
101
846
28
817
4,833
120
19
989
459
96
231
13
44,073
14.4
5.7
11.9
11.6
14.3
7.5
8.5
14.2
57.8
26.9
22.3
7.8
1.7
13.5
7.5
3.4
4.8
8.4
30.4
4.6
23.3
10.9
8.5
5.9
17.3
8.3
1.6
5.0
16.4
3.1
17.2
6.8
19.4
14.3
3.3
8.7
8.8
6.1
10.4
9.6
17.5
3.3
12.5
17.9
4.1
3.1
11.9
6.5
5.2
4.0
2.2
13.8
0
0
0
594
0
21
615
0
0
0
686
0
24
710
0.0
0.0
0.0
22.7
0.0
27.4
21.3
0
0
0
1
0
0
1
0
0
0
1
0
0
1
0.0
0.0
0.0
0.2
0.0
0.0
0.2
0
0
0
595
0
21
616
0
0
0
687
0
24
711
0.0
0.0
0.0
19.4
0.0
23.1
18.0
Totalb
40,333
44,608
16.6
160
176
0.3
40,493
44,784
13.9
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
Reported numbers less than 12, as well as estimated numbers (and accompanying rates and trends) based on these numbers, should be interpreted
with caution because the numbers have underlying relative standard errors greater than 30% and are considered unreliable.
a
Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting. Rates are per 100,000
population.
b Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may
not sum to the column total.
HIV Surveillance Report
107
Vol. 26
HIV Surveillance Report
Table 23. Stage 3 (AIDS), by area of residence, 2014 and cumulative—United States and 6 dependent areas
2014
Adults and adolescents
Children
Estimatedb
Cumulativea
Total
Estimatedb
Estimatedb
108
Vol. 26
Area of residence
No.
No.
Ratec
No.
No.
Ratec
No.
No.
Ratec
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
306
14
305
136
1,984
181
176
76
185
2,424
943
43
17
699
255
61
69
167
609
21
615
178
362
153
301
242
7
41
208
15
682
61
1,662
710
11
356
15
322
149
2,213
189
191
83
219
2,568
1,133
47
19
777
270
65
75
180
635
25
684
201
390
160
315
256
7
43
220
16
723
64
1,914
749
12
8.8
2.5
5.8
6.1
6.9
4.3
6.2
10.5
38.5
15.1
13.6
3.9
1.4
7.2
4.9
2.5
3.1
4.9
16.5
2.2
13.7
3.5
4.7
3.5
12.8
5.1
0.8
2.8
9.3
1.4
9.6
3.7
11.4
9.0
1.9
1
0
2
0
5
0
0
0
3
9
3
0
0
4
3
0
0
1
2
0
0
1
2
3
2
1
0
0
0
0
1
0
4
1
0
1
0
2
0
6
0
0
0
4
10
4
0
0
4
3
0
0
1
2
0
0
1
2
3
2
1
0
0
0
0
1
0
5
1
0
0.2
0.0
0.2
0.0
0.1
0.0
0.0
0.0
4.1
0.3
0.2
0.0
0.0
0.2
0.3
0.0
0.0
0.1
0.3
0.0
0.0
0.1
0.1
0.3
0.4
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.2
0.1
0.0
307
14
307
136
1,989
181
176
76
188
2,433
946
43
17
703
258
61
69
168
611
21
615
179
364
156
303
243
7
41
208
15
683
61
1,666
711
11
357
15
324
149
2,219
189
191
83
223
2,578
1,137
47
19
781
274
65
75
181
637
25
684
202
393
164
317
257
7
43
220
16
724
64
1,919
750
12
7.4
2.0
4.8
5.0
5.7
3.5
5.3
8.9
33.9
13.0
11.3
3.3
1.2
6.1
4.1
2.1
2.6
4.1
13.7
1.9
11.4
3.0
4.0
3.0
10.6
4.2
0.7
2.3
7.8
1.2
8.1
3.1
9.7
7.5
1.6
Estimatedb
Adults and
adolescents Children
11,842
819
13,813
5,124
172,642
10,875
16,944
4,467
21,295
132,488
47,658
3,539
828
42,684
10,895
2,356
3,550
6,393
23,988
1,395
39,656
23,684
19,262
6,578
9,355
13,971
532
2,005
7,775
1,329
57,734
3,411
203,817
23,407
210
77
7
48
39
706
34
189
28
196
1,568
262
17
4
289
60
14
17
39
146
9
338
229
119
33
58
66
3
12
29
10
806
9
2,443
140
2
Total
11,919
826
13,861
5,163
173,348
10,909
17,133
4,495
21,492
134,056
47,921
3,556
832
42,973
10,956
2,370
3,567
6,432
24,134
1,404
39,994
23,913
19,381
6,611
9,413
14,037
535
2,017
7,804
1,339
58,541
3,420
206,260
23,548
212
HIV Surveillance Report
Table 23. Stage 3 (AIDS), by area of residence, 2014 and cumulative—United States and 6 dependent areas (cont)
2014
Adults and adolescents
Children
Estimatedb
Cumulativea
Total
Estimatedb
Estimatedb
Estimatedb
Adults and
adolescents Children
109
Area of residence
No.
No.
Ratec
No.
No.
Ratec
No.
No.
Ratec
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
410
156
129
629
31
369
10
405
2,079
39
9
406
202
50
104
4
442
170
139
673
33
389
11
450
2,254
41
10
501
219
56
110
4
4.5
5.3
4.2
6.2
3.7
9.6
1.5
8.2
10.3
1.8
1.8
7.2
3.7
3.5
2.3
0.9
0
1
1
0
0
1
1
31
8
0
0
3
0
0
0
0
0
1
1
0
0
1
1
34
9
0
0
4
0
0
0
0
0.0
0.2
0.2
0.0
0.0
0.2
0.7
3.2
0.2
0.0
0.0
0.3
0.0
0.0
0.0
0.0
410
157
130
629
31
370
11
436
2,087
39
9
409
202
50
104
4
442
171
141
673
33
391
12
484
2,263
41
10
505
219
56
110
4
3.8
4.4
3.5
5.3
3.1
8.1
1.4
7.4
8.4
1.4
1.6
6.1
3.1
3.0
1.9
0.7
20,145
6,332
7,482
41,681
3,156
18,157
368
17,130
92,408
2,831
556
22,097
14,423
1,994
5,836
331
153
29
19
373
29
119
7
97
407
21
6
191
34
11
38
2
20,298
6,361
7,502
42,054
3,185
18,276
375
17,227
92,816
2,852
562
22,288
14,457
2,005
5,874
333
18,951
20,792
7.8
94
104
0.2
19,045
20,896
6.6
1,201,247
9,588
1,210,835
U.S. dependent areas
American Samoa
Guam
Northern Mariana Islands
Puerto Rico
Republic of Palau
U.S. Virgin Islands
0
0
0
305
0
14
0
0
0
404
0
17
0.0
0.0
0.0
13.4
0.0
19.8
0
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0.0
0.0
0.0
0.0
0
0
0
305
0
14
0
0
0
404
0
17
0.0
0.0
0.0
11.4
0.0
16.7
1
86
2
34,841
2
789
0
1
0
404
0
21
1
87
2
35,245
2
810
Subtotal
319
422
12.6
0
0
0.0
319
422
10.7
35,720
426
36,146
19,270
21,214
7.9
94
104
0.2
19,364
21,318
6.6
1,236,967
10,014
1,246,981
Subtotal
Totald
Total
Note. Reported numbers less than 12, as well as estimated numbers (and accompanying rates and trends) based on these numbers, should be interpreted with caution because the numbers have
underlying relative standard errors greater than 30% and are considered unreliable.
a
From the beginning of the epidemic through 2014.
b Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting.
c
Vol. 26
d
Rates are per 100,000 population.
Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
HIV Surveillance Report
Table 24. Adults and adolescents living with diagnosed HIV infection, by race/ethnicity and area of residence, year-end 2013—United States and 6 dependent areas
American Indian/
Alaska Native
Asiana
Estimatedc
Area of residence
Alabama
No.
No.
Rate
Black/African American
Estimatedc
No.
No.
Rate
Hispanic/Latinob
Estimatedc
No.
No.
Rate
Native Hawaiian/
Other Pacific Islander
Estimatedc
No.
No.
Rate
White
Estimatedc
No.
No.
Multiple races
Estimatedc
Rate
No.
No.
Rate
Total
Estimatedc
No.
No.
Rate
110
5
5
21.5
28
28
55.5
7,854
7,778
749.7
337
337
245.3
4
4
230.2
3,422
3,382
122.9
497
Alaska
145
144
180.0
15
15
43.2
74
73
335.5
67
67
187.1
3
3
47.6
303
301
76.8
24
23
77.7
Arizona
508
511
243.5
134
135
81.9
1,369
1,371
641.8
3,927
3,947
262.6
14
14
142.5
7,066
7,056
214.5
251
250
314.7
Arkansas
4
4
22.0
14
14
41.3
2,198
2,192
604.9
298
299
209.8
3
3
62.4
2,302
2,288
123.3
206
206
656.4
California
402
404
287.6
4,301
4,372
97.0
40,564 41,142
363.6
278
282
241.3
50,179 50,336
380.2
2,511
2,518
Colorado
63
63
219.7
102
103
80.3
1,626
1,629
967.1
2,372
2,382
288.9
10
10
185.5
7,237
7,234
230.0
204
Connecticut
8
8
132.5
78
79
62.6
3,354
3,332 1,144.2
3,368
3,348
827.2
4
4
391.8
3,315
3,286
149.9
Delaware
3
3
118.0
7
7
25.9
1,882
1,877 1,178.9
241
241
413.6
0
0
0.0
840
840
161.7
District of Columbia
12
12
929.9
79
Florida
63
63
144.2
388
392
89.2
48,599 48,631 1,978.4
Georgia
17
18
89.7
164
172
57.5
28,045 29,004 1,178.3
Hawaii
8
8
261.4
392
395
85.3
112
112
Idaho
12
12
82.3
5
5
29.1
40
40
Illinois
38
38
241.0
387
393
71.9
Indiana
6
6
47.3
70
71
69.9
3,469
3,480
Iowa
2
2
28.1
44
44
84.1
349
350
Kansas
9
9
45.4
24
24
38.0
728
Kentucky
5
5
62.9
31
31
68.3
1,908
Louisiana
21
21
88.3
63
64
96.1
7
7
98.9
4
4
30.8
Maryland
24
25
202.5
180
187
61.8
Massachusetts
16
16
161.9
305
321
94.5
5,336
5,513 1,498.0
Michigan
33
33
71.0
94
95
42.9
8,958
8,920
Minnesota
108
108
242.9
109
109
57.2
Maine
Mississippi
81 356.8
20,624 20,792 1,115.1
11,010 11,158 4,247.2
1,005
1,024 1,932.0
21,469 21,533
9
9
3,781.9
566.2
31
31
306.6
2,411
2,447 1,151.0
28,697 28,653
492 1,175.7
Estimatedc
No.
No.d
12,147 12,025
631
Rate
297.4
626
104.3
13,269 13,284
242.8
5,006
204.4
371.0 118,859 119,845
376.2
204
287.6
11,614 11,624
266.0
199
198
542.9
10,326 10,255
335.5
85
85
740.0
439
443 4,265.9
5,025
3,058
3,053
392.2
14,965 15,173 2,695.8
292.7
2,160
2,148 1,110.8 101,407 101,452
606.1
1,735 1,757.3
512.7
2,466
2,562
393.2
12
13
261.6
8,344
8,564
183.4
1,700
454.8
241
242
246.0
242
243
231.7
1,229
1,226
420.3
203
203
103.6
2,427
2,430
500.0
115
115
86.1
0
0
0.0
659
659
59.5
24
24
126.5
855
856
65.7
16,280 16,280 1,085.4
6,118
6,179
388.5
21
21
732.4
9,981 10,010
143.6
1,751
34,576 34,681
322.9
726.2
775
781
262.3
0
0
0.0
4,943
4,935
110.0
323
323
520.2
9,586
9,595
176.4
473.8
189
190
162.7
0
0
0.0
1,295
1,296
56.5
69
69
276.3
1,948
1,952
75.9
730
538.2
444
446
197.0
2
2
115.5
1,461
1,457
77.3
140
140
343.0
2,808
2,807
118.4
1,896
669.7
354
356
351.2
1
1
55.5
3,361
3,341
104.7
219
219
551.4
5,879
5,849
159.4
13,087 13,109 1,108.1
828
832
495.3
4
4
259.0
4,837
4,829
206.0
342
341
935.0
19,182 19,201
502.2
136 1,079.9
60
60
421.0
0
0
0.0
973
973
89.6
13
13
96.5
23,269 23,880 1,664.3
1,632
1,683
418.4
12
12
500.9
4,583
4,681
170.9
1,390
4,568
4,715
873.4
2
2
95.3
7,739
7,936
180.5
326
336
791.6
764
764
227.7
2
2
94.5
5,158
5,138
79.4
488
2,455
2,462 1,107.8
689
692
367.7
6
6
345.9
3,720
3,721
98.3
135
1,760 1,554.7
40,748 42,067
1,193
104.1
31,090 31,890
641.1
475.6
18,292 18,839
329.0
487
395.1
15,497 15,439
185.4
207
207
330.1
1,423 1,763.3
1,192
205.6
7,294
7,306
162.4
9,122
9,036
366.9
11,977 11,968
237.3
9
9
79.1
13
13
53.7
6,675
6,608
747.1
249
249
385.6
2
2
222.9
1,794
1,775
121.6
380
380 2,107.2
Missouri
10
10
47.1
66
67
73.0
5,234
5,241
930.1
631
633
379.8
2
2
39.1
5,742
5,727
138.8
292
289
414.6
Montana
23
23
50.4
1
1
16.3
13
13
313.2
18
18
73.3
0
0
0.0
323
323
42.7
18
18
114.2
396
396
46.4
Nebraska
21
21
183.7
23
23
75.1
493
495
747.6
257
259
201.0
2
2
227.2
990
993
78.0
46
46
268.7
1,832
1,839
120.3
Nevada
43
43
208.9
205
207 109.8
1,687
1,686
0
0
0.0
15
15
58.1
New Jersey
14
14
131.1
326
333
49.6
New Mexico
216
217
153.0
9
9
35.2
New Hampshire
New York
Vol. 26
North Carolina
North Dakota
79
79
165.3
1,605
176
174
189.1
121
1,619 118.6
122
60.7
9
9
33.2
2
2
26.6
904.7
1,783
1,793
312.2
22
22
165.7
3,739
3,727
291.4
209
210
385.1
7,688
7,689
331.8
151 1,140.6
148
147
470.7
0
0
0.0
830
825
78.5
40
40
330.5
1,183
1,178
103.6
17,603 17,704 1,855.5
9,805
9,921
749.7
10
10
435.7
7,598
7,649
172.3
2,185
37,541 37,832
505.8
1,314
1,319
171.5
0
0
0.0
949
946
129.7
54
43,278 43,356 1,502.8
26,038 26,088
150
132
132
414.0
52,108 52,210 2,172.8
17,265 17,144
44
44
2,201 2,745.5
54
259.6
2,677
155.7
7,321 3,555.2 130,433 130,691
784.1
17
17
243.6
267.5
7,308
992.6
1,836
1,846
303.8
11
11
224.2
6,697
6,663
121.8
809
809
809.7
453.7
14
14
96.1
0
0
0.0
139
139
25.9
10
10
132.8
2,674
26,915 26,770
218
218
326.3
36.2
HIV Surveillance Report
Table 24. Adults and adolescents living with diagnosed HIV infection, by race/ethnicity and area of residence, year-end 2013—United States and 6 dependent areas (cont)
American Indian/
Alaska Native
Asiana
Estimatedc
Area of residence
Ohio
No.
No.
Rate
Black/African American
Estimatedc
No.
No.
Rate
Native Hawaiian/
Other Pacific Islander
Hispanic/Latinob
Estimatedc
Estimatedc
No.
No.
Rate
No.
No.
Rate
White
Estimatedc
No.
No.
Rate
Multiple races
Estimatedc
No.
No.
Rate
Total
Estimatedc
No.
No.
Rate
Estimatedc
No.d
No.
15
15
78.4
76
77
42.1
8,535
8,562
751.3
1,055
1,059
378.7
1
1
34.0
9,026
9,038
113.8
684
688
544.7
280
277
111.3
43
44
69.7
1,301
1,300
569.7
493
494
192.8
5
5
138.4
3,047
3,028
136.0
286
285
208.1
5,455
5,433
171.8
Oregon
44
44
119.9
91
92
68.2
370
371
660.1
736
740
213.7
13
13
114.0
4,010
4,012
151.4
111
111
138.3
5,375
5,383
162.3
Pennsylvania
33
33
221.1
206
208
63.2
15,929 15,863 1,427.9
5,032
5,019
838.4
23
23
834.5
10,010
9,964
114.6
1,443
32,676 32,547
299.6
500 1,045.2
566
567
522.9
1
1
183.1
1,013
1,010
144.1
51
51
391.2
10,959 10,966 1,027.4
617
622
339.4
2
2
96.1
3,604
3,599
136.9
319
320
771.9
861.0
21
21
105.6
0
0
0.0
279
280
47.4
8
8
83.6
9,140 1,037.5
695
698
316.4
9
9
346.5
5,872
5,773
138.6
450
448
21,198 21,171
Oklahoma
8
8
217.7
32
32 111.1
South Carolina
11
11
74.5
31
31
54.6
South Dakota
79
79
154.3
5
5
61.7
100
7
7
45.6
58
58
67.0
9,297
Texas
51
51
68.7
636
646
69.8
297.2
19
19
114.4
211.5
2,454
Utah
20
20
90.8
36
36
68.5
215
216
965.2
496
498
181.2
4
4
20.6
1,725
1,729
95.2
62
62
198.7
2,558
2,565
Vermont
0
0
0.0
3
3
38.1
44
44
814.7
24
24
281.2
1
1
669.2
363
361
70.6
12
12
170.7
447
445
82.2
Virginia
16
16
84.0
240
240
57.9
12,915 12,743
981.1
1,731
1,730
320.7
6
6
119.9
6,477
6,408
141.6
638
630
521.5
22,023 21,774
314.5
140
140
188.5
354
357
77.7
1,655
1,663
794.4
1,468
1,478
250.8
45
46
132.8
7,406
7,414
173.0
343
343
201.4
11,411 11,441
196.5
2
2
59.7
4
4
32.7
426
424
775.1
66
66
335.1
0
0
0.0
1,092
1,094
74.2
74
74
449.5
1,664
1,664
105.3
Wisconsin
28
28
70.9
73
74
65.2
2,071
2,067
741.8
701
703
276.7
1
1
71.8
2,506
2,506
61.5
156
157
320.0
5,536
5,535
115.0
Wyoming
7
7
76.4
3
3
66.2
14
14
173.6
40
40
96.5
0
0
0.0
173
173
41.9
12
12
199.9
249
249
51.6
Subtotal
2,860
2,862
152.4
83.2 395,305 397,067 1,243.8 188,496 189,946
462.0
856
866
815.1 927,732 931,526
353.2
American Samoa
0
0
—
1
1
—
0
0
—
0
0
—
0
0
—
0
0
—
0
0
—
1
1
2.4
Guam
0
0
—
47
47
—
5
5
—
4
4
—
10
10
—
9
9
—
7
7
—
82
82
65.8
Northern Mariana Islands
0
0
—
0
0
—
0
0
—
0
0
—
2
2
—
0
0
—
0
0
—
2
2
5.2
Puerto Rico
1
1
—
3
3
—
7
7
—
18,479 18,548
—
1
1
—
14
14
—
0
0
—
18,505 18,574
610.0
Republic of Palau
0
0
—
0
0
—
1
1
—
1
1
—
2
2
—
0
0
—
0
0
—
4
4
23.4
U.S. Virgin Islands
0
0
—
0
0
—
349
352
—
219
222
—
0
0
—
45
46
—
4
3
—
617
623
705.8
Subtotal
1
1
—
51
51
—
362
365
—
18,703 18,775
—
15
15
—
68
68
—
11
10
—
19,211 19,286
574.5
2,861
2,863
—
— 207,199 208,721
—
871
882
— 946,943 950,811
355.9
Washington
West Virginia
111
11,295 11,462
101
26,807 26,918 1,074.0
22,531 22,694
201.3 296,695 297,003
2,173
200.5
Rhode Island
Tennessee
502
1,436 1,275.4
19,392 19,441
Rate
2,168
240.1
15,543 15,550
389.3
494
71.3
761.1
16,388 16,133
297.2
2,459 1,124.5
73,696 73,959
345.8
174.0 32,225 32,319
492
114.6
U.S. dependent arease
Totalf
11,346 11,513
— 395,667 397,432
— 296,763 297,071
— 32,236 32,329
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis.
Reported numbers less than 12, as well as estimated numbers (and accompanying rates and trends) based on these numbers, should be interpreted with caution because the numbers have underlying relative standard errors greater than 30% and
are considered unreliable.
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanics/Latinos can be of any race.
c Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting. Rates are per 100,000 population.
d Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
Vol. 26
e Rates by race/ethnicity are not provided because U.S. census information for U.S. dependent areas is limited.
f Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
HIV Surveillance Report
Table 25. Adults and adolescents living with diagnosed HIV infection ever classified as stage 3 (AIDS), by race/ethnicity and area of residence, year-end 2013—United States and 6 dependent areas
American Indian/
Alaska Native
Asiana
Estimatedc
Area of residence
Alabama
No.
No.
Rate
Black/African American
Estimatedc
No.
No.
Rate
Hispanic/Latinob
Estimatedc
No.
No.
Rate
Native Hawaiian/
Other Pacific Islander
Estimatedc
No.
No.
White
Estimatedc
Rate
No.
No.
Rate
Multiple races
Estimatedc
No.
No.
Rate
Total
Estimatedc
No.
No.
0
0
0.0
12
12
24.0
3,287
3,280 316.2
168
169 122.8
1
1
56.4
1,352
1,340
48.7
223
Alaska
91
92
114.9
14
14
40.5
42
42 192.5
46
46 129.3
2
2
32.4
168
168
42.9
13
Arizona
Rate
223 533.8
12
Estimatedc
No.
No.d
5,043
5,025 124.3
42.0
376
377
Rate
62.8
282
283
134.7
60
61
36.7
637
638 298.4
1,953
1,959 130.4
11
11
112.4
3,381
3,376 102.6
132
132 165.7
6,456
6,459 118.1
Arkansas
3
3
17.1
7
7
20.9
994
996 274.9
144
145 101.6
2
2
41.4
1,105
1,100
59.3
126
127 405.2
2,381
2,381
California
229
229
163.0
2,448
2,478
55.0
25,160 25,406 224.5
145
147
125.5
30,560 30,561 230.9
1,585
1,591 234.4
Colorado
12,643 12,702 681.2
97.2
72,770 73,113 229.5
112
28
28
98.1
49
49
38.4
743
745 442.2
1,237
1,242 150.6
4
4
74.0
2,905
2,905
92.4
114
115 161.9
5,080
5,087 116.4
Connecticut
7
7
116.9
41
42
33.0
2,301
2,287 785.3
2,328
2,319 573.0
4
4
396.0
2,153
2,133
97.3
173
172 472.0
7,007
6,965 227.8
Delaware
2
2
79.0
5
5
18.8
1,234
1,236 776.6
151
152 261.0
0
0
0.0
519
521 100.3
48
48 418.7
1,959
1,965 252.4
District of Columbia
4
4
303.1
38
38
168.2
6,745
6,803 2,589.5
592
599 1,130.1
4
4 1,676.4
1,170
1,178 554.3
299
300 2,894.2
8,852
8,927 1,586.0
Florida
20
20
45.1
174
175
39.7
28,206 28,190 1,146.8
11,367 11,360 298.7
11
16,156 16,071 164.2
1,387
1,380 713.5
57,321 57,205 341.8
Georgia
8
8
40.8
73
76
25.2
15,256 15,644 635.5
1,439
1,483 227.5
4
4
87.6
4,495
97.5
1,121
1,144 1,158.8
22,396 22,910 279.2
Hawaii
3
3
97.2
234
237
51.3
74
74 302.7
151
152 154.7
163
165
156.8
730
732 250.7
125
126
64.3
1,480
Idaho
4
4
27.8
2
2
11.6
17
17 209.7
62
46.4
0
0
0.0
318
319
28.8
15
15
79.3
418
Illinois
14
14
86.3
193
193
35.4
8,716
8,588 572.6
3,474
3,471 218.2
11
11
385.4
5,009
4,969
71.3
1,014
1,012 894.2
Indiana
0
0
0.0
47
47
46.8
1,735
1,738 362.6
435
437 146.7
0
0
0.0
2,635
2,631
58.7
175
175 282.0
5,027
5,028
92.4
Iowa
1
1
14.2
19
19
36.5
236
237 321.2
120
120 102.9
0
0
0.0
778
776
33.8
41
41 163.1
1,195
1,195
46.5
Kansas
6
6
30.1
11
11
17.1
374
374 275.8
272
271 120.0
0
0
0.0
859
854
45.3
79
79 194.3
1,601
1,595
67.3
Kentucky
3
3
37.7
13
13
28.4
944
936 330.7
223
224 220.9
1
1
55.8
1,812
1,803
56.5
125
125 315.5
3,121
3,105
84.6
Louisiana
11
11
45.9
22
22
33.2
6,963
6,981 590.1
440
442 263.0
2
2
128.9
2,606
2,601 111.0
181
181 495.3
Maine
4
4
58.8
4
4
33.7
63
64 509.6
33
33 231.4
0
0
0.0
556
559
51.4
10
Maryland
5
5
42.0
80
82
27.0
13,037 13,236 922.5
980
996 247.6
6
6
247.0
2,371
2,395
87.4
900
911 1,129.7
17,379 17,630 354.4
Massachusetts
10
10
96.6
173
173
50.8
3,298
3,271 888.8
2,753
2,730 505.8
1
1
44.8
4,387
4,328
98.4
200
199 282.0
10,822 10,712 187.1
Michigan
13
13
27.9
42
43
19.3
4,691
4,686 415.9
424
425 126.5
2
2
94.7
2,683
2,677
41.4
280
281 227.4
8,135
8,126
97.6
Minnesota
56
56
126.3
54
54
28.4
1,156
1,160 522.0
375
376 199.9
1
1
57.4
1,583
1,584
41.8
108
108 171.4
3,333
3,339
74.2
Mississippi
3
3
24.6
6
6
24.6
3,122
3,067 346.7
131
130 202.0
1
1
111.2
815
798
54.7
220
220 1,220.0
4,298
4,225 171.5
331 198.7
174 249.2
6,296
6,289 124.7
Missouri
5
5
23.4
29
29
31.9
2,774
2,777 492.8
330
Montana
15
15
32.7
0
0
0.0
8
8 191.4
15
Nebraska
11
11
97.3
13
13
42.3
277
278 419.9
Nevada
24
24
118.1
91
92
48.5
834
834 447.7
New Hampshire
0
0
0.0
7
7
27.2
80
81 610.2
New Jersey
9
9
83.1
164
165
24.6
9,204
9,166 960.7
New Mexico
69
69 216.7
108.3
4,552
10
73.8
1,489 126.0
419
32.2
18,431 18,259 170.0
10,225 10,239 267.8
670
674
58.8
Vol. 26
1
1
19.5
2,982
2,972
72.0
175
61.7
0
0
0.0
202
202
26.7
12
12
76.5
252
252
29.5
162
162 126.2
2
2
226.0
511
512
40.2
30
30 173.6
1,006
1,008
65.9
902
904 157.5
11
11
81.6
1,747
1,740 136.0
117
118 217.3
3,726
3,724 160.7
85
85 271.2
0
0
0.0
427
424
40.3
29
29 239.8
5,150
5,152 389.3
4
4
172.7
3,857
3,835
86.4
1,328
1,329 1,657.8
99.1
0
0
0.0
622
621
85.1
39
39 186.8
27,161 27,501 953.2
3
3
43.5
13,922 14,125 144.8
4,726
4,810 2,335.8
78,565 79,693 478.1
1
1
19.9
2,706
2,683
49.0
364
364 364.5
11,352 11,264 137.3
0
0
0.0
60
60
11.2
5
115
115
81.4
5
5
19.7
New York
40
41
84.8
800
814
59.6
North Carolina
77
76
82.5
37
37
18.5
7,336
7,271 420.9
831
North Dakota
8
8
29.7
2
2
26.5
17
17 173.3
7
31,913 32,399 1,348.3
62
11
761
15
762
832 136.9
7
48.5
5
67.7
628
626
55.0
19,716 19,661 262.8
1,611
99
1,611
99
93.7
16.5
HIV Surveillance Report
Table 25. Adults and adolescents living with diagnosed HIV infection ever classified as stage 3 (AIDS), by race/ethnicity and area of residence, year-end 2013—United States and 6 dependent areas (cont)
American Indian/
Alaska Native
Asiana
Estimatedc
Area of residence
Ohio
No.
No.
Rate
Estimatedc
No.
No.
Rate
Estimatedc
No.
No.
Rate
Native Hawaiian/
Other Pacific Islander
Hispanic/Latinob
Black/African American
Estimatedc
No.
No.
White
Estimatedc
Rate
No.
No.
Rate
Multiple races
Estimatedc
No.
No.
Rate
Total
Estimatedc
No.
No.
Rate
Estimatedc
No.
No.d
Rate
7
7
37.3
29
29
16.1
4,068
4,118 361.4
528
534 190.9
0
0
0.1
4,325
4,370
55.0
348
353 279.1
9,305
9,411
97.1
147
146
58.5
22
22
35.6
594
596 261.0
232
233
90.7
3
3
82.9
1,482
1,476
66.3
129
129
94.2
2,609
2,604
82.3
Oregon
25
25
68.3
52
52
39.1
230
232 411.8
495
501 144.4
8
8
70.5
2,489
2,503
94.4
72
72
89.7
3,371
3,392 102.3
Pennsylvania
10
10
66.6
110
110
33.5
9,308
9,225 830.4
2,976
2,959 494.2
10
10
359.3
5,642
5,591
64.3
920
914 811.3
Rhode Island
5
5
136.0
24
24
83.6
354
353 737.9
391
390 360.0
1
1
183.5
645
644
91.8
32
32 246.4
1,452
1,449 160.4
South Carolina
5
5
31.5
19
19
33.5
6,084
6,094 571.0
359
360 196.8
2
2
95.9
1,845
1,846
70.2
192
193 465.8
8,506
8,519 213.3
South Dakota
35
35
68.8
2
2
24.5
42
42 361.2
8
40.1
0
0
0.0
102
102
17.3
5
4
4
24.3
25
24
28.0
4,502
4,352 494.1
390
390 176.6
2
2
76.9
3,060
2,960
71.1
Texas
26
26
34.7
305
308
33.3
13,021 13,045 170.8
8
8
46.8
12,086 11,993 119.8
Utah
Oklahoma
Tennessee
14,200 14,215 567.1
8
5
18,976 18,819 173.2
52.3
194
280
279 474.3
8,263
1,433
1,433 655.0
36 116.0
195
28.1
8,012 147.6
41,079 41,027 191.8
113
15
15
68.0
19
19
35.7
114
114 511.8
287
288 104.7
2
2
10.5
960
961
52.9
36
Vermont
0
0
0.0
2
2
25.8
28
28 514.0
15
15 176.2
1
1
670.5
209
208
40.6
6
Virginia
8
8
42.4
123
125
30.0
5,692
5,627 433.2
888
896 166.1
3
3
60.4
3,025
2,987
66.0
Washington
92
93
124.5
199
202
43.9
971
980 468.3
875
884 150.1
25
25
73.9
4,177
4,208
West Virginia
0
0
0.0
0
0
0.1
196
197 360.6
29
29 146.5
0
0
0.0
639
643
Wisconsin
12
12
30.2
30
30
26.6
1,000
1,000 358.9
383
384 151.0
0
0
0.0
1,218
Wyoming
5
5
54.3
1
1
25.6
7
62.3
0
0
0.0
101
Subtotal
1,507
1,506
80.2
5,931
5,997
43.5 216,416 217,074 680.0 110,765 111,441 271.1
463
468
American Samoa
0
0
—
0
0
—
0
0
—
0
0
—
0
0
—
0
0
—
1
1
—
1
1
2.4
Guam
0
0
—
22
22
—
1
1
—
0
0
—
6
6
—
1
1
—
2
2
—
32
32
25.6
Northern Mariana Islands
0
0
—
0
0
—
0
0
—
0
0
—
2
2
—
0
0
—
0
0
—
2
2
5.3
Puerto Rico
1
1
—
0
0
—
2
2
—
10,668 10,651
—
0
0
—
10
10
—
0
0
—
Republic of Palau
0
0
—
0
0
—
0
0
—
0
0
—
1
1
—
0
0
—
0
0
—
1
U.S. Virgin Islands
0
0
—
0
0
—
191
191
—
118
118
—
0
0
—
29
29
—
2
2
—
340
Subtotal
1
1
—
22
22
—
194
194
—
10,786 10,769
—
9
9
—
40
40
—
5
5
—
1,508
1,507
—
5,953
6,019
— 121,551 122,211
—
472
477
— 160,187 159,953
—
7
87.0
26
26
1,433
1,435
64.1
85.6
261
260
47.9
310
307 254.4
10,049
9,953 143.7
98.2
193
194 114.1
6,532
6,587 113.1
43.6
55
55 338.2
919
925
58.5
1,218
29.9
73
73 149.2
2,716
2,717
56.5
100
24.3
11
11 184.5
151
151
31.2
108.8 160,147 159,913
93.7
6
19,614 19,730 497.6 514,843 516,129 195.7
U.S. dependent arease
Totalf
— 216,610 217,268
19,619 19,734
10,681 10,664 350.2
1
5.7
340 385.8
11,057 11,040 328.9
— 525,900 527,170 197.4
Note. Reported numbers less than 12, as well as estimated numbers (and accompanying rates and trends) based on these numbers, should be interpreted with caution because the numbers have underlying relative standard errors greater than
30% and are considered unreliable.
a Includes Asian/Pacific Islander legacy cases (see Technical Notes).
b Hispanics/Latinos can be of any race.
c Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting. Rates are per 100,000 population.
d Because the estimated totals were calculated independently of the corresponding values for each subpopulation, the subpopulation values may not sum to the totals shown here.
e
Rates by race/ethnicity are not provided because U.S. census information for U.S. dependent areas is limited.
Vol. 26
f Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Table 26. Diagnoses of HIV infection, 2014, and persons living with diagnosed HIV infection (prevalence), year-end
2013, by metropolitan statistical area of residence—United States and Puerto Rico
Prevalence of diagnosed HIV infection,
year-end 2013
Diagnosis, 2014
Estimateda
MSA of residence
No.
No.
Rate
Estimateda
Rankb
No.
No.
Rate
Akron, OH
47
50
7.1
88
852
855
121.6
Albany–Schenectady–Troy, NY
54
57
6.5
92
2,099
2,102
239.2
Albuquerque, NM
67
71
7.8
83
1,339
1,341
148.4
Allentown–Bethlehem–Easton, PA–NJ
58
62
7.5
86
1,471
1,470
177.8
Atlanta–Sandy Springs–Roswell, GA
1,095
1,454
25.9
7
27,136
27,993
506.6
Augusta–Richmond County, GA–SC
77
99
17.0
26
2,168
2,216
381.9
Austin–Round Rock, TX
303
334
17.2
25
4,949
4,951
262.6
Bakersfield, CA
111
123
14.0
42
1,779
1,778
205.3
Baltimore–Columbia–Towson, MD
549
678
24.3
10
18,375
18,821
678.5
Baton Rouge, LA
350
369
44.7
1
4,584
4,594
560.0
Birmingham–Hoover, AL
152
168
14.6
37
3,842
3,805
333.9
15
16
2.4
104
466
467
71.7
411
555
11.7
53
12,961
13,357
284.3
Boston Division
246
334
17.0
—
7,723
7,957
407.6
Cambridge Division
157
212
9.1
—
4,944
5,108
219.9
95
101
10.7
60
2,716
2,702
286.8
110
116
10.2
64
2,316
2,321
204.3
96
102
14.9
34
1,691
1,691
255.6
Charleston–North Charleston, SC
140
148
20.3
18
2,366
2,366
332.3
Charlotte–Concord–Gastonia, NC–SC
427
451
19.0
22
7,222
7,186
307.4
58
62
11.4
57
1,155
1,141
210.4
1,347
1,544
16.2
30
30,562
30,665
321.3
1,190
1,373
18.7
—
27,851
27,949
380.8
Elgin Division
52
57
9.0
—
630
632
100.5
Gary Division
60
64
9.1
—
1,229
1,231
174.5
Lake County Division
45
50
5.7
—
852
854
98.0
Cincinnati, OH–KY–IN
209
221
10.3
62
3,602
3,611
168.9
Cleveland–Elyria, OH
232
245
11.9
51
4,951
4,960
240.2
Colorado Springs, CO
40
42
6.1
93
819
818
120.5
Columbia, SC
194
205
25.6
8
4,030
4,034
509.1
Columbus, OH
244
258
13.0
46
5,221
5,241
266.2
1,311
1,498
21.5
17
22,530
22,796
334.1
1,068
1,231
26.7
—
17,883
18,155
402.4
243
267
11.4
—
4,647
4,641
200.8
67
70
8.8
74
1,481
1,487
185.4
Deltona–Daytona Beach–Ormond Beach, FL
108
114
18.7
23
1,496
1,493
248.3
Denver–Aurora–Lakewood, CO
283
299
10.9
58
9,111
9,120
337.8
35
37
6.0
94
620
623
103.9
Boise City, ID
Boston–Cambridge–Newton, MA–NH
c
Bridgeport–Stamford–Norwalk, CT
Buffalo–Cheektowaga–Niagara Falls, NY
Cape Coral–Fort Myers, FL
Chattanooga, TN–GA
Chicago–Naperville–Elgin, IL–IN–WI
Chicago Division
Dallas–Fort Worth–Arlington, TX
Dallas Division
Fort Worth Division
Dayton, OH
Des Moines–West Des Moines, IA
HIV Surveillance Report
114
Vol. 26
Table 26. Diagnoses of HIV infection, 2014, and persons living with diagnosed HIV infection (prevalence), year-end
2013, by metropolitan statistical area of residence—United States and Puerto Rico (cont)
Prevalence of diagnosed HIV infection,
year-end 2013
Diagnosis, 2014
Estimateda
MSA of residence
Detroit–Warren–Dearborn, MI
No.
No.
Estimateda
Rate
Rankb
No.
No.
Rate
529
559
13.0
45
10,118
10,073
234.5
Detroit Division
364
385
21.8
—
7,341
7,293
410.7
Warren Division
165
174
6.9
—
2,777
2,780
110.3
80
84
15.5
33
2,050
2,036
381.5
108
118
14.1
41
1,879
1,883
225.6
19
21
4.1
101
537
536
108.8
110
121
12.5
48
1,637
1,634
170.9
Grand Rapids–Wyoming, MI
65
69
6.7
90
1,018
1,018
100.1
Greensboro–High Point, NC
114
120
16.1
31
2,413
2,403
324.1
Greenville–Anderson–Mauldin, SC
106
113
13.1
44
1,677
1,679
197.4
Harrisburg–Carlisle, PA
49
52
9.2
71
1,347
1,342
240.6
Hartford–West Hartford–East Hartford, CT
90
96
7.9
82
3,496
3,469
285.3
Durham–Chapel Hill, NC
El Paso, TX
Fayetteville–Springdale–Rogers, AR–MO
Fresno, CA
Honolulu (Urban), HI
77
81
8.2
79
1,678
1,680
170.2
1,474
1,567
24.1
11
25,120
25,153
397.1
Indianapolis–Carmel–Anderson, IN
242
255
13.0
47
4,775
4,784
245.0
Jackson, MS
176
186
32.2
4
3,440
3,404
589.7
Jacksonville, FL
336
357
25.1
9
6,300
6,301
451.4
Kansas City, MO–KS
181
191
9.2
70
4,828
4,824
234.7
Knoxville, TN
44
47
5.5
98
1,202
1,184
139.0
Lakeland–Winter Haven, FL
89
94
14.9
35
1,805
1,804
289.5
Houston–The Woodlands–Sugar Land, TX
Lancaster, PA
28
30
5.6
97
773
771
145.4
Las Vegas–Henderson–Paradise, NV
387
412
19.9
19
6,453
6,459
318.3
Little Rock–North Little Rock–Conway, AR
147
161
22.1
15
1,946
1,942
268.1
2,235
2,578
19.4
20
52,832
53,648
407.2
281
325
10.3
—
6,796
6,873
220.2
1,954
2,253
22.3
—
46,036
46,775
465.2
174
185
14.6
38
3,092
3,071
243.3
25
26
4.2
100
690
690
110.0
Los Angeles–Long Beach–Anaheim, CA
Anaheim Division
Los Angeles Division
Louisville/Jefferson County, KY–IN
Madison, WI
McAllen–Edinburg–Mission, TX
78
85
10.3
61
1,076
1,079
131.7
348
370
27.6
6
7,404
7,293
543.5
2,399
2,535
42.8
2
52,663
52,709
898.9
792
836
44.7
—
17,072
17,086
925.8
1,257
1,328
49.9
—
27,614
27,650
1,046.6
350
371
26.5
—
7,977
7,974
579.4
Milwaukee–Waukesha–West Allis, WI
133
140
8.9
73
3,102
3,097
197.3
Minneapolis–St. Paul–Bloomington, MN–WI
272
288
8.2
77
6,480
6,492
187.5
Memphis, TN–MS–AR
Miami–Fort Lauderdale–West Palm Beach, FL
Fort Lauderdale Division
Miami Division
West Palm Beach Division
Modesto, CA
Nashville–Davidson–Murfreesboro–Franklin, TN
HIV Surveillance Report
16
17
3.3
103
542
540
102.6
228
242
13.5
43
5,144
5,069
288.3
115
Vol. 26
Table 26. Diagnoses of HIV infection, 2014, and persons living with diagnosed HIV infection (prevalence), year-end
2013, by metropolitan statistical area of residence—United States and Puerto Rico (cont)
Prevalence of diagnosed HIV infection,
year-end 2013
Diagnosis, 2014
Estimateda
MSA of residence
No.
New Haven–Milford, CT
New Orleans–Metairie, LA
c
New York–Newark–Jersey City, NY–NJ–PA
Nassau County Division
New York Division
Newark Division
North Port–Sarasota–Bradenton, FL
Ogden–Clearfield, UT
Oklahoma City, OK
Omaha–Council Bluffs, NE–IA
Orlando–Kissimmee–Sanford, FL
Oxnard–Thousand Oaks–Ventura, CA
Palm Bay–Melbourne–Titusville, FL
No.
Rate
Estimateda
Rankb
No.
No.
Rate
81
86
9.9
68
3,130
3,107
360.0
437
462
36.9
3
8,372
8,368
673.7
4,077
4,496
22.4
14
144,508
144,963
724.7
266
285
10.0
—
6,009
6,037
211.2
3,286
3,605
25.2
—
122,139
122,464
859.7
494
572
22.8
—
15,053
15,153
605.7
102
108
14.5
39
1,705
1,705
232.7
13
14
2.2
105
302
303
48.6
148
164
12.2
50
2,668
2,660
201.5
66
70
7.7
84
1,304
1,308
146.0
631
669
28.8
5
10,450
10,462
460.7
52
57
6.7
89
903
900
107.0
57
60
10.9
59
1,250
1,246
226.0
942
1019
16.8
28
26,647
26,578
440.3
140
164
13.1
—
3,118
3,150
251.5
94
100
5.1
—
2,291
2,285
117.2
Philadelphia Division
620
657
30.9
—
18,773
18,679
881.9
Wilmington Division
88
98
13.7
—
2,465
2,464
344.0
Phoenix–Mesa–Scottsdale, AZ
604
638
14.2
40
10,084
10,100
229.3
Pittsburgh, PA
164
174
7.4
87
3,091
3,084
130.6
Philadelphia–Camden–Wilmington, PA–NJ–DE–MD
Camden Division
Montgomery County Division
Portland–South Portland, ME
40
42
8.1
80
657
658
126.5
Portland–Vancouver–Hillsboro, OR–WA
183
193
8.2
78
4,432
4,440
191.8
Providence–Warwick, RI–MA
134
153
9.5
69
3,263
3,289
204.9
3
3
0.6
107
151
151
26.9
Raleigh, NC
174
184
14.8
36
3,447
3,442
283.2
Richmond, VA
191
202
16.0
32
4484
4418
354.3
Riverside–San Bernardino–Ontario, CA
472
545
12.3
49
8,191
8,281
188.6
78
82
7.6
85
2,979
2,981
275.0
Sacramento–Roseville–Arden-Arcade, CA
171
187
8.3
75
3,829
3,818
172.2
St. Louis, MO–IL
297
321
11.4
55
6,957
6,975
249.0
Salt Lake City, UT
90
95
8.2
76
1,920
1,925
168.6
San Antonio–New Braunfels, TX
358
393
16.9
27
5,457
5,462
239.3
San Diego–Carlsbad, CA
460
530
16.3
29
12,542
12,672
393.2
San Francisco–Oakland–Hayward, CAc
725
798
17.4
24
24,729
24,755
546.5
Oakland Division
310
357
13.1
—
7,359
7,426
277.2
San Francisco Division
392
416
25.8
—
16,491
16,461
1,034.2
San Jose–Sunnyvale–Santa Clara, CA
159
175
9.0
72
3,285
3,276
169.9
San Juan–Carolina–Caguas, PR
458
527
23.5
12
13,200
13,248
583.2
Provo–Orem, UT
Rochester, NY
HIV Surveillance Report
116
Vol. 26
Table 26. Diagnoses of HIV infection, 2014, and persons living with diagnosed HIV infection (prevalence), year-end
2013, by metropolitan statistical area of residence—United States and Puerto Rico (cont)
Prevalence of diagnosed HIV infection,
year-end 2013
Diagnosis, 2014
Estimateda
MSA of residence
No.
No.
Rate
Estimateda
Rankb
No.
No.
Rate
Santa Rosa, CA
30
33
6.5
91
1,223
1,217
245.5
Scranton–Wilkes-Barre–Hazelton, PA
24
25
4.5
99
597
594
105.7
349
369
10.0
66
8,803
8,827
244.3
Seattle Division
305
322
11.3
—
7,756
7,776
278.4
Tacoma Division
44
46
5.6
—
1,047
1,051
128.1
6
6
1.2
106
441
442
82.6
Springfield, MA
47
63
10.0
67
1,883
1,938
308.4
Stockton–Lodi, CA
74
82
11.4
56
1,231
1,227
174.0
Syracuse, NY
72
76
11.5
54
1,124
1,127
170.1
632
669
22.9
13
10,688
10,682
371.7
Toledo, OH
46
49
8.0
81
980
981
161.2
Tucson, AZ
97
103
10.2
63
2,054
2,052
205.6
Seattle–Tacoma–Bellevue, WA
Spokane–Spokane Valley, WA
Tampa–St. Petersburg–Clearwater, FL
Tulsa, OK
104
114
11.7
52
1,680
1,672
173.7
Virginia Beach–Norfolk–Newport News, VA–NC
313
331
19.3
21
6,652
6,561
384.3
1,108
1,304
21.6
16
33,081
33,567
562.5
Silver Spring Division
196
244
19.1
—
4,141
4,256
337.5
Washington Division
912
1,060
22.3
—
28,940
29,311
622.8
Wichita, KS
34
36
5.6
96
801
801
125.5
Winston-Salem, NC
63
66
10.1
65
1,719
1,705
261.8
Worcester, MA–CT
27
36
3.9
102
1812
1852
199.6
Youngstown–Warren–Boardman, OH–PA
31
33
6.0
95
685
685
123.1
33,068
36,594
16.8
—
790,818
794,576
368.1
Metropolitan areas (population of 50,000–499,999)
4,784
5,232
9.0
—
97,640
97,723
168.8
Nonmetropolitan areas
2,338
2,547
5.5
—
52,051
51,977
112.1
40,472
44,760
13.9
—
948,623
952,532
297.6
Washington–Arlington–Alexandria, DC–VA–MD–WV
Subtotal for MSAs (population of 500,000)
Totald
Abbreviation: MSA, metropolitan statistical area.
Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. Because of the lack of U.S. census information for all
U.S. dependent areas, table includes data for only the United States and Puerto Rico.
MSA definitions for this report can be found at http://www.census.gov/population/metro/.
Reported numbers less than 12, as well as estimated numbers (and accompanying rates and trends) based on these numbers, should be interpreted with
caution because the numbers have underlying relative standard errors greater than 30% and are considered unreliable.
a Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting. Rates are per 100,000
population.
b
c
Based on estimated rate.
Counts of diagnoses of HIV infection for the metropolitan divisions do not sum to the MSA total. MSA total includes data from 1 metropolitan division with
population of <500,000.
d Includes persons whose county of residence is unknown. Because column totals for estimated numbers were calculated independently of the values for the
subpopulations, the values in each column may not sum to the column total.
HIV Surveillance Report
117
Vol. 26
HIV Surveillance Report
Table 27. Stage 3 (AIDS), 2014 and cumulative, and persons living with diagnosed HIV infection ever classified as stage 3 (AIDS) (prevalence),
year-end 2013, by metropolitan statistical area of residence—United States and Puerto Rico
Diagnosis, cumulativea
Adults or
adolescents
Diagnosis, 2014
Estimatedb
MSA of residence
No.
No.
Children
Total
Prevalence of stage 3 (AIDS),
year-end 2013
Estimatedb
Ratec
Rankd
No.
No.
Estimatedb
No.
No.
No.
Ratec
Akron, OH
15
17
2.3
98
924
1
925
403
407
57.8
Albany–Schenectady–Troy, NY
28
33
3.8
75
2,707
27
2,734
1,182
1,219
138.8
Albuquerque, NM
34
35
3.9
72
1,832
3
1,835
820
820
90.8
Allentown–Bethlehem–Easton, PA–NJ
30
32
3.9
73
1,753
19
1,772
872
868
104.9
Atlanta–Sandy Springs–Roswell, GA
608
731
13.0
7
32,705
151
32,856
15,327
15,665
283.5
Augusta–Richmond County, GA–SC
44
51
8.7
24
2,635
24
2,659
1,132
1,154
198.8
117
123
6.3
40
6,185
26
6,211
2,929
2,907
154.2
33
36
4.1
71
2,101
8
2,109
1,207
1,207
139.4
Baltimore–Columbia–Towson, MD
313
348
12.5
10
25,692
225
25,917
10,334
10,498
378.4
Baton Rouge, LA
172
178
21.6
1
5,545
24
5,569
2,521
2,532
308.6
Birmingham–Hoover, AL
90
105
9.2
23
3,449
25
3,474
1,429
1,427
125.2
Boise City, ID
10
11
1.7
102
423
0
423
218
218
33.6
Austin–Round Rock, TX
Bakersfield, CA
118
e
Boston–Cambridge–Newton, MA–NH
127
143
3.0
86
16,645
159
16,804
7,695
7,625
162.3
Boston Division
71
80
4.1
—
10,329
96
10,425
4,592
4,547
232.9
Cambridge Division
53
60
2.6
—
5,935
62
5,997
2,952
2,928
126.1
Bridgeport–Stamford–Norwalk, CT
58
63
6.6
37
4,338
58
4,396
1,850
1841
195.4
Buffalo–Cheektowaga–Niagara Falls, NY
54
65
5.7
49
3,074
20
3,094
1,247
1,297
114.1
Cape Coral–Fort Myers, FL
50
53
7.8
27
2,236
25
2,261
1,003
1,002
151.6
Charleston–North Charleston, SC
46
48
6.6
39
2,697
24
2,721
1,269
1,272
178.7
249
264
11.1
16
5,838
30
5,868
2,948
2,937
125.6
28
32
5.8
46
1,315
3
1,318
623
607
112.0
623
694
7.3
31
38,234
267
38,501
16,441
16,263
170.4
562
628
8.6
—
35,008
244
35,252
14,949
14,767
201.2
Elgin Division
19
21
3.3
—
796
9
805
377
381
60.5
Gary Division
27
28
4.0
—
1,400
9
1,409
601
599
84.9
Lake County Division
59.2
Charlotte–Concord–Gastonia, NC–SC
Chattanooga, TN–GA
Chicago–Naperville–Elgin, IL–IN–WI
Chicago Division
Vol. 26
15
16
1.9
—
1,031
5
1,036
514
516
Cincinnati, OH–KY–IN
93
100
4.6
62
3,790
20
3,810
1,844
1,861
87.0
Cleveland–Elyria, OH
70
76
3.7
78
5,227
48
5,275
2,387
2,409
116.7
Colorado Springs, CO
17
18
2.6
92
727
5
732
333
333
49.1
Columbia, SC
93
98
12.2
11
4,447
27
4,474
2,303
2,306
291.1
Columbus, OH
130
140
7.0
33
4,683
25
4,709
2,203
2,234
113.5
HIV Surveillance Report
Table 27. Stage 3 (AIDS), 2014 and cumulative, and persons living with diagnosed HIV infection ever classified as stage 3 (AIDS) (prevalence),
year-end 2013, by metropolitan statistical area of residence—United States and Puerto Rico (cont)
Diagnosis, cumulativea
Adults or
adolescents
Diagnosis, 2014
Estimatedb
MSA of residence
Dallas–Fort Worth–Arlington, TX
No.
No.
Children
Total
Prevalence of stage 3 (AIDS),
year-end 2013
Estimatedb
Ratec
Rankd
No.
No.
Estimatedb
No.
No.
No.
Ratec
625
691
9.9
20
26,847
64
26,912
12,355
12,410
181.9
Dallas Division
478
537
11.7
—
21,249
38
21,287
9,855
9,933
220.2
Fort Worth Division
147
154
6.6
—
5,598
26
5,624
2,500
2,477
107.1
Dayton, OH
37
40
5.0
59
1,591
14
1,605
761
769
95.9
Deltona–Daytona Beach–Ormond Beach, FL
58
61
10.1
19
2,067
19
2,086
891
886
147.5
130
136
5.0
60
8,492
24
8,516
3,888
3,893
144.2
19
20
3.2
82
748
4
752
374
374
62.4
244
263
6.1
43
13,328
78
13,407
5,417
5,408
125.9
Detroit Division
182
196
11.1
—
10,447
61
10,509
4,024
4,011
225.9
Warren Division
62
67
2.7
—
2,881
17
2,898
1,393
1,397
55.4
Durham–Chapel Hill, NC
64
68
12.6
9
1,591
10
1,601
666
660
123.7
El Paso, TX
47
48
5.8
47
2,072
10
2,082
1,120
1,114
133.4
Fayetteville–Springdale–Rogers, AR–MO
14
16
3.1
84
513
7
520
273
272
55.2
Fresno, CA
41
45
4.6
63
2,118
11
2,129
1,008
1,007
105.4
Grand Rapids–Wyoming, MI
24
26
2.6
93
1,197
6
1,203
591
593
58.3
Greensboro–High Point, NC
30
32
4.3
69
1,752
20
1,772
802
796
107.3
Greenville–Anderson–Mauldin, SC
44
46
5.3
55
2,009
4
2,013
934
935
109.9
Harrisburg–Carlisle, PA
25
27
4.8
61
1,610
9
1,619
773
768
137.7
Hartford–West Hartford–East Hartford, CT
56
61
5.1
58
5,924
48
5,973
2,369
2,354
193.6
Denver–Aurora–Lakewood, CO
Des Moines–West Des Moines, IA
Detroit–Warren–Dearborn, MI
119
Honolulu (Urban), HI
31
33
3.4
81
2,403
13
2,416
1,017
1,024
103.7
Houston–The Woodlands–Sugar Land, TX
707
776
12.0
13
34,059
180
34,238
14,269
14,299
225.8
Indianapolis–Carmel–Anderson, IN
129
137
7.0
34
5,274
25
5,299
2,516
2,519
129.0
85
88
15.2
5
3,466
30
3,496
1,658
1,631
282.6
Jacksonville, FL
175
185
13.0
8
8,114
78
8,192
3,677
3,667
262.7
Kansas City, MO–KS
108
114
5.5
52
5,966
16
5,982
2,745
2,739
133.2
Knoxville, TN
12
14
1.6
104
1,310
8
1,319
640
621
72.9
Lakeland–Winter Haven, FL
56
59
9.2
21
2,493
22
2,515
1,122
1,119
179.6
Lancaster, PA
15
16
3.0
85
890
22
912
403
400
75.5
180
191
9.2
22
6,393
28
6,421
3,161
3,161
155.8
51
56
7.7
28
1,842
14
1,856
894
895
123.6
Jackson, MS
Las Vegas–Henderson–Paradise, NV
Vol. 26
Little Rock–North Little Rock–Conway, AR
HIV Surveillance Report
Table 27. Stage 3 (AIDS), 2014 and cumulative, and persons living with diagnosed HIV infection ever classified as stage 3 (AIDS) (prevalence),
year-end 2013, by metropolitan statistical area of residence—United States and Puerto Rico (cont)
Diagnosis, cumulativea
Adults or
adolescents
Diagnosis, 2014
Estimatedb
Children
Total
Estimatedb
Estimatedb
No.
Ratec
Rankd
891
1,000
7.5
29
Anaheim Division
122
137
4.4
—
8,421
45
8,467
Los Angeles Division
769
863
8.5
—
62,929
262
63,191
Louisville/Jefferson County, KY–IN
94
102
8.0
26
3,217
30
3,247
Madison, WI
13
14
2.1
100
674
5
679
MSA of residence
Los Angeles–Long Beach–Anaheim, CA
McAllen–Edinburg–Mission, TX
Memphis, TN–MS–AR
Miami–Fort Lauderdale–West Palm Beach, FL
No.
Prevalence of stage 3 (AIDS),
year-end 2013
No.
No.
No.
71,351
307
71,658
No.
No.
Ratec
30,938
31,264
237.3
3,931
3,941
126.2
27,007
27,323
271.8
1,524
1,516
120.1
315
315
50.2
50
52
6.2
42
1,041
13
1,054
598
595
72.7
253
279
20.8
2
7,349
46
7,395
3,461
3,359
250.3
120
1,019
1,084
18.3
3
68,640
1,011
69,651
28,564
28,520
486.4
Fort Lauderdale Division
333
354
19.0
—
21,045
266
21,311
9,284
9,270
502.3
Miami Division
497
528
19.8
—
35,874
516
36,391
14,356
14,336
542.6
West Palm Beach Division
189
201
14.4
—
11,720
228
11,948
4,924
4,915
357.1
57
60
3.8
74
3227
20
3,247
1,498
1,498
95.4
120
126
3.6
80
5773
24
5,797
2,930
2935
84.8
Modesto, CA
12
13
2.4
97
848
6
854
389
387
73.5
Nashville–Davidson–Murfreesboro–Franklin, TN
98
109
6.1
44
5,133
24
5,157
2,585
2,508
142.6
New Haven–Milford, CT
48
52
6.0
45
5,209
75
5,284
2,183
2,169
251.3
204
213
17.0
4
11,129
80
11,209
4,411
4,405
354.7
1,926
2,156
10.7
17
230,132
3,028
233,160
85,124
85,927
429.6
114
137
4.8
—
9,606
119
9,725
3,633
3,748
131.1
1,541
1,731
12.1
—
194,255
2,527
196,782
72,924
73,617
516.8
260
274
10.9
—
24,201
369
24,569
7,811
7,787
311.3
North Port–Sarasota–Bradenton, FL
41
43
5.8
48
2,445
29
2,474
1,052
1,049
143.2
Ogden–Clearfield, UT
10
11
1.7
103
328
4
332
170
170
27.4
Oklahoma City, OK
77
84
6.3
41
2,983
7
2,990
1,253
1,253
94.9
Omaha–Council Bluffs, NE–IA
32
33
3.7
77
1,387
5
1,392
696
697
77.8
317
336
14.5
6
11,723
95
11,818
5,596
5,584
245.9
Oxnard–Thousand Oaks–Ventura, CA
20
21
2.5
95
1,250
5
1,255
550
548
65.1
Palm Bay–Melbourne–Titusville, FL
27
29
5.1
57
1,831
11
1,842
807
801
145.3
Milwaukee–Waukesha–West Allis, WI
Minneapolis–St. Paul–Bloomington, MN–WI
New Orleans–Metairie, LA
New York–Newark–Jersey City, NY–NJ–PAe
Nassau County Division
New York Division
Newark Division
Orlando–Kissimmee–Sanford, FL
Vol. 26
HIV Surveillance Report
Table 27. Stage 3 (AIDS), 2014 and cumulative, and persons living with diagnosed HIV infection ever classified as stage 3 (AIDS) (prevalence),
year-end 2013, by metropolitan statistical area of residence—United States and Puerto Rico (cont)
Diagnosis, cumulativea
Adults or
adolescents
Diagnosis, 2014
Estimatedb
MSA of residence
Philadelphia–Camden–Wilmington, PA–NJ–DE–MD
No.
No.
Children
Total
Prevalence of stage 3 (AIDS),
year-end 2013
Estimatedb
Ratec
Rankd
Estimatedb
No.
No.
No.
No.
No.
Ratec
480
510
8.4
25
34,858
320
35,178
15,378
15,263
252.9
Camden Division
72
76
6.1
—
3,880
43
3,923
1,568
1,566
125.1
Montgomery County Division
39
42
2.1
—
2,851
12
2,863
1,207
1,199
61.5
Philadelphia Division
312
330
15.5
—
24,429
242
24,671
11,054
10,944
516.7
Wilmington Division
57
62
8.6
—
3,698
23
3,722
1,549
1,554
216.9
Phoenix–Mesa–Scottsdale, AZ
233
246
5.5
53
10,027
31
10,058
4,760
4,765
108.2
Pittsburgh, PA
80
86
3.6
79
3,986
21
4,007
1,703
1,693
71.7
Portland–South Portland, ME
13
16
3.0
87
728
1
729
354
357
68.5
Portland–Vancouver–Hillsboro, OR–WA
94
102
4.3
67
5,971
9
5,980
2,678
2,696
116.5
Providence–Warwick, RI–MA
47
51
3.2
83
4,760
45
4,806
2,145
2,131
132.7
2
2
0.4
107
151
3
154
86
86
15.3
79
82
6.6
38
3,000
16
3,016
1,661
1,653
136.0
Provo–Orem, UT
121
Raleigh, NC
Richmond, VA
75
92
7.3
30
4,469
34
4,503
1,949
1,926
154.4
216
245
5.5
51
10,993
63
11,056
5,209
5,219
118.9
Rochester, NY
39
47
4.3
70
3,801
17
3,819
1,681
1,736
160.1
Sacramento–Roseville–Arden-Arcade, CA
56
61
2.7
89
4,982
29
5,011
2,200
2,195
99.0
144
153
5.4
54
7,661
44
7,705
3,475
3,472
123.9
Riverside–San Bernardino–Ontario, CA
St. Louis, MO–IL
Salt Lake City, UT
24
26
2.2
99
2,000
9
2,009
1,061
1,063
93.1
San Antonio–New Braunfels, TX
149
155
6.7
36
6,755
32
6,788
3,103
3,073
134.6
San Diego–Carlsbad, CA
199
224
6.9
35
15,605
69
15,674
7,308
7,324
227.3
San Francisco–Oakland–Hayward, CAe
291
324
7.0
32
46,092
102
46,194
16,251
16,282
359.5
Oakland Division
135
153
5.6
—
12,027
53
12,080
5,131
5,144
192.0
San Francisco Division
146
160
9.9
—
32,352
44
32,396
10,512
10,539
662.2
San Jose–Sunnyvale–Santa Clara, CA
68
74
3.8
76
4,787
17
4,805
2,278
2,274
117.9
203
266
11.9
14
24,915
277
25,192
7,522
7,513
330.7
Santa Rosa, CA
12
13
2.6
94
2,161
8
2,169
872
866
174.9
Scranton–Wilkes-Barre–Hazelton, PA
13
14
2.5
96
708
7
715
320
317
56.5
152
164
4.5
66
11,038
28
11,066
4,921
4,963
137.3
Seattle Division
132
143
5.0
—
9,753
18
9,771
4,363
4,400
157.5
Tacoma Division
20
21
2.6
—
1,285
10
1,295
558
563
68.6
4
5
0.9
106
655
1
656
273
275
51.4
San Juan–Carolina–Caguas, PR
Seattle–Tacoma–Bellevue, WA
Vol. 26
Spokane–Spokane Valley, WA
HIV Surveillance Report
Table 27. Stage 3 (AIDS), 2014 and cumulative, and persons living with diagnosed HIV infection ever classified as stage 3 (AIDS) (prevalence),
year-end 2013, by metropolitan statistical area of residence—United States and Puerto Rico (cont)
Diagnosis, cumulativea
Adults or
adolescents
Diagnosis, 2014
Estimatedb
MSA of residence
No.
No.
Children
Total
Prevalence of stage 3 (AIDS),
year-end 2013
Estimatedb
Ratec
Rankd
No.
No.
Estimatedb
No.
No.
No.
Ratec
Springfield, MA
15
17
2.7
91
2,442
28
2,470
1,007
993
Stockton–Lodi, CA
30
33
4.6
64
1,461
14
1,475
706
704
99.9
Syracuse, NY
31
37
5.6
50
1,613
10
1,623
679
703
106.0
Tampa–St. Petersburg–Clearwater, FL
158.0
337
355
12.2
12
14,461
116
14,577
6,216
6,201
215.7
Toledo, OH
10
11
1.8
101
1,038
15
1,053
483
488
80.3
Tucson, AZ
43
46
4.6
65
2,485
11
2,496
1,070
1,069
107.1
Tulsa, OK
47
51
5.3
56
1,973
10
1,983
845
843
87.6
Virginia Beach–Norfolk–Newport News, VA–NC
141
175
10.2
18
6,157
66
6,223
2,581
2,534
148.4
Washington–Arlington–Alexandria, DC–VA–MD–WV
587
683
11.3
15
40,178
336
40,514
18,450
18,592
311.6
Silver Spring Division
97
107
8.4
—
4,029
27
4,056
2,231
2,260
179.2
Washington Division
122
490
576
12.1
—
36,149
309
36,458
16,219
16,332
347.1
Wichita, KS
16
17
2.7
90
1,033
2
1,035
447
445
69.7
Winston-Salem, NC
18
19
2.9
88
1,307
10
1,317
639
636
97.6
Worcester, MA–CT
11
12
1.3
105
2,463
22
2,485
1,162
1,149
123.8
Youngstown–Warren–Boardman, OH–PA
22
24
4.3
68
734
0
734
317
320
57.5
15,429
16,993
7.8
—
1,046,393
8,663
1,055,056
441,278
442,547
205.0
Metropolitan areas (population of 50,000–499,999)
2,419
2,653
4.6
—
119,268
836
120,104
52,744
52,751
91.1
Nonmetropolitan areas
1,374
1,500
3.2
—
64,254
441
64,695
28,808
28,787
62.1
19,350
21,300
6.6
—
1,236,088
9,992
1,246,080
525,796
527,069
164.7
Subtotal for MSAs (population of 500,000)
Totalf
Abbreviation: MSA, metropolitan statistical area.
Note. Because of the lack of U.S. census information for all U.S. dependent areas, table includes data for only the United States and Puerto Rico.
MSA definitions for this report can be found at http://www.census.gov/population/metro/.
Reported numbers less than 12, as well as estimated numbers (and accompanying rates and trends) based on these numbers, should be interpreted with caution because the numbers have underlying
relative standard errors greater than 30% and are considered unreliable.
a From the beginning of the epidemic through 2014.
b Estimated numbers resulted from statistical adjustment that accounted for reporting delays, but not for incomplete reporting.
c Rates are per 100,000 population.
d Based on estimated rate.
Vol. 26
e Counts of stage 3 (AIDS) classifications for the metropolitan divisions do not sum to the MSA total. MSA total includes data from 1 metropolitan division with population of <500,000.
f Includes persons whose county of residence is unknown. Because column totals for estimated numbers were calculated independently of the values for the subpopulations, the values in each column
may not sum to the column total.
Web Addresses for Reports of State and Local HIV Surveillance
Alabama
Alaska
Arizona
Arkansas
California
Chicago
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Guam
Hawaii
Houston
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Los Angeles
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
New York City
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Philadelphia
Puerto Rico
Rhode Island
San Francisco
South Carolina
South Dakota
Tennessee
Texas
U.S. Virgin Islands
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
http://www.adph.org/aids/Default.asp?id=984
http://www.epi.hss.state.ak.us/bulletins/catlist.jsp?cattype=HIV+(Human+Immunodeficiency+Virus)
http://www.azdhs.gov/phs/edc/odis/hiv-epidemiology/reports/index.php?pg=annual
http://www.healthy.arkansas.gov/programsServices/healthStatistics/Pages/stdHIVRegistry.aspx
http://www.cdph.ca.gov/data/statistics/Pages/OAHIVAIDSStatistics.aspx
http://www.cityofchicago.org/city/en/depts/cdph/provdrs/sti_hiv_aids.html
http://www.colorado.gov/pacific/cdphe/sti-and-hiv-data-and-trends
http://www.ct.gov/dph/cwp/view.asp?a=3135&q=393048
http://www.dhss.delaware.gov/dhss/dph/epi/disstatshiv.html
http://doh.dc.gov/service/hiv-aids-reports-and-publications
http://www.floridahealth.gov/diseases-and-conditions/aids/surveillance/index.html
http://dph.georgia.gov/georgias-hivaids-epidemiology-surveillance-section
http://dphss.guam.gov/content/hiv-surveillance-program
http://health.hawaii.gov/std-aids/hiv-aids/data-and-statistics/
http://www.houstontx.gov/health/HIV-STD/
http://healthandwelfare.idaho.gov/Health/FamilyPlanningSTDHIV/STDStatistics/tabid/393/Default.aspx
http://www.idph.state.il.us/aids/stats.htm
http://www.in.gov/isdh/23266.htm
http://idph.iowa.gov/PublicHealthData/reports
http://www.kdheks.gov/sti_hiv/epi_profiles.htm
http://chfs.ky.gov/dph/epi/hivaids/surveillance.htm
http://publichealth.lacounty.gov/dhsp/Reports.htm
http://new.dhh.louisiana.gov/index.cfm/newsroom/category/63
http://www.maine.gov/dhhs/mecdc/infectious-disease/hiv-std/data/hiv.shtml
http://phpa.dhmh.maryland.gov/OIDEOR/CHSE/SitePages/statistics.aspx
http://www.mass.gov/eohhs/gov/departments/dph/programs/id/hiv-aids/epi-profile/
http://michigan.gov/mdch/0,4612,7-132-2940_2955_2982_46000_46003--,00.html
http://www.health.state.mn.us/divs/idepc/diseases/hiv/hivstatistics.html
http://www.msdh.state.ms.us/msdhsite/index.cfm/14,0,150,134,html
http://health.mo.gov/data/hivstdaids/data.php
http://dphhs.mt.gov/publichealth/hivstd
http://dhhs.ne.gov/publichealth/Pages/dpc_hiv.aspx
http://dpbh.nv.gov/Programs/HIV-OPHIE/dta/Publications/HIV/AIDS_Surveillance_Program_(HIV-OPHIE)_-_Publications/
http://www.dhhs.nh.gov/data/index.htm
http://www.state.nj.us/health/aids/aidsqtr.shtml
http://nmhealth.org/data/infectious/20/
http://www.health.state.ny.us/diseases/aids/statistics/index.htm
http://www.nyc.gov/html/doh/html/living/std-hiv.shtml
http://epi.publichealth.nc.gov/cd/stds/figures.html
http://www.ndhealth.gov/hiv/
http://www.odh.ohio.gov/healthstats/disease/hivdata/hivcov.aspx
http://www.ok.gov/health/Disease,_Prevention,_Preparedness/HIV_STD_Service/HIV_STD_Statistics/index.html
http://public.health.oregon.gov/DiseasesConditions/CommunicableDisease/DiseaseSurveillanceData/HIVData/Pages/index.aspx
http://www.portal.state.pa.us/portal/server.pt?open=514&objID=557343&mode=2
http://www.phila.gov/health/AACO/AACODataResearch.html
http://www.salud.gov.pr/Estadisticas-Registros-y-Publicaciones/Pages/VIH.aspx
http://www.health.ri.gov/programs/hivaidssurveillance/
http://www.sfdph.org/dph/files/reports/default.asp
http://www.dhec.sc.gov/health/disease/stdhiv/surveillance.htm
http://doh.sd.gov/diseases/infectious/HIV-AIDS/
http://tn.gov/health/topic/STD-surveillance
http://www.dshs.state.tx.us/hivstd/reports/default.shtm
http://www.healthvi.com/programs/communicable-disease/index.html
http://health.utah.gov/epi/diseases/hivaids/surveillance/index.html
http://healthvermont.gov/prevent/aids/quarter/reports.aspx
http://www.vdh.virginia.gov/epidemiology/DiseasePrevention/DAta/
http://www.doh.wa.gov/DataandStatisticalReports/DiseasesandChronicConditions/HIVAIDSData.aspx
http://www.dhhr.wv.gov/oeps/std-hiv-hep/HIV_AIDS/Pages/HIVSurveillance.aspx
http://dhs.wisconsin.gov/aids-hiv/Stats/index.htm
http://www.health.wyo.gov/PHSD/hivsurveillance/index.html
Note. Electronic reports are not available for the following areas: American Samoa, the Northern Mariana Islands, and the Republic of Palau.
HIV Surveillance Report
123
Vol. 26
| File Type | application/pdf |
| File Title | HIV Surveillance Report 2014 |
| Subject | HIV, AIDS, HIV infection, surveillance report, surveillance data on HIV infection, diagnosed HIV infection, HIV prevention, HIV |
| Author | CDC/OID/NCHHSTP/DHAP/HICSB |
| File Modified | 2015-12-21 |
| File Created | 2009-01-27 |